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Abstract
Rupture of the anterior cruciate ligament (ACL) of the knee leads to chronic joint
instability and reduced range of motion while the long term results are marred by a high
prevalence of  degenerative joint  disease especially osteoarthritis.  Bundles of  collagen
threads have been widely investigated for the repair of torn ACL, but are limited by
insufficient  tissue ingrowth to  repopulate  and completely regenerate  these grafts.  We
have developed a novel in vitro method of characterizing fiber-based thread matrices by
probing their ability to promote tissue ingrowth from a wound margin as a measure of
their  ability  to  promote  repopulation  and  regeneration.  This  method  is  useful  in  the
optimization of thread scaffolds, and is sensitive enough to distinguish between subtle
variations in biopolymer chemistry and organization. Furthermore, this method was used
to  characterize  the  effects  of  crosslinking  on  the  cell  outgrowth  and  correlated  the
findings  with  the  mechanical  properties  of  collagen  threads.  The  results  suggest  that
crosslinking  is  required  to  achieve  sufficient  mechanical  properties  for  high  stress
applications  such  as  ACL  replacement,  but  regardless  of  technique,  crosslinking
attenuated  the  cell  outgrowth  properties  of  the  threads.  To  improve  the  regenerative
capacity  of  these  scaffolds,  novel  fibrin  microthread matrices  were developed with a
similar  morphology  to  collagen  threads  and  sufficient  mechanical  strength  to  be
incorporated  in  composite  thread  scaffold  systems.  These  fibrin  microthreads  were
loaded with FGF-2, a potent mitogen and chemotactic agent that works synergistically
with  fibrin  in  regulating  cell  signaling  and  gene  expression.  Increases  in  fibroblast
migration  and  proliferation  in  FGF-2-loaded  fibrin  threads  were  successfully
demonstrated with the concomitant promotion of oriented, aligned, spindle-like fibroblast
morphology.  These  results  suggest  that  fibrin-FGF-2  microthreads  have  distinct
advantages as a biomaterial for the rapid regeneration of injured tissues such as the ACL. 
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CHAPTER 1: OVERVIEW
Rupture of the anterior cruciate ligament (ACL) of the knee leads to chronic joint
instability and reduced range of motion while the long term results are marred by a high
prevalence of degenerative joint disease especially osteoarthritis.[1, 2]  The ACL has
limited  intrinsic  regenerative capacity  necessitating surgical  repair,  typically  utilizing
autografts which are limited by the need for a secondary surgical/donor site and still lead
to laxity or  possible secondary revision surgery.[3,  4]  Functional  tissue engineering
methods have been suggested as a means for achieving the ideal replacement of ACL,
however, no tissue engineered ACL has reached clinical trials due to a need for a readily
available cell source and  adequate biomaterial scaffolds.[5]  Furthermore, the research
and development of implants is in need of quantitative  in vitro and in vivo methods of
characterization.[5] Therefore, our goal is to develop and characterize biomaterials for
ligament regeneration.
PART I:  COLLAGEN THREADS FOR LIGAMENT REGENERATION
Threads composed of type I collagen, the native structural protein of tendons and
ligaments, have been widely investigated for ACL regeneration.  Bundles of threads or
fibers  extruded  from  dispersions  of  acid-insoluble  collagen  demonstrated  strengths
similar  to  native  tendon  and  ligament  tissues  with  crosslinking[6-17] and  induced
neotendon and neoligament  formation[15,  18-20] during  in  vivo implantation studies.
However,  functional  regeneration  of  collagen-based  ligament  grafts  was  impeded  by
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insufficient tissue ingrowth from the wound margin to completely repopulate the graft,
remodel, and regenerate the tissue.[9]  Furthermore, the cellular infiltration into the grafts
was inconsistent and difficult to control.[9]  Self-assembled type I collagen threads were
developed  with  an  increased biomimetic  substructure.   These  threads,  self-assembled
from solutions of acid soluble collagen, possess a fibrillar substructure marked by a D
periodic banding pattern[21] and mechanical properties comparable to native ligament
with  crosslinking.[22]  While  these  self  assembled  collagen  biomaterials  offer
considerable  promise  as  scaffolds  for  ligament  regeneration,  their  strength  and tissue
ingrowth characteristics for ligament regeneration have yet to be determined.
Therefore,  the  first  goal  of  this  thesis  was  to  develop  an  in  vitro method  to
quantitatively  characterize  tissue  ingrowth,  in  order  to  assess  the  utility  of  thread
scaffolds for ACL tissue regeneration.  
The development of a novel method for quantitatively characterizing tissue ingrowth
on the surface of  collagen thread scaffolds  is  discussed in Chapter  3.   Threads were
suspended across elevated platforms seeded with fibroblast-populated collagen lattices.
Fibroblast  populations  were  visualized  and  imaged  on  each  discrete  thread  and  the
distance to the furthest cell was measured at time intervals.  Evaluation of this metric,
termed cellular  outgrowth velocity,  showed similar  velocities  between self-assembled
collagen threads and native tendon controls.  Furthermore, increased  cellular outgrowth
was seen on self-assembled type I  collagen threads relative to the  first  generation of
collagen threads derived from insoluble collagen.  However, these rates were attenuated
on threads crosslinked by a dehydrothermal treatment (DHT) commonly employed for
increasing  in vivo  stability.   This  novel in vitro model  system allows examination of
tissue  ingrowth  from a  wound  margin  onto  biomaterials  to  determine  the  effects  of
various  cell  types,  matrix  materials,  and  surface  biochemistries  on  cell-matrix
interactions.  Ultimately, this assay will allow us to identify design parameters that will
be  most  effective  for  enhancing  the  rate  of  tissue  ingrowth  on  fiber-based  collagen
scaffolds for soft tissue regeneration. 
Chapter 4 describes the application of the quantitative method developed in Chapter
3 to crosslinking of collagen threads.   Collagen threads are commonly crosslinked to
increase  the  mechanical  properties  and  decrease  the  otherwise  rapid  in  vivo rate  of
degradation in a wound site.  The initial studies in Chapter 3 determined that the cellular
outgrowth velocity was attenuated after crosslinking with a technique selected because of
its  prevalence during prior  in  vivo studies.   We hypothesized that  implementation of
2
Chapter 1: Overview
alternate  crosslinking modalities  that  had yet  to  be tested on self-assembled  collagen
threads could increase thread stability without the concurrent decrease in tissue ingrowth
seen with DHT crosslinking.  The major limitations of collagen threads, including limited
tissue ingrowth, could thereby be circumvented.  The mechanical properties and cellular
outgrowth rates were measured  for self-assembled collagen threads utilizing the most
promising crosslinking strategies.  Although all the techniques investigated increased the
strength and decreased the rate of degradation, they also subsequently decreased the in
vitro rate of tissue ingrowth.  These findings indicate that there remains a need to develop
a  scaffold  material  that  both  provides  mechanical  stability  and  promotes  new tissue
ingrowth.  To meet these additional requirements, novel biopolymer microthreads were
developed to promote rapid tissue ingrowth and tissue regeneration in conjunction with
collagen threads.
PART II: FIBRIN THREADS FOR LIGAMENT REGENERATION
While self-assembled collagen threads structurally and biochemically mimic native
tendon and ligament, our studies suggested that when crosslinked they may not elicit a
response  that  best  promotes  the  spatially  and  temporally  complex  process  of  tissue
regeneration.   A  key  initial  step  of  tissue  regeneration  is  the  deposition  of  a  fibrin
provisional matrix that fills the wound space and promotes fibroblast infiltration from the
wound margin.  Fibrin matrix regulates cell migration, proliferation, and gene expression
through integrin signaling[23-25] and through the localization of matrix bound signaling
proteins  resulting  from  fibrin's  high  binding  affinity  for  growth  factors,  especially
fibroblast growth factor-2 (FGF-2).[26, 27]  We hypothesize that the development of a
fibrin biomaterial with a thread-like structural morphology would promote the cellular
alignment seen on fiber scaffolds[28] with sufficient mechanical stability to allow for
integration with other  thread scaffolds  such as  collagen.   Furthermore,  fibrin  threads
incorporating FGF will deliver growth factors and stimulate migration and proliferation
to ultimately guide wound healing.  
Therefore, the second goal of this thesis was to develop fibrin microthreads with a
comparable  morphology to collagen threads that can be combined with other matrices
for  ligament  tissue  regeneration.   Ultimately  these  microthreads  will  guide  wound
healing spatially and temporally, through  aligned regeneration, growth factor delivery,
and variable matrix signaling.
3
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The development of fibrin microthreads is described in Chapter 5, focusing on the
optimization  of  production  parameters  for  consistent  structural  morphology  and
maximum tensile strength.  Fibrin microthreads were produced by co-extruding solutions
of 70mg/ml fibrinogen and 6 U/ml thrombin through small diameter polyethylene tubing
using  an  automated  extrusion  device.   Fibrin  microthreads  averaged  55-65  μm  in
hydrated  diameter  and  achieved ultimate  tensile  strengths  approaching  4.5  MPa.   In
conjunction with surface structural analyses, these results demonstrate the development
of  fibrin  microthreads  with  comparable  morphological  properties  to  the  previously
investigated collagen threads.
The potential of fibrin microthreads to regenerate tissues such as the ACL through
aligned regeneration and growth factor delivery is investigated in Chapter 6.  Fibroblast
growth factor (FGF-2) was coextruded into fibrin microthreads and investigated for the
ability  to  increase  cell  proliferation  and  cellular  outgrowth.   Fibroblasts  cultured  on
bundles of fibrin microthreads with FGF-2 showed increased proliferation, while the rate
of  cellular  outgrowth  increased  on  discrete  fibrin  microthreads  containing  FGF-2.
Furthermore,  cells  cultured  on  bundles  and  discrete  fibrin  threads  demonstrated
alignment along the long axis of the threads regardless of FGF incorporation.  Thus, the
increase  in  alignment  over  flat  substrata  was  attributed  to  contact  guidance  and  the
cylindrical fiber morphology.  
CONCLUSIONS
Collagen  and  fibrin  biopolymer  microthreads  are  promising  technologies  for  the
repair of torn ACLs.  This thesis utilized mechanical testing and novel  in vitro cellular
techniques for the evaluation of various biopolymer threads for their potential application
to  the  repair  of  torn  ACL.   Second  generation,  self-assembled  collagen  threads
demonstrated improved properties over the first generation of insoluble collagen threads.
These  collagen  threads  attain  strengths  capable  of  withstanding  the  initial  loading
environment of the ACL with crosslinking and have demonstrated some success during
in vivo implantation studies.  However, the regenerative capabilities of these biomimetic
threads are ultimately hampered by the current crosslinking techniques required.
The  paradigm  shift  towards  the  development  of  fibrin  biopolymer  microthreads
allows  for  the  continued  use  of  aligned  biomimetic  structures,  with  the  simple
incorporation  of  growth  factors  and  the  potential  of  early  wound  healing  integrin
signaling.  Fibrin microthreads have morphologically cylindrical geometries comparable
4
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to collagen threads with diameters in the 50-100 μm range and promote cell alignment.
Furthermore these threads are orders of magnitude stronger than fibrin gels, and can be
readily  incorporated  into  other  fiber  or  thread  matrices.   The  growth  factor  FGF-2,
commonly  found  matrix  bound  and  shown  to  be  a  cofactor  with  fibrinogen,  was
incorporated into fibrin threads and lead to increased fibroblast proliferation and cellular
outgrowth.   Ultimately,  these  results  suggest  that  composites  of  collagen  and  fibrin
biopolymer microthreads could be used to control the spatially and temporally complex
process of tissue regeneration to improve the repair of torn ACLs.
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CHAPTER 2: BACKGROUND
Ligaments in the human body are aligned bundles of dense connective tissue linking
adjacent bones to stabilize and guide joint motion.  In connecting long bones, ligaments
often present as white and shiny bands,  sheets,  or  bundles anchored directly through
fibrocartilage  insertions  to  bones.   Of  particular  interest,  due  to  their  propensity  for
injury,  are  the  four  ligaments  of  the  knee,  especially  the
anterior cruciate ligament (ACL).
2.1 ANTERIOR CRUCIATE LIGAMENT
(ACL)
2.1.1 Healthy ACL
The ACL is one of two decussating ligaments of the knee
acting as a major joint stabilizer connecting the anterior side of
the tibia at the intercondylar eminence to the medial surface of
the lateral femoral condyle, well posterior to the longitudinal
axis of the femoral shaft (Figure 2.1).[2]  In general the ACL
accounts for approximately 85% of the resistance to anterior
displacement of the tibia when the knee is at 90 degrees flexion
and neutral rotation.[2, 3] The general mechanical properties ofFigure  2.1:  Ventral  view
of a right knee joint[1]
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the ACL are summarized in Table 2.1, however, the biomechanical role of the ACL in the
knee is more complex than a simple rope connecting the tibia and femur.   The ACL
consists of two bundle subunits which become differentially taut  during full  range of
motion[4] leading to forces of about 300 N during walking alone (Figure 2.2).[5]  The
anteromedial  subunit  of  the  ACL is  primarily  tight  throughout  extension  and  tighter
during  flexion,  while  the  posterolateral  subunit  becomes  relaxed  while  the  knee  is
flexed.[6]
The  ACL is  an  intercapsular  ligament  covered  by  a  thin  layer  of  synovium.[7]
Nutrients are supplied to the ACL from the middle genicular artery that gives rise to
periligamentous vessels that ensheath the ACL within the synovial membrane.[8, 9]  The
central  portion  of  the  ACL is  considerably  less  vascular  than  the  proximal  or  distal
portions while the osseous-ligament attachments are largely avascular.[8, 9]  The poor
vascularity of the tissue is linked in part to the demonstrably lower healing potential of
the ACL in comparison to other tendons and ligaments (see 2.1.1.3, pg. 13).[10]  
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Figure  2.2: Forces transmitted to the cruciate ligaments, the collateral ligaments,
and the posterior capsule of the knee over one cycle of normal level walking. The
knee ligaments were more heavily loaded in stance than in swing. The ACL bore the
largest overall force with a peak transmitted force of 1/2 body weight at 15% gait
cycle.[5]
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2.1.1.1 ACL Composition
Matrix
The  ACL,  like  most  ligaments,  is  composed  predominantly  of  type  I  collagen,
including  upwards  of  80%  of  the  dry  weight,[11,  12] arranged  in  a  highly  aligned
hierarchical structure.   Type I collagen, is a long rod-like protein comprised of three
chains of the approximately 1000 amino acid repeat of glycine-X-Y where X and Y are
often proline and hydroxyproline, respectively.[13]  The abundance of glycine, a residue
with an extremely small non-polar R-group, and the three amino acid repeat allows for
the tight 100 nm pitch width coiling of the three chains into a left-handed triple helix
stabilized  by  hydrogen  bonds.[14] The  soluble  protein,  assembled  intracellularly  and
packaged into vesicles, initially termed procollagen, is only 1.5 nm in diameter, but 290
nm in  length  with  short  10  and  15  nm non-coiled  telopeptide  ends.   During  matrix
synthesis,  cells  secrete  procollagen  into  the  extracellular  matrix,  specific  proteinases
cleave the telopeptide ends, and the resulting collagen molecules self-assemble laterally
into tightly packed arrays of collagen fibrils.  [15]  The molecules within the arrays are
packed in a quarter staggered manner leading to the collagen fibril characteristic 67 nm
striated banding pattern visible after heavy metal staining and electron microscopy.[15]
Adjacent molecules in these arrays are crosslinked for strength and stability through lysyl
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Table 2.1: Geometry and mechanical properties of normal ACL
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hydrosylysyl oxidation by the enzyme lysyl oxidase.[16]  These fibrils are on the order of
10-300 nm in diameter but can be up to hundreds of microns long.[13, 15]  The fibrils are
further assembled into larger collagen fibers or fascicles (20-200  μm in diameter) that
group  to  form the  visible  ligament  structure.   The  ACL has  an  additional  levels  of
structural complexity as the fascicles twist 180o from the femoral to tibial attachments.[8,
13]
While consisting of a large percentage of type I collagen, the matrix of the ACL is
comprised  other  constituents  including  Type  III  collagen  and  glycosaminoglycans
(GAGs).   Type III  collagen is  a fibril  forming collagen with three identical  α chains
connected by intramolecular disulfide crosslinks.[13]  This particular collagen is typically
localized to the loose connective tissue in the regions between type I collagen bundles.[8]
While there is approximately 7.3 times more type I collagen than type III collagen,[12] it
has  been recently  suggested that  the type III  collagen molecule  is  more  flexible  and
therefore might alter the elastic modulus of collagen fibrils.[17]  Ligaments contain two
to four times as much GAG as tendons approaching 10 mg hexosamine/g dry tissue[11]
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Figure  2.3: A tendon or ligament is comprised of hierarchically aligned type I collagen molecules
packed into larger scale fibrils, fibers and fascicles as well as a small percentage of fibroblasts.[15]
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including  chondroitin sulfate, hyaluronic acid, and dermatan sulfate.[18]  Furthermore,
the ACL has been found to contain more type III collagen and GAGs than the medial
collateral ligament.[19, 20]  
Cells
The  ACL  also  contains  a  small  percentage  of  ligament  fibroblasts  with
morphological  properties  similar  to  fibroblasts  from other  tissues  such  as  tendon  or
dermis, but with cellular characteristics that vary even within the ligament superfamily.
Ligament  fibroblasts  are  elongated  spindle  shaped  connective  tissue  cells  with  small
diameter processes attaching and extending between collagen fibrils while connecting in
a  vast  three-dimensional  network  to  each  other  through  gap  junctions.[7,  21,  22]
Ligament  fibroblasts  are  considered  phenotypically  different  from  tenocytes  with
increased metabolic activity, more plump cell nuclei,[11] and slower proliferation.[23]
Similar  decreases  in  proliferation  and  matrix  synthesis  were  found  when  comparing
ligament fibroblasts to dermal fibroblasts.[24]  Furthermore, fibroblasts isolated from the
ACL  have  decreased  migration,[25] proliferation,[26] and  collagen  synthesis[27]
compared to fibroblasts from the medial collateral ligament (MCL).  These characteristics
of ACL fibroblasts have been correlated to the poor intrinsic healing capacity of the ACL
compared with tendons or the MCL.  However, the intraarticular synovial environment of
the ACL is linked to the decreased healing because the nutrient and metabolite exchange
for ACL fibroblasts is increasingly dependent on diffusion[7] (See Blood Supply above
and ACL: Injury and Healing below).  
2.1.1.2 ACL Injury and Repair
Clinical Significance
In  2003,  more  than  9.5  million  people  visited  orthopaedic  surgeons  with  knee
problems, including a high prevalence of ACL injury.[28]  These ACL injuries occur
most  frequently  as  a  result  of  a  non-contact  deceleration  or  landing  situation  that
produces valgus twisting of the knee during athletic activities.[29-32]  Complete tears of
the ACL heal very poorly, are painful, and lead to joint instability, increased occurrences
of  meniscal  tears  and  early  osteoarthritis.[33-35]  Surgical  intervention  by  means  of
complete  ACL  reconstruction  has  reduced  the  frequency  and  severity  of  these
complications.  However, the long term results of the ACL injury are still marred by a
high prevalence of degenerative joint disease (DJD), including reports of as many as 88%
of patients demonstrating radiological signs of DJD[36] especially osteoarthritis[37] in
both men[38] and women[39] regardless of the surgical repair technique.  Patients with
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reconstructed ACLs also still have increased occurrences of meniscal damage,[40, 41]
biomechanical  alterations  to  their  normal  gait,[42,  43]  as  well  as  reduced  range  of
motion[36]  and chronic instability.[44] Surgical reconstructions of the ACL occur with
increasing frequency, with recent estimates ranging from 100-200,000 occurring annually
in the United States alone [2, 12, 45-48] that cost a reported five billion dollars.[12, 45,
48]  While other orthopedic injuries in non-geriatric patients, such as ankle sprains and
tibia fractures, have decreased more than 85% in the last 15 years, knee ligament injuries
have increased 172%[49]  with an incidence rate of about 1 in 3000 Americans.[50]
Surgical Repair
Patellar or hamstring tendon local autografts are currently considered the standard
for ACL replacement because of their size, strength, and availability.[7, 46, 51]   During
surgical revision, the medial third of the patellar tendon including the tibial and patellar
bony attachments is resected.  This autograft is then most commonly inserted through
drilled  femoral  and  tibial  tunnels  and  secured  with  interference  screws  (Figure  2.4).
Despite relative success compared with non-surgical treatments, the long term success
rates still do not exceed 85%[46] and studies have shown these autografts fail to reach
strengths comparable to native ACLs with strength deficits measured at greater than 34%
when  compared  to  the  contralateral  limb  after  rehabilitation.[52]  These  procedures
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Figure 2.4: The current surgical repair strategy for a torn ACL included the the
use of a bone-patellar tendon-bone (BPTB) autograft.  The BPTB autograft is
inserted through a drilled tibial tunnel, into the femoral tunnel, and secured with
interference screws.(image courtesy of Nucleus Communications, 2002)
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require a secondary surgical and donor site to retrieve autograft tissue that is of limited
quantity,  and  even  after  repair  often  lead  to  joint  laxity  as  well  as  patellar  tendon
abnormalities.[46, 51, 53]  Furthermore, due to complications from the first surgery or
reinjury, between 10-15% of these procedures require secondary revision surgery with
successful results occurring less than 60% of the time.[51]  Although a feasible solution,
allografts, mostly acquired from cadavers, could potentially transmit disease[54] or elicit
an  undesired  immunologic  response.  It  has  also  been  suggested  that  these  allografts
cannot be sterilized without altering the mechanical properties of the tissue.[47]
2.1.1.3 ACL Healing
Wound healing of the ACL is considered to occur following principles similar to
most other soft connective tissues (see Stages of Ligament Wound Healing 2.1.1.3, pg.
14), however the ACL specifically demonstrates limited healing capacity.  This limited
healing capacity is seen during investigations both in comparison to tendons as well as in
contrast to other ligaments of the knee such as the MCL.  The phenomenon has been
attributed to wide variety of causes including intrinsic cell deficiencies, the intraarticular
synovial environment, limited blood supply and complete separation of the torn ligament
ends.  
Variations in ACL ligament fibroblasts have been seen in comparison to tenocytes,
dermal  fibroblasts,  mesenchymal  stem  cells  and  MCL  fibroblasts.  Van  Eijk  et  al.
investigated  multiple  cells  sources  for  properties  and  parameters  of  importance  to
ligament tissue engineering.  They found that both mesenchymal stem cells and dermal
fibroblasts  proliferated more rapidly and produced higher  collagen content  than ACL
fibroblasts.[24]  Bellincampi et  al.  found increased survival  of dermal  fibroblasts over
ACL ligament  fibroblasts  during  intraarticular  implantation  studies.[55]   Those  same
researchers  found ACL fibroblast  to  be  more  plump with  decreased  proliferation  on
collagen threads compared with patellar tenocytes.[23]  Differences have also been seen
with regard to response of ligament fibroblasts to growth factors[56, 57] and adhesive
strength.[58-60]  Furthermore,  several  studies  have  reported  decreases  in  migration,
proliferation,  collagen  synthesis,  and  response  to  growth  factors  of  ACL  fibroblasts
compared to MCL fibroblasts.[25, 26, 61-63]  
Other researchers have suggested that the environment may be the limiting factor in
ligament regeneration rather than intrinsic cellular characteristics.  Being an intraarticular
ligament, the vascularity of the ACL is less than that of extraarticular ligaments such as
the MCL or tendons, which are attached to highly perfused muscles.[8-10]  Furthermore,
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it has been suggested that the synovial environment of the ACL limits diffusional nutrient
exchange,  particularly  important  to  the  least  vascularized  central  portion  of  the
ligament.[7, 9]   In a recent review, Patrigliano et al. suggested that disruption of the
synovial sheath precludes the formation of a local hematoma that is the foundation for
chemotactic  cytokines  and  growth  factors,  leading  to  the  paucity  of  healing.[64]
Corroborating  evidence  for  this  hypothesis  is  supported  from  work  in  a  ligament
transection study that demonstrated partial healing of ligament where an intact synovial
sheath facilitated the deposition of a fibrin mesh.[65]
Stages Of Ligament Wound Healing
The stages of ACL wound healing are considered similar to most other soft connect
tissues and most information on ligament wound healing is garnered from work with the
more consistently healing and easily accessible MCL.[66]  Although the principles are
the same, the number and delineations of these overlapping stages are arbitrary and vary
by author, with one example in Table 2.2 and another described in  stages as follows:
PHASE I:  HEMORRAGE AND INFLAMMATION (0-72 HOURS)
After  a  ligament  is  torn,  blood  vessels  rupture  filling  the  discontinuity.   Blood
coagulation and platelet aggregation follow rapidly producing a blood clot to reestablish
hemostasis.   The  trapped  platelets  release  a  battery  of  growth  factors,  most  notably
platelet-derived  growth  factor  (PDGF),  transforming  growth  factor  β (TGF-β),  and
insulin-like growth factor (IGF-I and IGF-II) that promote inflammation.[67]  The blood
clot  matrix,  formed  largely  of  fibrin  and  fibronectin  (see  2.1.1.3,  pg.  13),  acts  as  a
provisional scaffold, soaking up cytokines and growth factors while trapping leukocytes
and lymphocytes within several hours.[68]  By 24-48 hours, inflammation begins with
the arrival of macrophages that phagocytose necrotic tissue and further secrete growth
factors that promote granulation tissue formation.[30] 
PHASE II: REPOPULATION AND PROLIFERATION(3-7 DAYS)
By approximately  day  three,  fibroblasts  are  recruited  into  the  fibrin  provisional
matrix,  induced  by  a  lack  of  cell-cell  contacts,  matrix  signaling,  and  chemotactic
attractants released during the inflammation stage.[68]  The fibroblasts migrate from both
the  neighboring  tissue  as  well  as  the  systemic  circulation  and  proliferate  within  the
matrix,  ultimately  synthesizing  new  extracellular  matrix  including  collagens  and
GAGs.[30]  These  cells  then begin  to  produce  large  amounts  of  type  III  and type  I
collagen in response to the milieu of growth factors, particularly PDGF and TGF-β.[67]  
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PHASE III: REMODELING AND REGENERATION(1-8 WEEKS)
The final phase of ligament wound healing is marked by the long term remodeling of
the ECM and can last many months.  The migrated fibroblasts in the wound gradually
switch from migratory phenotype into a profibrotic myofibroblast phenotype, marked by
the presence of a smooth muscle actin, that is responsible for contracting the wound.[69-
71]  With  time,  the  fibrin  provisional  matrix  is  slowly  degraded  and  replaced  with
increased type I  collagen content  and density,  while  the  high cellularity decreases as
many  of  these  fibroblasts  apoptose.[72]  Eventually  GAG  content  increases  and  the
matrix becomes longitudinally oriented, although this scar tissue will never attain normal
morphological characteristics and mechanical properties.[30]
2.1.1.4 ACL Regeneration
Due to the poor regenerative capacity of the ACL and the suboptimal results of the
standard  surgical  repair  techniques  with  autografts,  many  researchers  have  suggested
investigating the regeneration of ACL tissue utilizing tissue engineering techniques.[6,
12, 30, 47, 64]  In general, tissue engineering applies the use of a degradable scaffold,
cells, and growth factors, in any combination to promote the complete regeneration of an
injured or  damaged tissue.   Specifically  for  ligament  regeneration,  the  ideal  scaffold
would  be  designed  to  demonstrate  mechanical  properties  similar  to  native  ACL and
slowly degrade  under  natural  pathways  matching the  rate  of  new tissue  synthesis  to
ultimately regenerate the damaged tissue without further surgical revision.  The scaffold’s
compositional, degradative, and mechanical properties are considered to dictate the mass
transport and mechanotransduction at both a cell and tissue scale.[12]  Furthermore, an
ideal scaffold should cause minimal inflammatory response, be porous, and promote the
formation of neoligament tissue.[47]   
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Table 2.2: The phases of ligament wound healing.[67]
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Currently, no tissue engineered ACLs have yet reached clinical trials due to various
reasons.   Most  researchers  agree  that  current  scaffolds  lack  appropriate  mechanical
properties.   The strength, stiffness,  and viscoelasticity of engineered ligaments do not
match those of the healthy ACL and cannot withstand the complex in vivo loading.[6, 12,
30,  47,  73]  Others  mention  the  a  lack  of  a  readily  available  cell  source.[12,  24]
Furthermore,  the  blood  supply  is  disrupted  after  injury  and  many  consider  the
regeneration to be too slow.[6,  73]  Also of major importance is  the development of
appropriate scaffolds that regulate cell stimuli to facilitate cell adaptation.  Ideally the
system should provide temporal matrix and cytokine stimulation dictated by the phases of
regeneration (see Stages of Ligament Healing  2.1.1.3, pg.  14).[12, 64]  In general, the
field of ligament tissue engineering also lacks quantitative in vitro and in vivo methods of
characterization.[12]  The implications of matrix mediated signaling on cell function in
tissue engineered constructs has yet to be investigated.
2.2 THREAD SCAFFOLDS FOR ACL REPAIR
Fiber  or thread-based scaffolds have significant advantages as scaffolds for  ACL
regeneration including a natural structural homology to native tissues (see  2.1.1.1 ACL
Composition, pg  9 ) as well as an ability to be woven or braided into larger, stronger,
controlled  porosity  structures.[47]  Additionally,  studies  have  shown  that  contact
guidance  on  cylindrical  substrata  less  than  100  μm  facilitates  the  alignment  and
orientation of cells.[74]  Therefore, fiber-based scaffolds dominate current research for
ACL  regeneration.   However,  the  materials  investigated  are  quite  diverse.   These
materials  fall  into  two
categories: Synthetic polymers
threads made from degradable
plastics  and  biopolymer
threads  derived  from  native
ECM structural proteins.
2.2.1 Synthetic Polymers
A wide range of polymer-
based  synthetic  fiber  grafts
including  polypropylene,
polyethylene,
polytetraflouroethylene
(PTFE),  and  polyester  were
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Figure  2.5:  SEM  of  polyester  fibers  visualized  after  removal
from an explanted ACL prosthesis demonstrating fracture and
axial splitting.[75]
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manufactured and FDA approved for ACL replacement between the mid 1970’s and the
late 80’s.  These polymer grafts are no longer used because orthopedic surgeons reported
high rates of failure due to flexural and torsional fatigue, leading to axial failure as well
as structural  changes and loss of integrity due to unpredictable tissue infiltration.[75]
Recently,  researchers  have investigated a host  of  braided or  woven degradable fibers
including  poly  desaminotyrosyl-tyrosine  ethyl  carbonate  (poly  DTE  carbonate),[76]
polydioxanone  (PDS),[77] and  poly  L-lactic  acid  (PLLA),[78] with  the  intention  of
developing  a  tissue  engineered  scaffold  with  controlled  porosity  and  degradation  to
match tissue ingrowth and regeneration.  Synthetic grafts, however, are limited by the
formation  of  acidic  bi-products  during  degradation  with  the  possibility  of  long-term
undesirable immunogenic response by the host tissue.  Furthermore, these scaffolds have
mechanical impediments including abrasive wear, stress shielding, and creeping.[75]
2.2.2 Biopolymer Threads
Biopolymer threads are materials reconstituted from basic ECM structural proteins
found in nature, such as collagen and silk fibroin.  These biomimetic materials not only
provide the geometric advantages of fiber and thread matrices, but with the additional
advantage  of  compositional  homology.   Biopolymer  threads  typically  degrade  under
physiologically  normal  pathways  that  produce  no  acidic  byproducts  and  are  either
reprocessed by the body or excreted.  Furthermore, these proteins in certain cases provide
biochemically relevant cell adhesion and signaling.  Of this group of biopolymer threads,
the most highly investigated are threads composed of type I collagen.
2.2.2.1 Collagen Threads
Threads composed of type I collagen, the native structural protein of soft connective
tissues (), have been widely investigated for repair of torn tendons and ligaments.  These
collagen threads or fibers are typically produced by extrusion through small  diameter
tubing and bundled in large sets to form ligament prostheses.  Research into the in vitro
mechanical  properties  and  degradation  profiles  of  collagen  threads  has  successfully
demonstrated  strengths  comparable  to  native  tendon  and  ligament  tissues  with
crosslinking (Table 2.2).  Studies of the cellular response on collagen threads  in vitro
have found that cells will attach and proliferate on thread bundles,[23, 55, 79] the threads
did not lose strength during 20 days of culture with cells,[80, 81]  and cells actually
increased  the  strength  of  collagen  thread  bundles.[80,  81]  In  vivo,  these  scaffolds
demonstrate  promising  results  inducing  neotendon  and  neoligament  formation  with
varying  degrees  of  success  (Table  2.2).   Overall,  thread  matrices  that  degraded  too
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slowly,  typically in excess  of  one year,  showed lower neo-ligament  regeneration and
advanced  signs  of  long  term  immunogenicity.[82,  83]  In  general,  the  complete
regeneration  of  collagen-based  ligament  grafts  was  impeded  by  insufficient  tissue
ingrowth  from  the  wound  margin  to  completely  repopulate  the  graft,  remodel,  and
regenerate  the  tissue  while  the  cellular  infiltration  was  inconsistent  and  difficult  to
control.[23]
Self-Assembly Of Type I Collagen Threads
The spontaneous self-assembly of collagen molecules  in vitro  can be exploited to
develop novel  collagen threads with improved properties.   Collagen threads are most
commonly produced from insoluble aggregates of collagen derived from blended, highly
crosslinked tissues such as tendon and corium.  However, it has been well established that
solutions of soluble type I collagen self-assemble into fibrils possessing the characteristic
67  nm  repeat  through   thermodynamically  favorable  interactions  between  collagen
molecules that  allow for  increased water  mobility by phase separation.[15,  84]  This
knowledge  was  leveraged  to  develop  novel  self-assembled  collagen  threads  with
improved properties over those extruded from insoluble collagen aggregates.[85]  The
ultimate tensile strength and elastic modulus of self-assembled threads were found to be
comparable  to  native  rat  tail  tendon  fibers  and  greater  than  reconstituted  insoluble
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Figure  2.6: Schematic  model of  in  vitro collagen self-assembly.   Collagen
molecules initially assemble linearly and laterally resulting in the formation
of staggered dimers.  Once formed, these approximately 4 nm subunits fuse
laterally and longitudinally[15]  
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collagen  threads.[86]  Furthermore,  these  self-assembled  threads  posses  a  fibrillar
substructure marked by the D periodic banding pattern seen with electron microscopy as
well as fibril diameters comparable to those seen in the early stages of development.[85]
The results of these studies suggest that these threads are a promising scaffold material
for the development of a second generation ligament replacement.
Collagen Crosslinking
Numerous crosslinking strategies have been investigated for collagen thread matrices
to  improve  the  mechanical  stability  of  these  materials.    While in  vivo crosslinking
between  collagen  molecules  occurs  via  the  enzyme  lysyl  oxidase,  collagen  threads
produced  in vitro must  be crosslinked  post-extrusion to increase the macromolecular
protein  stability.   These  various  collagen  crosslinking  methodologies  employ  either
chemical  or  physical  techniques  to  alter  the  proteins  stability  by  inserting  addition
intermolecular and intramolecular crosslinks between adjacent collagen molecules.  The
positive  mechanical  outcomes  of  these  processes  are  materials  that  demonstrate  a
decreased proteolytic degradation rate, increased stiffness, and increased tensile strength.
Numerous techniques that have been employed to add crosslinks to collagen matrices
through either physical or chemical means .  Specifically, collagen threads have been
chemically crosslinked using gluteraldehyde, cyanamide, 1-3 ethyldimethyaminopropyl
carbodiimide (EDC), and  Nordihydroguaiaretic acid  (NDGA)(see  Table 2.3).  Physical
crosslinking techniques including dehydrothermal treatment (DHT) and exposure to UV
light  (UV)  have  also  been  employed  in  order  to  achieved  the  desired  mechanical
properties without the addition of possibly cytotoxic reaction products to the matrices
(see Table 2.3).  While each of these techniques has advantages and disadvantages, the
effect of these crosslinking techniques on self-assembled collagen threads and their effect
on cell matrix interactions is still unclear.
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2.2.2.2 Other Novel Biopolymer Threads
Although collagen threads have typically been the mostly highly investigated thread
for  ACL  regeneration,  researchers  have  recently  begun  investigating  alternatives
including  silk  and  chitosan  hybrid  co-polymers.   Research  by  Altman,  Kaplan,  and
colleagues has investigated the use of spider silk for ACL repair because of the inherent
mechanical strength of the material.  Bundles of twisted silk threads have mechanical
strengths large enough to withstand normal ACL loading,[87] and have been modified by
coating in RGD sequences to improve attachment and proliferation on the matrices  in
vitro.[88]  While these materials have demonstrated some success  in vitro,  silk based
biomaterials necessitate the removal of sericin to avoid biocompatibility issues, can lead
to encapsulation when proteolytic attack by macrophages and giant cells is aborted, and
have possible sensitization or allergic responses in certain individuals.[89]  Furthermore,
these materials have markedly slow in vivo degradation profiles that may not be suitable
to  match  the  rate  of  neoligament  synthesis  for  tissue  regeneration  applications.[89]
Investigators  have  also  begun  to  examine  chitosan[90,  91] and  chitosan/hyaluronan
hybrids[92,  93] because  of  the  advantageous  cell  adhesive  properties  of  these
matrices.[94]    Chitosan, a cationic polysaccharide, was mixed with alginate, an anionic
polysaccharide, to make polyion threads with tensile strengths reaching those necessary
for  applications  in  ligament  regeneration.[90,  91]   However,  these  ultimate  tensile
strengths  were  determined  dry,  while  the  hydrated  strength  has  been  estimated  to
decrease greater than 40%.[90]  Furthermore the in vivo degradation profiles are unclear
while  the  strength of  the  matrices  are  determined by calcium ions which are  readily
removed in vivo causing rapid degradation and loss of strength.[90]
2.3 EXTRACELLULAR MATRIX (ECM)
The ECM makes up the structural environment surrounding connective tissue cells,
providing the bulk of the mechanical properties of connective tissue.  ECM also asserts a
strong  influence  on  cell  shape,  growth,  metabolism,  migration,  differentiation  and
ultimately in cell fate (Figure 2.7).  Although collagens make up a significant portion of
healthy  connective  tissue  (see  ACL  Composition  2.1.1.1,  pg.  9),  the  ECM  contains
numerous  other  families  of  molecules  that  play  significant  roles  in  cell  signaling
including proteoglycans, GAGs, and other matrix glycoproteins such as fibronectin and
tenascin.   Furthermore,  during  wound  healing,  a  strikingly  different  ECM  milieu
surrounds a cell signaling it to slowly remodel and regenerate healthy tissue.  This matrix
signaling occurs largely through cell to matrix connections called integrins.
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2.3.1 Integrins and Matrix Signaling
Integrins are heterodimeric transmembranous proteins that anchor a cell to the ECM
and connect the matrix outside the cell to the cytoskeleton and ultimately regulate gene
expression.  Integrins consist  of two subunits,  α and  β,  noncovalently bound to each
other, that in various combinations have different binding and signaling specificity.[95]
Both subunits have long extracellular domains, a transmembrane portion, and often short
cytoplasmic tails  that  attach to  the cytoskeleton,  enabling integrins  to  act  as  the link
between the ECM and cytoskeleton.[95]  As integrins bind to the ECM, they cluster and
associate  with  signaling  complexes  that  promote  the  assembly  of  cytoskeletal  actin
filaments.[96]  In a positive feedback loop, this reorganization of actin filaments, in turn,
increases integrin clustering leading to large aggregates called focal adhesions that can be
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Figure 2.7: ECM control of cell signaling.  The matrix, through transmembranous integrin receptors,
sends signals to the nucleus that regulate transcription and gene expression.  The changes in gene
expression ultimately alter cell fate processes such as differentiation and migration.[96b]
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visualized  with  immunofluorescence  microscopy.[96]  Consequently,  the  high  local
concentrations of integrins and associated signaling proteins facilitate the regulation of
intracellular signaling pathways ultimately leading to changes in gene expression.[96]  
In  this  manner,  cells  actively  attach  to  the  matrix,  modify  the  matrix,  and  are
regulated by the matrix simultaneously.  The ability of a cell to make these anchorages
dictate  whether  it  will  migrate,  proliferate,  differentiate,  or  synthesize  matrix.[97]
Furthermore, as a cell modifies the surrounding ECM, the surrounding ECM alters the
cell  signaling  in  a  continually  changing  feedback  loop  termed  dynamic  reciprocity.
Dynamic reciprocity plays a critical role in modulating fibroblast function in the spatially
and temporally complex environment of a healing wound.
2.3.2 ECM in Wound Healing
During  wound  healing,  the  ECM  acts  not  only  as  structural  support,  but  helps
actively direct  and guide wound healing.   A provisional  matrix  composed largely of
fibrin, fibronectin, and a host of growth factors (see Fibrin Provisional Matrix 2.4.1, pg.
24) is initially formed in the wound and gradually replaced with new ECM components
such  as  type  I  collagen  and  type  III  collagen.   All  of  these  components  have  been
implicated in directing cell migration, proliferation, and differentiation through matrix
signaling.  Fibroblasts migrate into the wound attaching readily to fibronectin bound to
fibrin[98-100] and likely fibrin itself.[68, 101]  Once the fibroblasts have repopulated the
wound, they switch from a migratory phenotype to a profibrotic phenotype marked by the
drastic  increase in collagen production[71] as  well  as  TGF-β  production,[102] which
concurrently stimulates increased collagen production[103, 104] in a positive feedback
loop.[68]  However,  as  the  fibrin  matrix  is  degraded  and  replaced  with  the  newly
synthesized collagen, the fibroblasts cease collagen production despite the persistence of
TGF-β expression.[102]   Furthermore,  collagen  matrix  has  been  demonstrated  to
suppress  fibroblast  proliferation[105]  while  fibrin  matrices  show  no  effect  on  the
proliferative or matrix synthesizing potential of fibroblasts.[68, 102]
2.4 FIBRIN, FGF-2, AND THE PROVISIONAL MATRIX
2.4.1 Fibrin Provisional Matrix
The provisional matrix acts not only as hemostatic plug to prevent blood loss, but
also promotes granulation tissue formation by providing a scaffold for the contact guided
migration and proliferation of fibroblasts into the wound and a sponge for cytokines and
24
Chapter 2: Background
growth factors.[106]  The basic structural protein of this matrix is fibrin, assembled from
the plasma protein fibrinogen (see Fibrin Formation, pg. 25).  Fibrin has a high binding
affinity  for  cytokines,  growth factors,  proteases,  and protease  inhibitors.   It  therefore
binds and localizes key ingredients from the plasma milieu to the matrix to promote key
cell functions of wound healing.  Fibrin directly binds matrix proteins that support cell
migration  including  fibronectin,[107] vitronectin,[108] and  hyaluronan[109] as  well
growth factors that  promote proliferation and matrix synthesis including TGF-β,[110]
FGF-2,[111] and  PDGF.[110]  Also,  due  to  its  ability  to  bind  heparin  and  heparin
sulfate,[112] fibrin  indirectly  alters  other  heparin-binding  growth  factors  and  can
modulate those growth factor's functions.[113]  Furthermore, through integrin signaling,
fibrin  itself  has  demonstrated  some control  over  cell  function  and  response  to  other
factors  through  integrin  signaling.[102,  114]  When  combined,  the  elements  of  the
provisional  matrix  including  fibrin,  growth  factors,  and  other  biologically  active
molecules act synergistically to promote cellular infiltration and remodeling to ultimate
regenerate injured tissues. 
2.4.2 Fibrin
Fibrin is formed from the conversion of fibrinogen, a glycoprotein found circulating
in  blood  plasma  at  a  concentration  of  3-7  mg/ml,  into  fibrin  by  the  enzyme
thrombin.[110, 111]  Fibrinogen is an elongated protein, 45 nm in length, with two D
domains on the outside, connected by chains to a central E domain.  Upon exposure to
thrombin, binding sites are exposed through cleavage on the top (EA) and bottom (EB) of
the central E domain.  These open binding sites then allow for association with outer D-
domains  of  adjacent  fibrinogen  molecules,  leading  to  the  aligned,  end-to-middle
staggered  overlap  arrangement.   As  polymerization  occurs,  protofibrils  are  further
assembled laterally and branch forming a complex intertwined network.(Figure 2.8).[106,
115]  This network is naturally crosslinked by the formation of intermolecular isopeptide
bonds between γ chains by factor XIIIa.[116, 117]
2.4.2.1 Fibrin Biomaterials
Because of the role fibrin plays in the provisional matrix for wound healing (see
Fibrin  Provisional  Matrix  2.4.1,  pg.  24)  and  as  a  model  of  fibroplasia,[118] fibrin
biomaterials  have been studied for  diverse applications in the healing injured tissues.
Currently,  the  use  of  fibrin  for  applications  in  ligament  regeneration  have  not  been
investigated due to the limited initial mechanical strength of typical fibrin gel matrices.
However, biomaterials produced  in vitro of fibrin can have widely varying mechanical
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and  structural  properties
dependent  on  the  initial
concentration of fibrinogen. 
For  example,  fibrin
hydrogels  are  produced  at  low
fibrinogen  concentrations  and
have  been  widely  studied  for
engineering  applications  ranging
from  cardiovascular  grafts[119-
122] to  bioengineered
cartilage.[123-125]  However,
like  most  gels,  these  materials
lack  sufficient  mechanical
strength  necessary  for  the
functional  replacement  of  load
bearing tissue structures.  Higher
fibrinogen  concentrations  are
commercially  available  in
adhesive sprays or glues used as
sealants  to  control  bleeding
during surgery[126-129] and have
recently been investigated for cell
delivery.[130-132]  To  take
advantage  of  the  wound  healing
cell signaling capabilities of fibrin and compensate for its lack of mechanical strength,
cells have been seeded in fibrin gels onto a polymer mesh[133] for cardiovascular[134]
and orthopedic applications.[135, 136]
2.4.3 FGF-2
Fibroblast growth factor-2, (basic FGF (bFGF); FGF-2), is one of a family of 22
fibroblast growth factors originally isolated and investigated for it's mitogenic effect on
cells.[137]  Typical FGF-2 is an 18 kD, single-chain polypeptide constructed from 146
amino acids in a trigonal pyramid shape formed by 12 antiparallel β strands including a
100 amino core region largely conserved across the FGF family of growth factors.[137-
139]  FGFs activate a small subset of 4 specific single pass transmembrane receptors
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Figure  2.8:  Schematic  diagram  of  fibrin  assembly.  (Top)
Assembly  of  fibrin  begins  with  non-covalent  interactions
(D:E) to form end-to-middle staggered overlapping double-
stranded  fibrils.  Fibrils  also  branch  and  undergo  lateral
associations to form wider fibrils and fibers. [Inset: critical
point  dried  thin  fibril  matrix  containing  branch  junctions
(arrows);  bar,  100  nm].  (Bottom)  After  cleavage  of
fibrinopeptide B (FPB) , αC domains become available for
self-association with  other  αC domains,  thereby  promoting
lateral fibril associations and fiber assembly. [115]
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(FGFR1-4)  with  tyrosine  kinase
activity.[137, 138]  Ligand binding
to  the  extracellular  domain  of  the
FGFR  initiates  receptor
dimerization[113] leading to signal
transduction  that  ultimately
regulates gene expression.  
FGF-2 plays a role during both
development and wound healing in
a  vast  array  of  tissue  types
including bone, nerve, and lung as
well  as  soft  connective  tissue
including  skin,  tendon,  and
ligament.[140]   While  generally
considered  a  mitogen  to  most  cell
types,  FGF-2  causes  cell  type
dependent  effects  on  migration,
proliferation,  differentiation,  and
apoptosis.[138]  For example, while
FGF-2 promotes proliferation in keratinocytes[141] and endothelial cells,[142] it arrests
the  cell  cycle  in  chondrocytes[143] and  promotes  differentiation  of  neuronal  stem
cells.[144]  How any particular cell is affected is dependent on not only cell type, but
maturation  stage  as  well  as  other  concurrent  signaling  events.[138]  One  notable
confounding  factor  is  matrix  binding,  especially  to  heparin  and  fibrin,  which  can
significantly modulate FGF-2 activity.
2.4.3.1 ECM and FGF-2 Combinatorial Signaling
The ultimate response to FGF-2 is not dictated independently by the growth factor,
but rather the effects are mediated by extracellular matrix interactions in concert with
growth factor receptor binding.  Traditionally, FGF signaling involves heparin or heparin
sulfate  binding,  likely  forming  a  ternary  complex  between  FGF  and  FGFR.[113]
Dimerization  of  receptors  required  for  activation  are  promoted  by  heparin,[145]
increasing receptor-FGF-2 affinity 10 fold.[146]  However, the 3-D structure determined
by x-ray crystallography has shown the receptor binding site and heparin binding site are
separated  by  approximately  25  angstroms  and  are  on  different  faces  of  the  protein,
suggesting  that  these  functions  could  interact  independently.[139]   Heparin  has  been
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Figure  2.9: FGF-2 Structure.  (a) Diagram of conserved
core regions (black), heparin-binding domains (pink) and
FGFR  binding  domains  (green)  on  FGF-2.   (b)  3-D
diagram of FGF-2 color coded as above.[137]
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found  to  bind  fibrin  and  considered  present  in  the  provisional  matrix[112]  where
importantly,  FGF-2  binding  to  heparin  helps  to  prevent  thermal,  proteolytic,  or  pH
dependent degradation.[113]  
Although not investigated as abundantly as heparin and heparin sulfate, fibrin has
also been implicated in the regulation of FGF-2 signaling.  FGF-2 binds specifically and
saturably to both fibrinogen and polymerized fibrin with a low Kd values ranging from
1.3 nM for high affinity sites to 260 nM for low affinity binding sites.[111]  Therefore in
normal plasma concentrations (approximately 7 μM for fibrinogen and 6 pM or less for
FGF-2) all FGF-2 should be bound to fibrinogen[111] and in vivo, FGF is likely stored in
a bound state, becoming functionally available upon release[147].  Similar to heparin and
heparin  sulfate,  FGF-2  binding  to  fibrin  prevents  proteolytic  degradation.  [148]
Furthermore  the  binding  of  FGF-2  to  fibrin  also  has  the  potential  to  facilitate  the
aggregation of growth factor and integrin receptors to promote signal integration.[149]
Integrin αvβ3 and FGFR1 colocalize when both fibrinogen and FGF-2 are present [150]
within the focal adhesion complex.[151]     Together fibrin and FGF-2 potentiate  cell
proliferation[142]  in  a  manner  not  seen  with  FGF-1[149]  and  requires  the  integrin
αvβ3.[150, 152]  Additionally, fibrin acts as a cofactor with FGF-2 in regulating gene
expression of proteins involved in pericellular matrix degradation.[153]  Combined, this
data suggests that the matrix aids in the  spatial regulation of growth factor receptors,
integrins, and signaling molecules.  
2.4.3.2 FGF-2 In Tendon/Ligament
Specifically, the effects of FGF-2 have been investigated on tendon and ligament
during both in vitro and in vivo experiments and most typically demonstrating increased
wound healing characteristics.[154]  In vitro, FGF-2 increases proliferation[155, 156] as
well as migration of tendon fibroblasts in a wound closure model[156] while upregulating
the  expression of  integrins  αvβ3 and  α5β1,  which  are  important  for  angiogenesis  and
tendon healing.[152]  In vivo, after injection into healing tendons, FGF-2 increased type
III  collagen  content  as  well  as  tenocyte  proliferation.[157]   Using  an  in  vivo  canine
ligament model, addition of FGF-2 increased the healing response marked by enhanced
neovascularization.[158]  Similarly, early wound healing was enhanced with the addition
of FGF-2 in a fibrin gel to a defect MCL model.[159]
Like many growth factors, the effects of FGF-2 are considered both dose-dependent
and  time-dependent.   FGF-2  stimulated  proliferation   as  well  as  type  I  and  type  III
collagen production in rotator cuff tenocytes at low doses, but at higher values suppressed
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collagen  production  in  a  dose-dependent  manner.[155]   During  injury  and  surgical
reconstruction studies, researchers have seen time dependent effects.  Chang et al. found
expression of FGF-2 post injury remained elevated from the first postoperative day and
remained elevated through the 56 day length of experimentation.[160]  Similarly, Kuroda
et  al.  measured  growth  factors  including  FGF-2  during  ACL reconstruction  surgery.
They found high levels of FGF-2 at early post-operative times with levels increasing up
to  3  weeks,  followed  by  a  precipitous  decline.[161]  The  authors  suggest  that  these
temporal effects mimic the pattern of extrinsic cell infiltration and revascularization and
could therefore be partially attributed to those phenomena.[161]
2.5 MIGRATION IN WOUND HEALING
Cell migration plays a fundamental role in the healing of tissues including the ACL.
In order to repair torn tissues such as the ACL, cells, typically fibroblasts, must migrate
from the wound margin to repopulate and ultimately regenerate the damaged tissue.  This
migration  can  be  induced  by  stimuli  ranging  from  a  lack  of  cell-cell  contacts  to
chemotactic gradients, while the rate of migration is modulated by numerous chemical
and physical signals.  Furthermore, in vivo studies of collagen thread prostheses have
implicated  a  lack  of  fibroblast  tissue  ingrowth  as  a  crucial  impediment  to  complete
regeneration  of  torn  ligaments.[23]  The  following  sections  describe  current  in  vitro
models of cell migration and the stimuli that have shown to modulate migration in these
systems.
2.5.1 Mechanics of Cell Migration
Cell  migration  occurs  through  the  coordination  of  dynamic  matrix  adhesion  and
propulsion  by  cytoskeletal  contraction.   Although  occurring  simultaneously,  the
mechanics of cell migration can be conceptually divided into steps.  The process begins
by the  protrusion of  lamellipodia  at  the  leading edge of  the  cell,  extended outwards
through actin filament polymerization.  The cell then actively adheres to the matrix via
integrins which cluster into focal adhesions.  Contraction by myosin motor interaction
with  actin  filaments  translocates  the  cytoplasm  and  organelles  forward.   Finally,
adhesions  in  the  rear  of  the  cell  must  detach  to  release  the  cell  while  integrins  are
recycled to the leading edge to form new adhesions.[163, 164]  Although the direction of
locomotion is generally considered random in the absence of variable stimuli, cells are
polarized  in  the  direction of  movement  and  persistent,  oriented  migration  commonly
occurs in vivo and in vitro through various stimuli.[164]
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2.5.2 Stimuli of Cell Migration
Numerous  pathophysiological
conditions  such as  a  lack  of  cell-cell
contact after injury induce the directed
migration  of  fibroblasts  into  the
provisional  matrix.   Both  the  speed
(rate)  and  velocity  (vector)  of  cell
migration  can  be  altered  through
several  stimuli  including  chemotaxis,
haptotaxis,  durotaxis  and  contact
guidance.[165, 166]  Chemotaxis is the
directed migration of cells in response
to soluble  factors,  in  this  case  in  the
wound milieu.  During wound healing,
chemoattractants diffuse from a source
to  an  area  of  lower  concentration,
while  cells  including  leukocytes  and
fibroblast  migrate  up  the  gradient.
With  haptotaxis,  cell  migration  is
promoted  directionally  by  the
substratum rather than soluble factors.
Protruding  lamellopodia  compete  for
finite  attachments  and  will
preferentially extend in the direction of
increasing attachments sites.  Although
still  related  to  the  substratum  like
haptotaxis, contact guidance is simply
the  tendency  of  cells  to  align  along
discontinuities  in  the  substrata  and
preferentially  migrate  in  this  oriented
direction.[165]  The  stiffness  or
rigidity  of  the  matrix  upon  which  or
within  which  a  cell  exists  also  has
been  shown  to  alter  the  rate  and
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Figure  2.10:  Cell  migration  occurs  in  several
simultaneous  steps.   Lamellipodia  extend  by  actin
polymerization and create new attacments to the matrix
through focal adhesions.  The cytoskeleton contracts to
pull the cell forward and old focal adhesions at the rear
of the cell are detached.  [162, 163]
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directionality  of  cell  migration  with  preferential
migration  towards  stiffer  substrates,[167]   termed
durotaxis.
During wound healing, the migration of cells into
the  provisional  matrix  is  strongly  influence  by  the
matrix itself.  The fibrin-fibronectin matrix stimulates
fibroblast  migration  through  a  combination  of
haptotaxis  and  fibrin  fibril  mediated  contact
guidance.[165]  Furthermore, the ability of a cell  to
both  make  and  break  adhesions  with  the  matrix
influence the rate of motility (Figure 2.11).[166, 168]
Attachments  in  granulation  tissue  are  facilitated  by
fibronectin while hyaluronan has been implicated in the low impedance to cell motility or
disadhesion from the matrix.[165]
2.5.3 In Vitro Models of Cell Migration
Cell  migration  studies  in  vitro typically  employ  Boyden  chambers  or  visualize
migration on flat  surface-coated two-dimensional substrates, however these studies do
not accurately reflect the complex three-dimensional environment of wound healing.  To
improve on these systems, wound healing research has investigated alternative migration
models  utilizing reconstituted fibrin  gels.   Fibroblast  migration has  been modeled by
placing explants of tendons in a fibrin gel and measuring the migration and proliferation
of fibroblast from the explants into the matrix.[169]  Other researchers have placed fibrin
gels over cultured fibroblasts[170] or placed fibroblasts on plasma clots[171, 172] and
measured the migration on and into the clots.  Greiling and Clark developed the most
sophisticated of these systems by placing cells in a collagen gel and surrounding the cell-
seeded gel with a fibrin matrix.[173, 174]  In this manner, they were able to visualize
cells migrating from the collagen gel, generally considered an in vitro model of dermis or
wound margin tissue, and into a fibrin matrix that acts as a 3-D ECM structural model of
granulation tissue.
While no in vitro model of ligament wound healing or ligament scaffold regeneration
currently exists, some relevant assays have been developed specifically for tendon and
ligament.  For example, ACL and MCL fibroblasts were investigated in a wounded tissue
culture monolayer.  After reaching confluence, half of a monolayer culture of ACL or
MCL fibroblasts were scraped from a culture dish allowing the remaining fibroblasts to
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Figure 2.11: The rate at which a cell
migrates on a particular substratum
is a function of how well it attaches
to the surface.  Too many or two few
attachments  will  reduce  cell
speed.[166]
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migrate into the newly empty area and imaged.[62]   Ricci et al. measured tendon cell
growth rates on synthetic fibers by placing tendon explants perpendicularly across carbon
fibers elevated above tissue culture plates and measuring the migration of cells out of the
explants onto the fibers.[175, 176]  Other researchers have measured the outgrowth of
ACL  and  MCL  fibroblasts  from  explants  placed  onto  culture  dishes[177]  and  onto
collagen/GAG sponges.[178,  179]  Finally,  during  studies  of  the  biocompatibility  of
collagen  threads  crosslinked  with  a  novel  NDGA  crosslinker,  Koob  and  researchers
placed threads into a tendon explant and measured the quantity of cells grown onto the
threads at various time points.[180]
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CHAPTER 3: CELL OUTGROWTH BIOASSAY:  
DEVELOPMENT OF AN IN VITRO METHOD OF CHARACTERIZING
TISSUE INGROWTH ON DISCRETE THREADS.
3.1 INTRODUCTION
Research  and  development  of  biomaterials  for  ACL  regeneration  requires
quantitative in vitro and in vivo methods of characterizing interactions between scaffold
materials and cells.[1]  In particular, in vitro tools allow for the evaluation of the efficacy
of  ligament  specific  biomaterials  or  biomaterial  modifications  in  a  controlled
environment,  without  the  use  of  costly  and  time-consuming  implantation  studies.
Furthermore,  improvements  on  these  assays  could  allow  for  the  high-throughput
screening of many conditions with limited extra resources.  
A vast subset of biomaterial scaffolds of specific interest to ligament regeneration
investigated with these tools are fiber or thread-based scaffolds (Chapter 2.2).  Thread
scaffolds have been extensively investigated for the repair of highly aligned tissues due to
both the structural homology and the ability to promote aligned regeneration (Chapter
2.2).  In particular, collagen threads have been investigated because of their biochemical
and morphological similarities to native ligament, as well as for their ability to degrade
under  natural  pathways  to  replace soft  tissues.   However,  the results  of  implantation
studies (Chapter 2, Table 3) indicated that the scaffolds required improvements in tissue
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ingrowth  and  cellular  infiltration  to  repopulate  and  regenerate  the  replaced  ligament
tissue.[2]  We have developed a second generation of collagen threads, self-assembled
from  solutions  of  acid  soluble  type  I  collagen,  that  demonstrated  an  increased
biomimetic,  fibrillar  substructure  marked  by  a  D  periodic  banding  pattern[3] and
mechanical properties comparable to native ligament with crosslinking.[4]  While these
self assembled collagen biomaterials offer considerable promise as scaffolds for ligament
regeneration, their strength and tissue ingrowth characteristics for ligament regeneration
have yet to be characterized in a wound healing model. 
To  predict the rate of new tissue ingrowth onto these aligned fibrous scaffolds for
soft tissue regeneration, several studies have focused on developing  in vitro assays to
measure  contact-guided  cell  migration  (for  more  see  Chapter  2.5.4).   Koob  et  al.
measured cell migration from tendon explants onto NDGA crosslinked collagen threads
to determine material biocompatibility.[5]  Ricci et al. developed a method for measuring
cell colony growth rates on carbon fibers from tendon explants, but could not determine
any variation in growth rates on different fiber types, except in the case where carbon
fibers  were  compared  with  collagen-coated carbon fibers.[6,  7]  Murray and Spector
measured non-oriented cell migration and proliferation from anterior cruciate ligament
(ACL)  explants  into  collagen-glycosaminoglycan  (GAG)  matrices  in  multiple
dimensions.[8,  9]  While  each  of  these  techniques  provides  some  measure  of  tissue
responses to implantable threads, there is presently no quantitative and definitive in vitro
method for characterizing cellular functions on the surfaces of biopolymer threads with
varied surface biochemistries and extracellular matrix compositions.  
Therefore  the  objective  of  the  work  described  in  this  chapter  is  to  develop  a
quantitative bioassay for investigating tissue ingrowth on biopolymer threads in order to
assess the utility of thread scaffolds for ACL regeneration.
This chapter will  focus on the development  of a novel  method for  quantitatively
characterizing tissue ingrowth on the surface of collagen thread scaffolds.  Threads were
suspended across elevated platforms seeded with fibroblast populated collagen lattices.
Fibroblast  populations  were  visualized  and  imaged  on  each  discrete  thread  and  the
distance to the furthest cell was measured at time intervals.  Evaluation of this metric
showed similar outgrowth velocities between self-assembled collagen threads and native
tendon controls.  Furthermore, increased  cellular outgrowth was seen on self-assembled
type I collagen threads relative to the first generation of collagen threads derived from
insoluble  collagen.   This  novel  in  vitro  model  system allows  examination  of  tissue
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ingrowth from a wound margin onto biomaterials to determine the effects of various cell
types,  matrix  materials,  and  surface  biochemistries  on  cell-matrix  interactions.
Ultimately,  this  assay  will  allow us  to  identify  design  parameters  that  will  be  most
effective for enhancing the rate of tissue ingrowth on fiber-based collagen scaffolds for
soft tissue regeneration. 
3.2 MATERIALS AND METHODS
3.2.1 Preparation of Collagen Solutions
Acid soluble type I collagen was obtained from rat tails as previously described.[10]
Briefly,  tendon  fibers  were  dissected  from  Sprague-Dawley  rats,  rinsed  in  PBS  and
stirred in 1000 mL of 3% (vol/vol) acetic acid overnight at 4°C.  The supernatant was
separated from the stock solution by centrifugation at 12,800g at 4°C for 2 hours.  The
supernatant was precipitated with 200 ml of 30% NaCl (wt/vol) solution, and the pellet
was collected by centrifugation at 4420g at 4°C for 30 minutes.  The pellet was dissolved
in 200 mL of 0.6% (vol/vol) acetic acid and dialyzed five times against 1.0 L of 1 mM
HCl.  The resulting collagen solution was lyophilized and stored at 4°C.  The purity of
the  starting  material  was  verified  by  sodium  dodecyl  sulfate  polyacrylamide  gel
electrophoresis (SDS-PAGE).  For collagen thread extrusion, a small quantity of type I
collagen was dissolved in 5 mM HCl solution at a final concentration of 10 mg/ml and
stored in syringes at 4°C.
Insoluble type I collagen from bovine Achilles tendon (Sigma, St. Louis, MO) was
prepared as previously described.[11]  For collagen thread extrusion, a 1% (wt/vol, 10
mg/mL) dispersion of insoluble type I collagen was prepared by blending 1.0 gram of
collagen material in 100 mL of 5 mM HCl for 10 minutes.  The dispersion was degassed
by centrifugation at 4420g at 4°C for 30 minutes and was stored in syringes at 4°C.
3.2.2 Collagen Thread Extrusion 
Collagen threads were extruded from solutions of either soluble or insoluble type I
collagen following a procedure similar to that described previously.[3]  Briefly, collagen
solutions were extruded through 0.38 mm inner diameter polyethylene tubing (Becton
Dickinson, Inc., Franklin, NJ) using a syringe pump (KD Scientific, New Hope, PA) set
at a flow rate of 0.7 mL/min.  Threads were extruded into a bath of fiber formation buffer
(pH 7.42, 135mM NaCl, 30mM TrizmaBase (Tris) and 5mM NaPO4 dibasic, Sigma, St.
Louis, MO) maintained at 37°C overnight.   The buffer was then replaced with a fiber
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incubation buffer (pH 7.42, 135mM NaCl, 10mM Tris, and 30mM sodium phosphate
dibasic, Sigma, St. Louis, MO) that was maintained at 37°C for 24 hours.  The incubation
buffer was then replaced with distilled water, and the threads were incubated at 37°C
overnight.  Finally, the threads were removed from the water bath, air dried, and stored at
room temperature in a desiccator.
Half of the threads extruded from both soluble and insoluble collagen solutions were
subsequently crosslinked by thermal dehydration (DHT) in which they were heated to
105°C under 100 mTorr vacuum for 24 hours.[4]  These crosslinked threads were also
stored at room temperature in a desiccator.
Native  collagen  thread
controls  were  obtained  by
dissecting  collagen  fibers  from
rat  tail  tendons  of  Sprague-
Dawley rats.  Tendon fibers were
split repeatedly along their axes
under  a  microscope  until  the
fibers were approximately 75 μm
in diameter.   These fibers  were
washed  in  distilled  water,  air
dried while hanging, and stored
in a desiccator.
3.2.3 Fibroblast Culture
For  the  cell  migration
bioassays,  primary  human
dermal  fibroblasts  were isolated
from  neonatal  foreskins  and
cultured in Dulbecco’s Modified
Eagles Medium (DMEM; Gibco
BRL,  Gaithersburg,  MD)
supplemented  with  10%  fetal
bovine  serum  (FBS;  Atlanta
Biologicals,  Lawrenceville, GA)
and penicillin/streptomycin (100
U/ 100 μg per mL) (Gibco BRL,
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Figure  3.1:  Bioassay  schematic.   A  schematic  illustration
showing the bioassay in both a 3-D view (a) and a side view
(b).  A schematic illustration (c) and a digital image at day 4
(d) of cells fluorescently labeled with Fura-2 migrating from
the platform onto a self-assembled collagen thread (SCT) as
visualized  under  an  inverted  microscope.   The  measured
distance to the furthest cell is illustrated by the horizontal bar
in  figures (c) and (d).
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Gaithersburg, MD)).  Briefly, sections of dermis from human neonatal foreskins were cut
and placed onto scored areas of standard tissue culture dishes.  The sections were allowed
to  dry  for  30  minutes,  and  then  were  incubated  in  DMEM  with  10%  FBS  and
penicillin/streptomycin (100 U/ 100 μg per mL) at 37°C and 10% CO2 until the culture
dishes were confluent with fibroblasts.  The fibroblasts were then removed by trypsin and
expanded in culture.  Passages 5-9 were used for all migration experiments.
3.2.4 Genetically Modified Fibroblasts
3.2.4.1 Retrovirus production and cell culture
For  the  cell  migration  experiments,  normal  human  dermal  fibroblasts  were
genetically  modified  to  express  green  fluorescent  protein  (GFP).   GFP-encoding
amphotropic retrovirus producing cells (originally provided by Dr. Steven J. Greenberg,
Roswell  Park  Cancer  Institute,  Buffalo,  NY)[12]  were  produced  by  transfection  of
murine fibroblast derived PA317 packaging cells with the LXCGN retroviral vector.[13,
14]  Retrovirus was harvested from producer cells as described previously. [15] Briefly,
fresh medium (32mL in 182-cm2 tissue culture flasks (Marsh Biomedical,  Rochester,
NY)) was added to confluent cultures of virus producer cells.  After 24 hr the virus-
containing medium was harvested, filtered through 0.45 μm pore sized bottle top filters
(Corning Costar, Corning, NY), aliquoted and stored at -75oC until use.  The virus titer
(~1x107cfu/mL)  was  measured  by  quantifying  the  neomycin  resistant  colonies  as
described previously.[16]
3.2.4.2 Retroviral Transduction
Primary human fibroblasts were transduced on recombinant fibronectin as described
previously.[17]  Briefly 2 mL of 10 μg/mL recombinant fibronectin (rFN; Takara Mirus
Bio Corporation, Madison, WI) was loaded onto non-tissue culture treated 6-well plates
overnight at 4°C.  On the next day, GFP-encoding retrovirus (2 mL/well) was loaded
onto FN-coated surfaces for 7.5 hr at 10% CO2 and 37°C.  After removal of unbound
virus, primary human fibroblasts were plated at 15,000 cells/cm2and transduction was
allowed to occur overnight at 37°C.  The next day, cells were exposed to a fresh stock of
retrovirus (2 mL/well) in the absence of polybrene. After 2 hr incubation, retrovirus was
removed from the wells and replaced with fresh culture medium containing 1 mg/mL
Geneticin (GibcoBRL). After 4 weeks of selection, cells were cryopreserved until they
were used for experiments.
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3.2.5 Cell Outgrowth Bioassay
3.2.5.1 Construction
Tissue  culture  systems  for  measuring  the  migration  of  cells  onto  threads  were
modeled on methods described previously.[6]  Raised platforms of Thermanox® tissue
culture plastic (5.5 mm X 15 mm) (Nalge Nunc, Rochester, NY) were elevated 1.5 mm
above  the  surface  of  tissue  culture  dishes  using  molded  silicone  plugs  of
polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning, Midland, MI) (Figure 3.1a, b,
Pg. 44).  Threads were laid across the raised platforms, and the ends were attached to the
tissue culture plates with Silastic® medical adhesive made from silicone type A (Dow
Corning,  Midland,  MI)  (Figure  3.1,  pg.  44).   Each  experimental  system contained  6
different  thread  types,  including  crosslinked  (-X)  and  uncrosslinked  collagen  threads
(self-assembled from acid-soluble type I collagen (SCT) or reconstituted from insoluble
type I collagen (ICT)), native tendon threads from rat tails (NTT) for positive controls
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Figure  3.2:  Bioassay  consisting  of  threads  elevated  across  platforms  seeded  with  a  fibroblast
populated collagen lattice.  Images were taken before the addition of cell culture media.  Scale bar =
1.5 cm (inset = 6 mm)
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and Prolene® polypropylene suture  (PPT)  for  negative controls  (Ethicon,  Somerville,
NJ).  
Migration tissue culture systems including all thread types were sterilized 48 hours
prior to migration experiments.  The systems were rehydrated in distilled water for 60
minutes, and then soaked in 70% isopropyl alcohol overnight.  The alcohol was removed
with 3 rinses of sterile distilled water for at least 60 minutes.  The systems were then air
dried in a laminar flow hood.
3.2.5.2 Cell Seeding
To  seed  cell  migration  assays,  0.5  mL  aliquots  of  fibroblast-populated  collagen
lattice were placed onto each platform (Figure 3.2, pg. 46).  These lattices were produced
by mixing 3.0 mL of 5x105 cells/mL subconfluent human dermal fibroblasts (passages 5-
9) with 2.4 mL of acid soluble type I collagen (2.5 mg/mL) and 0.6 mL 5x DMEM.  After
the gels were allowed to set at room temperature for 2 hours, the migration plates were
filled with 15 mL of DMEM supplemented with 10% FBS to a height just above the
platforms and threads (Figure 3.1 a, b, pg. 44 And Figure 3.2, pg. 46).
3.2.5.3 Measurement
To measure cell migration on the collagen threads, fibroblasts were stained with a
fluorescent intracellular Ca2+ probe, Fura-2 AM (Molecular Probes, Eugene, OR), every
24 hours.  100 μL of 50mM Fura-2 in DMSO was added to the cell culture media of the
system and incubated for 30 minutes.  The media was then replaced with 15mL of fresh
culture  medium  before  the  plates  were  viewed  on  a  Nikon  Eclipse  TS100  inverted
epifluorescent microscope coupled with a SpotRT CCD Camera (Diagnostic Instruments,
Sterling Heights,  MI)  (Figure  3.1c,  d,  pg.44).   At  each time  point,  measurements  of
distances migrated were made from the edge of the platform to the furthest fluorescently
labeled cell using a calibrated reticle in the eye piece of the microscope.
In isolated cases, the threads detached from the plate and floated above the collagen
gel on the platforms.  These cases were considered to be invalid data points and therefore
excluded from our analyses.
3.2.6 Inhibition of Proliferation
For  experiments  investigating the mechanism of  cell  front  translation,  subsets  of
fibroblasts  were  chemically  pretreated  to  inhibit  proliferation.   Two  hours  prior  to
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seeding  on  platforms,  the  media  was  removed  for  subconfluent  monolayer  fibroblast
cultures and replaced with DMEM (10% FBS, 1% penicillin streptomycin) containing 10
μg/ml mitomycin C.  After 2 hours of incubation, the cultures were rinsed three times
with sterile DMEM, chemically detached from tissue cultures plates with trypsin, and
seeded into collagen lattices as previously described.  In these assays, the thread type was
held constant using only self-assembled collagen threads. 
3.2.7 Statistical Analyses
All migration data was analyzed using SPSS for
Windows (SPSS Inc., Chicago, IL).  Data points of
migration versus time were fit with a standard linear
regression  (r  ≥  0.95)  to  determine  how  well  the
outgrowth velocities represented the data.  The data
points of outgrowth velocity were then tested with a
one-way  ANOVA  to  determine  a  significant
difference between the means.  Post hoc comparisons
between two sample groups were made with Tukey’s
honest significant difference (HSD) test with p < 0.05
indicating significant difference between groups.
3.3 RESULTS
3.3.1 Imaging
One  of  the  challenges  associated  with  the
development  of  this  assay  system  was  the
visualization of cells on threads.  Initial studies used a
daily staining regiment of Fura-2 (see Measurement
3.2.5.3).   To improve the  imaging consistency and
reliability,  fibroblasts  modified  to  express  green
fluorescent  protein  were  used.   This  increased  the
ease  of  fibroblast  visualization  by  working  in  a  spectrum  with  less  collagen
autofluorescence as well as by removing certain stain uptake inconsistencies involved
with daily application of intracellular calcium indicators.  Fibroblasts were significantly
easier to distinguish on the threads when expressing GFP than when stained with Fura-2
(Figure 3.3)
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Figure  3.3:  Fibroblasts  genetically
modified  to  over-express  green
fluorescent  protein  (GFP)  improved
visualization  of  fibroblasts  and
increased the bioassay consistency by
removing the need for daily staining.
Scale bars represent 50 μm.
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3.3.2 Metric Development
Fluorescent  microscopy  was  used  to
measure  cell  migration  distances  from  the
edges  of  the  cell-seeded  platforms  to  the
farthest fibroblast on various threads in order
to  quantitatively  evaluate  the  capability  of
cells  to  interact  with  aligned  scaffolding
materials  indicative  of  tissue  ingrowth.
Observationally,  no  fluorescently  labeled
cells were visualized on any threads for the
first  48 hours  (Figure  3.4a,  d;  pg.  49 And
Figure 3.5, pg. 50).  However, 72 hours after
seeding the platforms with fibroblasts, cells
began  to  migrate  onto  the  threads  (Figure
3.4b,  e;  pg  49 and  Figure  3.5,  pg.  50).
Consequently, day 3 was considered the first
time point for outgrowth velocity analyses.
By day 4, while only a small number of cells
were observed on the PPT threads, a large
number of cells were observed on the SCT
threads (Figure 3.4c, f; pg. 49).  
To quantify these observations, the total
cell  migration  distance  traveled  each  day
was  averaged  for  each  type  of  thread  and
plotted as a function of time.  These plots for
each thread type were accurately modeled by
standard  linear  regression  (R>0.95),
including both positive and negative controls
(Figure  3.6,  pg  51).   Since  the  rate  of
migration is linear as a function of time, we
averaged the distance traveled by the  cells
on days 3 through 8 to determine our metric,
an  outgrowth  velocity,  along  each  thread  (outgrowth  velocity/thread).   These  5-day
average  values  were  each  represented  as  single  data  point  for  a  particular  thread
extending  from  a  particular  platform.   From  all  of  these  data  points,  averages  and
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Figure  3.4:  Fluorescent  microscopy  images  of
fibroblast cell  outgrowth.   Inverted fluorescent
microscopy  images  of  Fura-2  labeled  cells
migrating onto a polypropylene thread (a-c) and
a self-assembled collagen thread (SCT) (d-f) at
day 2 (a,d), day 3 (b,e), and day 4 (c,f).  Cells
cannot be seen at day 2 on either thread.  By day
4  a  few  initial  cells  can  be  seen  leaving  the
platform  onto  the  polypropylene  thread
(PPT)while many cells have migrated onto the
self-assembled  collagen  thread  (SCT).
Examples  of  labeled  cells  are  indicated  with
white arrowheads.  Scale bars represent 100μm.
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standard  deviations  were
calculated,  and  statistical
comparisons  between  thread
types were made using analysis
of variance (ANOVA).  
3.3.3 Additional Model
Considerations
The  cell  density  of
migrating cells varied widely on
different  thread  types;  some
threads (SCT, NTT) maintained
a  relatively  high  cell  density
and  a  front  of  migrating  cells
while  other  threads  (ICT-X,
PPT)  were  found  to  have
limited  cell  density  with  no
definitive  front  of  migrating
cells.   Quantification  of  this
phenomenon  was  estimated
(data  not  shown),  but  distinct
differences  between  thread
groups were equivocal. 
To  determine  whether  the
extension  of  the  fibroblast
population front were migrating
or  proliferating,  measurements
were obtained for cells with and
without  inhibition  of
proliferation.  In the same test apparatus, half the platforms were seeded with standard
fibroblast populated collagen lattices, while the second half were seeded with mitomycin
C pretreated fibroblasts in collagen lattices to inhibit  proliferation.  The inhibition of
proliferation  was  verified  simultaneously  through  continued  culture  under  standard
conditions on tissue culture plastic.  The migration rate significantly decreased when cells
chemically treated to inhibit proliferation, however, the values were non-zero (Figure 3.3,
pg.  48) Furthermore, the visualized cell density was also decreased, but not quantified.
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Figure  3.5:  Images  of  fibroblast  cell  outgrowth  with  time.
Fibroblasts stained with Fura-2 were imaged every 24 hours.
No cells can be seen at day 2 on any thread type.   Therefore
measurements  began  at  day  3  of  incubation.   By  day  6,
fibroblasts  fill  the  image  area  on  self-assembled  collagen
threads (SCT) and the positive control  native tendon threads
(NTT)  while  very  few cells  are  seen on the  negative  control
polypropylene threads (PPT).  Variance in population density
can also be seen.
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These findings suggest  a combination of proliferation and migration of  fibroblasts  to
extend the front.
3.3.4 Effect of Collagen Source and Crosslinking
We compared the effects of the two different collagen sources, as well as the effect
of  crosslinking,  on  the  outgrowth  velocity  of  fibroblasts  on  the  surfaces  of  collagen
threads.  In these studies the cell migration rates ranged from 0.75 to 1.25 mm/day.  All
of the collagen threads and the native tendon fibers were found to facilitate significantly
greater outgrowth velocities than the PPT negative control threads.  SCT threads were
found  to  promote  a  significantly  greater  migration  rate  than  ICT  threads  under
comparable  crosslinking  conditions  (Figure  3.8,  pg  53).   Additionally,  fibroblast
migration rates on SCT threads were found to be comparable to the cell migration rates
on  NTT positive  control  threads  (Figure  3.9,  pg  53).   When cell  migration  rates  on
uncrosslinked threads were compared with DHT crosslinked threads, it was found that
DHT crosslinking significantly decreased the rate of fibroblast migration on both self-
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Figure  3.6: outgrowth velocities  Represent  Accurate Metrics.   Graph of  migration
distance  versus  time  highlighting  control  native  tendon  threads  (NTT)  and
polypropylene threads (PPT).  The  strong fit with standard linear regression analysis
demonstrates that outgrowth velocities were accurate metrics of data obtained as a
function of time.
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assembled collagen threads and collagen threads reconstituted from insoluble collagen
(Figure 3.10, pg. 55). 
3.4 DISCUSSION
In this study, we describe a novel in vitro model system for quantitatively measuring
tissue ingrowth onto discrete biopolymer thread matrices that closely mimics ACL tissue
regeneration with acellular matrices.  Cells suspended in fibroblast-populated collagen
lattices migrated out of the 3-D matrix and onto threads that were suspended like bridges
across platforms submersed in culture medium.   Fibroblasts  cultured in 3-D collagen
lattices are commonly employed as an in vitro model of wound healing because the 3-D
collagen matrix closely mimics the contextual cues of the native environment.[18]   This
environment provides the biochemistry of the ECM as well as the spatial regulation of the
three-dimensional  cellular  environment.[18]   In  our  model  system  we  combine  this
widely  accepted model  of  wound healing with  high density  collagen thread matrices
developed for the regeneration of torn tendons and ligaments (Chapter 2.2.2.1).  In this
system  we  maintain  a  structurally  and  biochemically  relevant  3-D  contextual
environment, but in a system that closely mimics the mechanisms of cellular repopulation
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Figure 3.7: Migration With Proliferation Inhibited.  The migration rate significantly
decreased but was non-zero when fibroblasts were pretreated with Mitomycin C, a
potent  inhibitor  of  proliferation.   Therefore  the  cell  outgrowth  metric  is  a
combination of migration and proliferation.
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that  occurs  during  ACL  replacement
surgery.   During  non-autograft  ACL
revision surgeries,  the  torn  ligament  is
typically  replaced  with  an  acellular
thread  composite  graft  that  triggers
fibroblasts from the wound margin and
surrounding  tissue  to  migrate  into  the
graft,  repopulate  and  regenerate  the
tissue.  In a similar manner, fibroblasts
in  our  in  vitro model,  migrate  and
proliferate from the collagen gel wound
margin  onto  collagen  thread  scaffolds.
The combined mechanism of migration
and proliferation observed in our model
is supported by evidence suggesting that
migration  occurs  in  the  absence  of
proliferation, but at reduced values and
with reduced population density (Figure
3.3, pg. 48).
Within this model system, we have developed a metric quantitatively characterizing
tissue ingrowth that enables us to differentiate variable cell matrix interactions and new
tissue ingrowth in an accurate, repeatable manner.  The distances traveled per day were
approximately constant for any one particular thread type, as clearly demonstrated from
the strong linear regression fit of the distance traveled with time data (Figure 3.6, pg. 51).
Given that the measurements are uni-directional along the long axis of the threads, the
best fit linear regression, or slope of the tangent on a position versus time graph, is by
definition the velocity of outgrowth.  Once determined, this outgrowth velocity provided
a representative metric, for comparison between experimental conditions.  The outgrowth
velocity of fibroblasts on collagen threads were measured to be between 0.75 and 1.25
mm/day.  These data are similar to published data which determined the rate of tendon
cell colony growth from explants onto collagen coated Dacron fibers to be 1.53 ± 0.96
mm/day.[6]
The cell outgrowth velocity was variable and non-zero under all conditions tested.
Because all of the threads, including common polypropylene suture threads, used in this
experiment  are  generally  considered  biocompatible,  it  is  unsurprising  that  none
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Figure  3.8:  The  outgrowth  velocity  is  significantly
greater  on self-assembled collagen threads than on
insoluble collagen threads 
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completely inhibited cell migration.
However,  all  threads  composed of
collagen  showed  a  significantly
greater  outgrowth  velocity  than
synthetic threads.  Since collagen is
a  ubiquitous  structural  element  in
soft  connective  tissues  (Chapter
2.1.1.1),  as  well  as  a  fundamental
component  of  wound  healing
processes,  these  findings  are
consistent  with  our  initial
hypothesis  that  the  biochemical
cues on the surfaces of the threads
enhance  the  rate  of  cell  migration
onto  biopolymer  scaffolds.   These
finding  are  also  consistent  with
previous studies that showed tendon
cell  colonies  grow  faster  on
collagen-coated  Dacron  threads
than on non-coated fibers.[6]
While both the first generation,
insoluble  collagen  threads  (ICT),  and  the  second  generation  self-assembled  collagen
threads (SCT) are both composed of type I collagen, the results of this study indicate
quite different outgrowth velocities.  Threads self-assembled from solutions of soluble
collagen  molecules  have  previously  been  shown  to  possess  improved  mechanical
properties with a higher density of aligned fibrils than threads extruded from insoluble
collagen.[19]  This  increase  in  aligned  fibril  density  in  SCT  threads  more  closely
resembles the structure of native tendon threads.  In this study, the SCT promoted higher
outgrowth velocity than ICT threads (Figure 3.8, pg. 53) and have a velocity that was not
significantly different than those seen on native NTT threads (Figure 3.9, pg. 54).  This
increase may be a result of the increased alignment of collagen fibrils in the SCT which
may promote increased directional migration through contacted guidance; however, this
increase  is  more  likely  a  result  of  differences  in  serum protein  interactions  with  the
surfaces of  the  threads.   In  particular,  differences in  the  binding of  proteins  such as
fibronectin, a key mediator of cell adhesions, have been widely shown to dramatically
alter  migration.[20-22]  Improved  protein  binding  on  the  surface  of  self-assembled
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Figure  3.9:  Self-Assembled  Similar  to  Native.   The
outgrowth velocity on self-assembled collagen threads was
almost 3 times greater than on negative controls and no
statistically different than positive controls (native tendon
threads). *significant difference
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collagen threads over  ICT may
account  for  the  outgrowth
velocity variation.
The  results  of  this  study
suggest  that  DHT  crosslinking
may adversely effect cell-matrix
interactions  and  the  rate  of
tissue regeneration (Figure 3.10,
pg.  55).   Crosslinking  of
collagen  using  various
techniques  has  been  shown  to
increase the strength of collagen
threads and decrease the rate of
degradation.   Crosslinking  by
severe  dehydration,  or  DHT
crosslinking,  is  a  commonly
used  technique  for  physically
crosslinking  collagen  and
collagen  threads  (Chapter
2.2.2.1  -  Crosslinking)  without
the addition of toxic chemicals that could be leached into the host tissue.  While this
technique has been shown to reduce collagen solubility, antigenicity, and degradation rate
to stabilize the scaffolds upon implantation,[23, 24] it may also mask integrin binding
sites or surface receptors that  mediate cell attachment and migration as well  decrease
binding to  adhesion mediating serum proteins.   The  preliminary results  of  this  study
suggest  that  crosslinking  decreases  the  average  cell  outgrowth  velocity  on  collagen
threads, regardless of the source of the material.  This finding supports our hypothesis
that  DHT  crosslinking  inhibits  cell-matrix  interactions.   The  duration  of  DHT
crosslinking (between 1-5 days) increases the quantity of crosslinks,  which correlates
with both an increase in the mechanical strength and a decrease the solubility or rate of
degradation.[25]  Future tests should examine the effects of DHT crosslinking time on
cell outgrowth velocity to definitively determine whether an increase in crosslink density
results in a decrease in cell migration.
The rate and velocity of migration is a function of any number and combination of
stimuli including chemotaxis, haptotaxis, durotaxis, and contact guidance (Chapter 1.5.2).
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Figure  3.10:  Crosslinking  Decreases  outgrowth  velocity..
outgrowth  velocities  for  self-assembled  soluble  collagen
threads  (SCT)  and  insoluble  collagen  threads  (ICT).
Crosslinked threads (-X) were found to have significantly (* p
<  0.05)  slower  outgrowth  velocities  than  non-crosslinked
threads of the same material.
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In this system, the exact mechanism regulating the velocity of ingrowth remains unclear;
however, we hypothesize that haptotactic or chemotactic effects caused by varied serum
protein binding to the surface of threads may be the dominant factor.  In the absence of
serum and serum proteins, no ingrowth occurred through 10 days of culture (data not
shown), further supporting this hypothesis.  Future studies should more clearly elucidate
this mechanism.  For example by using defined media and measuring outgrowth velocity
with cells modified to lack receptors for particular ECM proteins, the haptoctic response
of cells to particular surfaces could be probed.  Another example would investigate the
effect of durotaxis on outgrowth velocity by using threads increasingly crosslinked by a
single agent to increase the stiffness of the material. 
Although  successful,  the  method  for  characterizing  tissue  ingrowth  has  various
limitations.  Current methods for quantifying population density were suboptimal due to
poor  image  contrast,  cell  delineation  detail,  and  limited  imaging  field  of  view.
Improvements were clearly seen when daily staining protocols were replaced by the use
of a GFP expressing fibroblast cell line; however, using fibroblasts modified to express
GFP sequestered to the nucleus only, rather than the cytoplasm, could allow for simple
quantification of cell  number  using image analysis  software.   Furthermore,  the entire
system could be  improved by tracking cells  in  real  time with an automated stage to
reduce the day to day variations and experimental error.
The  bioassay  developed  here  may  be  useful  in  the  future  as  an  in  vitro test  of
parameters that affect the regeneration of soft connective tissues including tendon and
ligament  tissue.   The  assay contains  experimental  parameters  that  can  be  altered  for
determination of differential  characteristics including cell  types,  crosslinking methods,
collagen substructure, or the microtopography on the surface of the threads.  Ligaments
have been found to have less healing capacity than tendons, resulting in the use of a
patellar tendon as a common autograft for the repair of the anterior cruciate ligament in
the  knee.[26]  One  experiment  might  compare  ligament  fibroblasts  with  tendon
fibroblasts  to  evaluate  their  relative  abilities  to  migrate  and  proliferate  on  aligned
collagen threads, and therefore their ability to interact with the extracellular matrix during
wound  healing.   The  addition  of  wound  healing  cytokines  may  help  elucidate  the
different intrinsic ability of cell types to regenerate in an in vitro wound healing model.
Fibroblasts that are responsible for the wound healing capability of tendons are thought to
originate in the epitenon, or the fascia surrounding native tendon.[5]  Separate cultures of
epitenon fibroblasts and internal tendon fibroblasts may help answer the question of the
origin of the fibroblasts responsible for the increased wound healing capability seen in
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tendon.   By  keeping  the  cell  type  constant,  crosslinking  techniques,  including  both
chemical  and physical, may be evaluated for their suitability for engineering collagen
thread constructs to optimize the rate of new tissue ingrowth.
Researchers have found that cells will migrate and proliferate on collagen threads
under various crosslinking conditions in vivo,[5, 27] but currently there is no quantitative
deterministic methodology to characterize how cells migrate or the cellular interactions
with these threads.   Thus,  up until  now no  in vitro comparison between crosslinking
methods,  collagen  sources,  surface  biochemistries,  or  microtopographies  has  been
available.   In  this  study  we  developed  a  sensitive  technique  to  measure  fibroblast
migration  on  aligned  fibrous  scaffolds  to  elucidate  the  differences  in  cell  matrix
interactions  and  to  predict  the  rate  of  tissue  regeneration  of  grafts  for  soft  tissue
regeneration.  Unlike previous studies which could not determine significant differences
in migration rates on various synthetic fiber types,[6, 7] our method can accurately detect
the fine variations between the measured migration rate on biological materials, which
may  be  indicative  of  how  well  the  scaffold  will  facilitate  tissue  ingrowth  upon
implantation.   Using  this  technique,  we  found  that  self-assembled  collagen  threads
increase fibroblast migration rates while DHT crosslinking decreases fibroblast migration
rate.  The system also establishes a wound healing model of fibroblast migration from a
wound margin.  In the future, this in vitro bioassay will enable us to identify parameters
to optimize the rate of tissue ingrowth for the development of constructs for soft tissue
regeneration, as well as to determine fine variations in the cell-matrix interactions as a
function of matrix materials and surface biochemistries.
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CHAPTER 4: OPTIMIZED SELF-ASSEMBLED
COLLAGEN MICROTHREADS:
EFFECT OF CROSSLINKING ON COLLAGEN MICROTHREAD STRENGTH
AND CELL OUTGROWTH.
4.1 INTRODUCTION
Design  of  biomaterials  scaffolds  that  promote  anterior  cruciate  ligament
regeneration requires structures that  replicate the  mechanical  properties  of  the  native
tissue, facilitate cell infiltration and biodegrade at a rate that matches the rate of tissue
formation.[1]  Fibrous biopolymer materials, especially collagen (see Chapter 2.2.2.1),
have been studied as scaffolds to promote the repair and regeneration of torn tendons and
ligaments  due  to  their  structural  and  biochemical  homology  to  native  ligament  (see
Chapter  2.1.1).   However,  their  success  has  been  limited  both  by insufficient  tissue
ingrowth from the wound margin[2] as well as insufficient initial mechanical stability
without effective crosslinking strategies.  
Numerous crosslinking strategies have been employed to improve the mechanical
properties  of  collagen  thread  scaffolds  (see  Chapter  2.2.2.1  -  Crosslinking).   These
techniques insert inter- and intramolecular crosslinks using either chemical of physical
methodologies  to ultimately decrease the  rate of  proteolytic  degradation,  increase the
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material  stiffness,  and  increase  material  tensile  strength.   However,  our  previous
investigations utilizing a novel bioassay for the evaluation of in vitro tissue ingrowth (see
Chapter  3)  indicate  that  dehydrothermal  (DHT)  crosslinking,  a  commonly  employed
strategy for crosslinking collagen thread scaffolds, subsequently led to decreases in the in
vitro rate of tissue ingrowth (see Chapter 3).  During these previous studies, a decrease in
cell outgrowth with crosslinking was evident on both insoluble collagen threads as well
as our second generation collagen threads self-assembled from solutions of acid soluble
collagen.  
Self-assembled  collagen  threads  represent  a  promising  solution  for  ligament
regeneration.   They  possess  ultimate  tensile  strengths,  stiffnesses,  and  structural
properties  comparable  to  native tendon fibers  and significantly  greater  strengths  than
threads  extruded  from  insoluble,  type  I  collagen  dispersions.[3-5]  However,  self-
assembled collagen threads still require crosslinking to attain mechanical properties to
match  the ACL.  The ultimate effects of the various available crosslinking techniques on
the tensile strength and cellular outgrowth of self-assembled collagen threads has yet to
be characterized.  
Therefore the objective is to optimize the mechanical properties and cell outgrowth
of self-assembled collagen threads for ACL regeneration utilizing current crosslinking
techniques. 
The focus of this chapter is to describe the application of the quantitative method of
determining cellular ingrowth developed in Chapter 3 to crosslinking of collagen threads.
Collagen threads are commonly crosslinked to  increase the mechanical properties and
decrease the otherwise rapid  in vivo rate of degradation in a wound site.   The initial
studies  in  Chapter  3  determined  that  the  cell  outgrowth  rate  was  attenuated  after
crosslinking with a  technique selected because of  it's  prevalence during prior  in  vivo
studies.  We hypothesized that implementation of alternate crosslinking modalities that
had yet to be tested on self-assembled collagen threads could increase thread stability
without  the concurrent  decrease in cell  outgrowth seen with DHT crosslinking.   The
major limitations of collagen threads, including limited tissue ingrowth, could thereby be
circumvented.  The mechanical properties and cell outgrowth rates were measured for
self-assembled  collagen  threads  utilizing  the  most  promising  crosslinking  strategies.
Although all the techniques investigated increased the strength and decreased the rate of
degradation, they also subsequently decreased the in vitro rate of tissue ingrowth.  These
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findings  indicate  that  there  remains  a  need  to  develop  a  scaffold  material  that  both
provides mechanical stability and promotes new tissue ingrowth.  
4.2 MATERIALS AND METHODS
4.2.1 Production of Self-Assembled Collagen Threads
4.2.1.1 Preparation of acid soluble collagen 
Acid soluble type I collagen was extracted from rat tails as previously described.[6]
Briefly, tendon fibers were dissected from Sprague-Dawley rats with hemostats, rinsed
twice in phosphate buffered saline, and dissolved in 1600 mL of 3% (vol/vol) acetic acid
solution overnight at 4°C.  The solution was refrigerated, centrifuged at 4°C for 2 hours
at 8,000g, and the supernatant retained.  A volume of 320 ml of 30% NaCl (wt/vol)
solution was slowly dripped into the solution to  precipitate  the collagen.   The entire
solution  and  precipitate  were  centrifuged  at  4°C for  30  minutes  and  the  supernatant
discarded.  The pellets were resuspended in 400 ml of 0.6% (vol/vol) acetic acid solution
and stirred at 4°C overnight or until completely dissolved.  The solution was dialyzed
five times against 4 L of 1mN HCl, each for at least 4 h.  The resulting collagen solution
was  lyophilized  and  stored  at  4°C until  use.   Prior  to  extruding threads,  lyophilized
collagen was dissolved in a  rotating vessel  overnight at  4°C in 5mM HCl,  at  a final
concentration of 10mg/ml.  The collagen solution was degassed by centrifugation before
extrusion to remove trapped air bubbles.
4.2.1.2 Collagen thread extrusion
Collagen threads were extruded using a protocol described previously.[3]  Briefly,
the collagen solution was extruded through 0.86 mm inner diameter polyethylene tubing
(Becton Dickinson, Inc., Franklin, NJ) using a syringe pump (KD Scientific, New Hope,
PA) set at a flow rate of 0.7 mL/min.  The threads were extruded into a bath of fiber
formation buffer (pH 7.42, 135 mM NaCl, 30 mM TrizmaBase (Tris), and 5 mM NaPO4
dibasic; Sigma, St. Louis, MO) maintained at 37°C.  After 24 h, the buffer was replaced
with a fiber incubation buffer (pH 7.42, 135 mM NaCl, 10 mM Tris, and 30 mM sodium
phosphate dibasic, Sigma) that was maintained at 37°C.  After 24 h, the incubation buffer
was  replaced  with  distilled  water,  and  the  threads  were  incubated  at  37°C  for  an
additional 24h.  Finally, the threads were removed from the water bath, air dried, and
stored at room temperature in a desiccator.
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4.2.1.3 Collagen Thread Crosslinking
The  self-assembled  threads  were  separated  into  six  groups,  representing  5
crosslinking methods and an uncrosslinked control group.  Two groups of threads were
crosslinked by ultraviolet light in a UVP CL-1000 crosslinker as previously described.[7]
Threads were centered on a reflective surface 4.5 inches from a bank of 5-8 watt UV
tubes emitting at a primary wavelength of 254nm.  The threads were exposed to UV light
for either 15 minutes (UV-15) or 30 minutes (UV-30).   Two groups of threads were
crosslinked  by  severe  dehydration  as  previously  described.[4]  This  dehydrothermal
crosslinking was achieved by placing the threads in a vacuum oven maintained at 50-100
mTorr at 110°C for either 1 day (DHT-1) or 3 days (DHT-3).  The final group of threads
was chemically crosslinked by soaking the scaffolds in a 1% (w/v) solution of N-(3-
Dimethylaminopropyl)-N-ethylcarbodiimide  hydrochloride  (Sigma,  St.  Louis,  MO)  in
distilled water for 24 hours at 4°C, then rinsed in distilled water 24 hours at 4°C and
finally air dried (EDC).[8]  For this study, collagen threads were only exposed to one
level of EDC crosslinking (24 hours).  Previous studies in our laboratory indicate that the
maximum tensile strength of EDC crosslinked collagen threads reaches a plateau value
when threads are treated with EDC for as little as 4 hours (unpublished data).  All threads
were stored at room temperature in a desiccator until use.
4.2.2 Swelling Ratio and Crosslink Density Calculations
Average  molecular  weight  between  crosslinks  ( M c )  was  calculated  based  on
simplified version of the Flory-Rehner equation for equilibrium swelling in crosslinked
polymeric networks[9-11]:  
Qv5/3≃ v M cV 1   12­
where  Qv is  the  volumetric  swelling  ratio, v is  the  specific  volume of  the  dry
polymer, V1 is the molar volume of the solvent (18 mol/cm
3 for water), and  χ is the
Flory-Huggins polymer-solvent interaction parameter.  A value of 0.49 ± 0.05 was used
Flory-Huggins interaction parameter based on values determined in collagen gels.[12]
The volumetric swelling ratio (Qv) was calculated as the ratio of the wet cross-sectional
area to the dry cross-sectional area assuming no swelling occurs along the long axis of
the thread (less than 5% of volume change occurs along this axis, data not shown).  The
approximate cross-sectional areas were calculated from thread diameter measurements
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using  a  Nikon  Eclipse  E400  microscope  with  a  calibrated  reticule  and  by  assuming
cylindrical  thread  geometry.   The  diameters  were  measured  by  mounting  individual
threads  with  adhesive  (Silastic  Silicone  Type  A,  Dow  Corning)  on  vellum  frames
containing precut analysis windows.  Thread diameters were measured before (dry) and
after (wet) rehydrating the materials for at least 30 minutes in phosphate buffered saline
(PBS).  Each thread diameter was calculated as the average of 4 measurements along the
length of a thread.
The effective crosslink density (νe) was calculated from[9, 13]:
e=
 p
M c
where  ρp is the density of the dry polymer, assumed to be the density of proteins
(1.35g/cm3).[14]
4.2.3 Mechanical Testing of Collagen Threads
Threads from each crosslinking group were hydrated and mechanically loaded in
uniaxial tension to obtain stress-strain curves.  Individual threads were mounted vertically
with adhesive (Silastic Silicone Type A, Dow Corning) on vellum frames with precut
windows that defined the region of loading.  For tensile testing, the samples in the vellum
frames  were  clamped  into  a  custom  designed  micromechanical  testing  unit  (See
Appendix B) consisting of a horizontal linearly actuated crosshead and a fixed 150g load
cell.  An initial gauge length of 20 mm was defined as the distance between adhesive
spots at the edges of the precut window in the vellum frame.  Test unit operations and
data acquisition were controlled with LabView software (National Instruments, Austin,
TX).  Immediately prior to testing, the edges of the frames were cut leaving the threads
intact; then the threads were loaded to failure at a 50% strain rate (10 mm/min).  Curves
of the 1st Piola Kirchhoff  stress versus Green’s Strain were calculated from the load
displacement  data  assuming  a  cylindrical  cross-sectional  area  of  each  thread  and
calculating  cross-sectional  area  based  on  thread  diameter  measurements  made  as
previously described for swelling ratio.  Ultimate tensile strength (UTS), strain at failure
(SAF), and modulus (E) were calculated from the stress-strain curves.  Post-processing of
the mechanical data considered a strain of zero to be when a thread was minimally loaded
63
Chapter 4: Optimized Self-Assembled Collagen Microthreads:Effect of crosslinking on collagen
to a nominal threshold of 0.01 grams, or less than 1% of the ultimate load for the weakest
uncrosslinked thread.
4.2.4 Enzymatic Degradation of Crosslinked Collagen Threads
Collagen thread degradation in collagenase was assayed for total protein content by
ninhydrin  reactivity.[15]  Two-inch  segments  of  each  type  of  crosslinked  threads
including  uncrosslinked  control  threads  were  cut  into  8  pieces  and  placed  in  a
microcentrifuge tube.  The samples were incubated at 37°C in 200 μL of 0.1M Tris-base,
0.25M CaCl2 solution (pH 7.4) containing 125 U/mL bacterial collagenase (Clostridium
histolyticium, Calbiochem, Inc.) for either 4 or 24 hours.  After incubation, the samples
were centrifuged at 15,000 RCF for 10 minutes and the supernatant was reacted with 2%
ninhydrin reagent (Sigma, St. Louis, MO) in boiling water for 10 minutes.  The optical
density was then measured at 570 nm in a spectrophotometer (SpectraMax, Molecular
Devices, Sunnyvale, CA), and the relative optical density was calculated by subtracting
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Figure  4.1:  Characteristic  stress-strain  relationships  for  self-assembled
collagen  threads.  Representative  stress-strain  curves  for  uncrosslinked  and
crosslinked collagen threads demonstrate a linear trend with failure occurring
instantaneously.  Threads were crosslinked by dehydrothermal treatment for 1
day (DHT-1) or 3 days (DHT-3), by exposure to ultraviolet light for 15 minutes
(UV-15) or 30 minutes (UV-30) or by exposure to carbodiimide (EDC).
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the  value  of  the  background
(collagenase  only  control)
from  the  acquired  optical
density.   The  enzymatic
degradation  of  each  thread
type was assayed in triplicate.
4.2.5 Cell Outgrowth
Bioassay
 Cell outgrowth bioassay
systems  were  constructed
using methods modified from
those  described  in  Chapter
3.2.5.   Raised  rectangular
platforms (0.5 cm X 5 cm) of
Thermanox®  tissue  culture
plastic were elevated 1.5 mm
above the surface of rectangular one-well plates (Nalge Nunc International, Rochester,
NY).  Threads were suspended across the raised platforms spaced 2.5 cm apart, and the
thread ends attached to the tissue culture plates with Silastic® medical adhesive (Dow
Corning, Midland, MI).  The systems were sterilized with 70% isopropanol overnight and
rinsed 3 times in sterile distilled water.  The systems were air dried in a laminar flow
hood prior to seeding.
To seed cell outgrowth bioassays, 0.5-mL aliquots of fibroblast-populated collagen
lattice were placed onto each platform. These lattices were produced by mixing 3.0 mL of
5 × 105 cells/mL subconfluent GFP transduced fibroblasts with 2.4 mL of type I collagen
(2.5  mg/mL)  and 0.6 mL 5 × DMEM.  After  the  gels  were  allowed to  set  at  room
temperature for 1 hr, the one-well plates were filled with 15 mL of DMEM supplemented
with 10% FBS to a height just above the platforms and threads.  Every 24 hours, the
threads were visualized with a Nikon Eclipse TS100 inverted epifluorescent microscope
coupled with a SpotRT CCD Camera (Diagnostic Instruments,  Sterling Heights,  MI).
Measurements of the distance to the furthest  cell  on the thread from the edge of the
platform as the cells migrated out of the gel onto the threads were taken using a calibrated
reticule in the eyepiece of the microscope.  The average velocities reported are averages
of values measured daily between days 3-10.  The system contained 3 samples of each
65
Figure  4.2: Ultimate tensile strength of self-assembled collagen
threads with crosslinking. * denotes statistical difference from all
other conditions by one-way ANOVA
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thread type with 4 sample readings possible per thread, yielding a sample size of 12 per
crosslinking method.  Individual threads were randomly placed in the system, and the
experimenter was blinded to the identities until measurements were complete.  
4.2.6 Fibronectin Adsorption on Collagen Threads
To visualize  variations  in  protein  adsorption  with  crosslinking  on the  surface  of
collagen  threads,  fluorescently  labeled  fibronectin  was  adsorbed  to  the  surface  of
collagen threads.  Collagen threads were placed in 100  μg/mL solutions of fibronectin
(BD Biosciences,  Bedford,  MA)  conjugated  with  Alexafluor  594  (Molecular  Probes,
Eugene, OR) for 24 hours to facilitate for protein adsorption to the surface.  Threads were
rinsed three times in phosphate buffered saline and viewed hydrated using a Texas Red
filter on a Nikon Eclipse E400 microscope. 
4.2.7 Statistical Analyses
Statistical  differences  between  means  of  the  data  were  conducted  by  one-way
ANOVA  with  pairwise  multiple  comparisons  (Holm-Sidak  method)  using  SigmaStat
66
Table 4.2: Mechanical Properties Summary Table for Self-Assembled Collagen Threads
Table 4.1: Summary of Swelling Data and Effective Crosslink Density Calculations
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(Systat  Software  Inc.,  Point
Richmond,  CA).   For  mechanical
testing  and  swelling  ratio
measurements, 20 samples of each
type of crosslinked collagen thread
were tested.  A p < 0.05 indicated a
significant  difference  between
experimental groups.
4.3 RESULTS
4.3.1 The Mechanical
Properties of Self-Assembled
Collagen Threads are
Enhanced by Crosslinking
To  characterize  the  mechanical  properties  of  self-assembled  collagen  threads,
discrete  threads were  loaded under  uniaxial  tension until  failure.   The results  of  this
analysis are summarized in Table 4.1.  Representative stress-strain curves for the threads,
both uncrosslinked and crosslinked, were roughly linear in shape with failure generally
occurring  instantaneously  (Figure  4.1,  pg.  64).   Due  to  the  linearity  of  the  loading
profiles,  the bulk elastic  modulus of each sample was calculated using Hooke’s Law
(σ=Eε).  Relative to the uncrosslinked threads, the ultimate tensile strengths (Figure 4.2,
pg  65) and elastic moduli (Figure 4.3, pg.  67) of self-assembled collagen threads were
significantly  increased  by  each  of  the  crosslinking  methods  that  were  examined.
Similarly, the total elongation before tensile failure (strain at failure) for each crosslinked
thread decreased significantly relative to uncrosslinked collagen threads (Figure 4.4, pg.
68).
Different  crosslinking  techniques,  however,  had  different  effects  on  the  overall
mechanical properties of self-assembled collagen threads (Figure 4.2 and Figure 4.3, pg.
65 and  67).   The ultimate  tensile  strength and bulk elastic  modulus  of  threads DHT
crosslinked  for  3  days  (DHT-3)  were  significantly  higher  then  all  other  crosslinking
techniques.  By 15 minutes of exposure, UV crosslinked threads achieved ultimate tensile
strengths comparable to DHT crosslinking of 24 hours (UV-15 vs. DHT-1).  Doubling
the UV exposure time (UV-15 vs.  UV-30) did not significantly increase the ultimate
tensile strength or elastic modulus of the threads.  The ultimate tensile strengths and bulk
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Figure  4.3:  Elastic  modulus  of  self-assembled  collagen
threads  with  crosslinking.  *denotes  signicant  difference
from all other conditions by one-way ANOVA.
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moduli of EDC crosslinked threads were significantly lower than threads crosslinked by
other crosslinking methods in this study.  The strains at failure for threads crosslinked by
all of the methods in this study were similar to each other and significant less the strains
at failure for uncrosslinked threads (Figure 4.4, pg. 68).
4.3.2 Crosslink Densities Correlate with Ultimate Tensile Strengths of
Threads
To establish a relationship between the mechanical properties of the collagen threads
and structural  properties  of  the  crosslinked and uncrosslinked scaffolds,  the  effective
crosslink densities of the materials were calculated from the volumetric swelling ratios of
the hydrated scaffolds.[9, 11]  Cross-sectional areas of dry threads from each group were
not  statistically  different  from  each  other  (Figure  4.5,  pg.  69).   After  rehydration,
uncrosslinked threads swelled to more than 12 times their dry cross-sectional area with
swelling  ratios  averaging  close  to  4  times  greater  than  those  of  any  UV  or  DHT
crosslinked threads.  EDC crosslinked threads swelled significantly more than threads
crosslinked by other methods in this study (Figure 4.5, pg. 69).  From the Flory-Rehner
equation, these swelling ratios were used to approximate values for the molecular weights
between crosslinks and the effective crosslink densities of the different collagen threads
(Table 4.2), similar to those seen in collagen membranes.  [16] A plot of the ultimate
tensile strengths and the effective crosslink density for each of the thread types in the
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Figure 4.4: Strain to failure values of self-assembled collagen threads with
crosslinking.   Uncrosslinked  controls  were  stistically  greater  than  all
crosslinke conditions by one-way ANOVA.
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study, suggests that there is a strong positive correlation between the two values.  The
ultimate tensile strengths of the crosslinked threads appear to increase proportionally to
the scaffold’s crosslink density (Figure 4.6, pg. 70).  
4.3.3 Crosslinking Affects the In Vitro Enzymatic Stability of the Collagen
Threads
To  characterize  the  enzymatic  stability  of  self-assembled  collagen  threads  after
crosslinking,  we measured  the  relative  degradation of  collagen  scaffolds  by bacterial
collagenase.  The total protein content of thread solubilized after enzymatic digestion was
assayed by ninhydrin reactivity.  Uncrosslinked threads degraded rapidly and by 4 hours
the macroscopic morphology had been completely disrupted.  This complete degradation
was confirmed by equivalent optical density measurements at 4 and 24 hours (Figure 4.7,
pg.  71).   Crosslinking significantly  decreased the  in  vitro  rate  of  degradation for  all
crosslinking techniques.  Unlike the uncrosslinked threads, crosslinked collagen threads
maintained  their  macroscopic  morphologies  at  4  hours,  and  absorbance  values  were
significantly lower when compared to uncrosslinked threads at 4 hours (Figure 4.7, pg.
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Figure 4.5: Cross-sectional area and Swelling.  The mean and standard deviations for dry
and hydrated cross-sectional areas of self-assembled collagen threads are plotted against
the  left  y-axis.   Swelling  ratios  are  plotted  on  top  against  the  right  y-axis.  *denotes
significant difference from all other swelling ratios with a one-way ANOVA
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71).  By 24 hours, all crosslinked threads were significantly more degraded, relative to
the 4 hour time point.  Although statistical differences between crosslinked threads were
not  observed,  EDC crosslinked threads  consistently  demonstrated a  trend towards  an
increased enzymatic stability compared to threads crosslinked by other techniques.
4.3.4 Cell Outgrowth Is Decreased On Crosslinked Threads
To characterize fibroblast interaction with thread surfaces and to predict the rate of
new  tissue  ingrowth,  fibroblast  outgrowth  velocity  was  measured  on  self-assembled
threads.   Average  fibroblast  outgrowth  velocities  were  significantly  greater  on
uncrosslinked self-assembled threads than any crosslinked thread (Figure 4.8, pg.  72).
When velocities on crosslinked collagen scaffolds were compared with each other, EDC
crosslinked  threads  facilitated  significantly  higher  average  rates  than  all  crosslinking
methods, with the exception of threads that were DHT crosslinked for 1 day (DHT-1)
(Figure 4.8, pg.  72).  UV crosslinked threads and threads DHT crosslinked for 3 days
exhibited average velocities less than half the velocity observed on uncrosslinked threads
(0.86 mm/day), and approximately half the rate of EDC crosslinked threads.
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Figure  4.6:  The  effective  crosslink  density  calculated  from the swelling  ratios  of  collagen thread
crosslinked as specified, correlate roughly with an ultimate tensile strength.
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4.3.5 Fibronectin Adsorption
to Collagen Threads is
Dependent on Crosslinking
Technique 
To  assess  protein  binding
affinity  on  the  surfaces  of
crosslinked  collagen  threads,
fluorescently  labeled  fibronectin
was  adsorbed  to  the  scaffolds.
Fluorescent  images  of  fibronectin-
coated  threads  indicate  that  the
protein  binds  uniformly  to  the
surfaces of uncrosslinked and EDC
crosslinked threads (Figure 4.9, pg.
73).   In  contrast,  fibronectin
adsorption  to  DHT  crosslinked
threads appeared to be non-uniform,
with irregular striations and banding
regions that suggest inhomogeneous
protein  adsorption  (Figure  4.9,  pg.
73). 
4.4 DISCUSSION
 The  goal  of  this  study  was  to  investigate  physical  and  chemical  crosslinking
techniques that can enhance the bulk mechanical properties of self-assembled collagen
threads without decreasing the outgrowth velocity on their surfaces.  In a previous study,
we  described  a  technique  to  create  self-assembled  collagen  threads  with  mechanical
properties and fibrillar substructure comparable to native tendon tissue.[4]  A limitation
of  this  technique  is  that  the  threads  must  be  physically  or  chemically  crosslinked to
impart the strength and stiffness necessary to withstand the high tensile load demands of
a ligament tissue.  Until now, cellular responses to crosslinked self-assembled collagen
threads had yet to be characterized.  In the present study, self-assembled collagen threads
were stabilized with one of two physical crosslinking methods or a chemical crosslinking
method.  Uniaxial tensile tests showed that all of the crosslinking techniques significantly
increased the strengths and stiffnesses of the threads (Figure 4.2 and Figure 4.3, pg.  65
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Figure 4.7: Enzymatic stability of self-assembled collagen
threads  Total  protein  content  of  the  supernatant  after
degradation  by  bacterial  collagenase  was  assayed  by
ninhydrin reactivity and reported as a measure of relative
optical density (O.D.) at 4 and 24 hours.  The mean (n=3)
optical density of the background (collagenase only) was
subtracted from the mean (n=3) of each sample type to
calculate relative optical density.  Uncrosslinked threads
were completely degraded by 4 hours and not significantly
different from threads assayed after 24 hours.  (*-indicates
significant  difference  from  all  other  thread  types  at  4
hours)
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and 67) and decreased the enzymatic degradation rates of the scaffolds (Figure 4.7, pg.
71).  While each crosslinking technique also decreased the rate of fibroblast population
outgrowth,  velocity  across  the  surface  of  EDC  crosslinked  threads  was  significantly
greater than on most physically crosslinked threads (Figure 4.8, pg. 72).
In  developing a  functional  construct  to  regenerate  damaged tendon and ligament
tissues, researchers must create scaffolds that can withstand the immediate high tensile
load bearing environment  of the tissue while rapidly integrating with the surrounding
tissue to promote new tissue ingrowth and complete regeneration of the damaged tissue.
Self-assembled collagen threads are a promising material for regenerating tendons and
ligaments  because  of  their  biochemistry  and  structural  homology  to  native  tissue
constructs.   In  previous  model  systems,  it  was  suggested  that  physical  and chemical
crosslinking techniques may limit the performance of collagen scaffolds by decreasing
the cell outgrowth.[2]  
The results of this work confirm that the collagen crosslinking techniques examined
in this study differentially attenuate fibroblast outgrowth velocity on the surfaces of the
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Figure 4.8: Fibroblast Cell Outgrowth Is Decreased By Crosslinking.  Plot showing
means  (n=12)  and  standard  deviations  of  fibroblast  cell  outgrowth  velocities
measured  from  days  3-10  of  culture  for  each  crosslinking  technique.   *Denotes
significant difference from all other conditions.  **Denotes significant difference from
other conditions as indicated.  
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scaffolds.  The relationship between strength with crosslinking and cellular outgrowth
velocity is described in  Figure 4.10, page74.  Cellular outgrowth velocity was plotted
against ultimate tensile strength and fit with standard linear regression (R=0.94).  Using a
Spearman Rank Order Correlation, a correlation coefficient of -0.829 was calculated with
a  p  <0.0583.   This  correlation  coefficient  quantifies  the  strength  of  the  association
between the variables where a value of -1 would indicate a strong negative relationship
between the two variables, with one always decreasing as the other increases.   In this
case,  the p value is  greater than 0.05 and therefore not  strong enough to statistically
correlate the two parameters, but ultimate tensile strength and cellular outgrowth velocity
can still be considered reasonable related.
Interestingly, chemically crosslinking self-assembled collagen threads with EDC did
not increase the strength or stiffness of the scaffolds to the same extent as the physically
crosslinked threads;  however,  fibroblast migration was faster  on the EDC crosslinked
threads.  Furthermore, EDC crosslinked threads swelled to more than 4 times their dry
cross-sectional  area  and  to  a  significantly  greater  extent  than  physically  crosslinked
threads upon rehydration (Figure 4.5, pg. 69).  This increased swelling suggests that the
EDC crosslinked threads have a lower crosslink density and more hydrophilic surface
properties than physically crosslinked threads.  Hydrophilic surfaces have been shown to
enhance  the  biological  activity  of  fibronectin,  a  key  protein  associated  with  cell
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Figure 4.9: FN Attachment is Non-Uniform.  Fluorescently labeled fibronectin (FN) was adsorbed to
the surface of collagen threads (right), compared with no FN controls (left).  The FN adsorbed to the
surface of crosslinked threads was non-uniform and inconsistent.
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attachment,  proliferation,  and  migration[17,  18] and  cells  more  readily  deposit
endogenous fibronectin these surfaces.[19]  In this study, we found that EDC crosslinked
threads allowed for more consistent fibronectin binding than seen on DHT crosslinking
threads as well (Figure 4.9, pg. 73).  DHT crosslinking may alter the surface biochemistry
in a manner that changes the surface wettability and protein conformations critical for
fibroblast interactions with these surfaces.  Our findings are also consistent with studies
suggesting that physical crosslinking techniques such as UV or DHT denature collagen
by unwinding the triple-helix[7, 20] and mask fibroblast integrin binding sites (α1β1 and
α2β1)  that  are  dependent  on  maintenance  of  the  triple-helical  conformation  of
collagen.[21, 22]  It is also unclear whether factors such as variations in matrix stiffness
or surface topography play a role in modulating cell-matrix interactions on surfaces as
discussed in Chapter 3.  We plan to investigate these factors in future studies.
While  none  of  the  crosslinking  methods  investigated  in  this  study  effectively
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Figure 4.10: UTS Correlates to Cell Outgrowth - Cellular outgrowth velocity was plotted as function
of ultimate tensile strength and fit with standard linear regression.  A Spearman rank on correlation
factor was calculated of -0.829 with p<0.0583.  The two parameters are inversely correlated but not
strongly.
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CHAPTER 5: FIBRIN MICROTHREADS:
DEVELOPMENT OF NOVEL FIBRIN MICROTHREADS WITH
COMPARABLE PROPERTIES TO COLLAGEN THREADS
5.1 INTRODUCTION
While self-assembled collagen threads structurally and biochemically mimic native
tendon and ligament, the studies in the previous chapters of this thesis suggest that when
crosslinked, collagen threads may not elicit a response that dynamically regulates the
spatially and temporally complex process of tissue regeneration.  While type I collagen
is  the  basic  structural  protein  of  the  extracellular  matrix  in  healthy  ligament,  it  is
typically not the structural component immediately after injury.  During the initial stages
of wound healing and tissue regeneration, a fibrin provisional matrix is deposited to fill
the  wound  space  and  to  promote  fibroblast  infiltration from the  wound  margin  (see
Chapter 2.4.1).  This fibrin extracellular matrix regulates cell migration, proliferation,
and gene expression through integrin signaling[1-3] and localization of matrix bound
signaling proteins.[4, 5]  Since the ECM plays an important role in the regulation of
wound  healing  and  tissue  regeneration  (see  Chapter  2.3.2),  we  hypothesize  that  the
limitations of collagen thread-based matrices can be overcome through the addition of
the early wound healing structural protein, fibrin.
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Fibrin is  polymerized enzymatically  in vivo as part  of the natural  wound healing
cascade.  Initially fibrinogen, found in blood plasma at a concentration of 3 mg/ml, is
modified by the enzyme thrombin to expose binding sites in the central portion of the
elongated protein.[6, 7]  The fibrinogen monomers then assemble laterally in an end-to-
middle ½-staggered overlap pattern, forming long fibers.  These fibers further aggregate
laterally and branch into complex networks that constitute the fibrin matrix.[6, 7]
Similarly,  these  processes  are  duplicated  in  vitro for  the  development  of
biomaterials.  Unfortunately, traditional fibrin biomaterials lack the strong mechanical
properties demanded by high load bearing applications such as ligament regeneration.
The  structural  properties  can  be  modified,  most  significantly,  by  altering  the  initial
fibrinogen concentration.  For example, fibrin hydrogels are produced at low fibrinogen
concentrations and have been widely studied for engineering applications ranging from
cardiovascular grafts[8-11] to bioengineered cartilage.[12-14]  However, like most gels,
these materials are of limited mechanical strength.  Higher fibrinogen concentrations are
commercially available in adhesive sprays or glues used as sealants to control bleeding
during surgery[15-18] and have recently been investigated for cell delivery.[19-21]  To
take  advantage  of  the  wound  healing  cell-signaling  capabilities  of  fibrin  and  to
compensate for its lack of mechanical strength, cells have been seeded in fibrin gels onto
a polymer mesh[22] for cardiovascular[23] and orthopedic applications.[24, 25]
 Fibrin  matrices  or  scaffolds  synthesized  with  a  thread  morphology  would
theoretically benefit from the structural and mechanical advantages of fiber or thread-
based structures.  Most notably, cylindrical substrata with diameters  less than 100  μm
facilitate  contact  guidance,  the  natural  alignment  and  orientation  of  cells.[26]
Particularly in a highly aligned connective tissues such as the ACL (See Chapter 2.1.1.1),
aligned  fibroblasts  will  lead  to  aligned  matrix  deposition  and  ultimately  improved
strength  and  regeneration.   Secondly,  fibrin  threads  will  likely  possess  elevated
mechanical  strengths  and  stiffnesses  for  improved  handling  and  manipulation  for
assembly into macro-structures.  We theorized that a fibrin fiber could be produced by
beginning with high concentration fibrinogen[27] and by using extrusion technologies
similar to those for collagen thread production.[28]  Threads produced in this manner
should attain sufficient mechanical  stability to allow for integration with other thread
scaffolds while concurrently promoting the cell  alignment and aligned ECM deposition
seen on fiber scaffolds.
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Therefore, the second goal of this thesis was to develop fibrin microthreads with
comparable  morphology to collagen threads that can be combined with other matrices
for  ligament  tissue  regeneration,  to  ultimately  guide  wound  healing  spatially  and
temporally, through  aligned regeneration, growth factor delivery, and variable matrix
signaling.
This chapter will focus on the manufacturing and production development of fibrin
microthreads,  while  Chapter  6  will  investigate  the  cell  response  to  these  optimized
threads.   Fibrin  microthread  production  parameters  were  investigated  for  tensile
properties in order to quantify and maximize mechanical integrity.  Subsequently, these
optimized  microthreads  were  probed  for  their  morphological  similarities  to  collagen
threads.
5.2 MATERIALS AND METHODS
5.2.1 Fibrin Microthread Manufacturing
5.2.1.1 Material Preparation
Fibrin  microthreads  were  co-extruded from solutions  of  fibrinogen and thrombin
using  extrusion  techniques  similar  to  methods  described  previously  (Chapter  4,5
Methods).  Fibrinogen from bovine plasma (Sigma, St. Louis, MO F4753) was dissolved
in HEPES Buffered Saline (HBS, 20 mM HEPES, 0.9% NaCl, pH 7.4) at 70 mg/mL and
stored at -20  oC.  Thrombin from bovine plasma (Sigma, St. Louis, MO T4648) was
stored frozen as a stock solution at a concentration of 40 U/mL in HBS.  A working
solution of thrombin was diluted from the stock to a final concentration of 6 U/mL in 40
mM CaCl2 solution.  Both the fibrinogen and thrombin solutions were warmed to 37 
oC
and placed into separate 1 mL syringes and were inserted into a blending applicator tip
(Micromedics, Inc., St. Paul, MN). The blending applicators luer lock to the two syringes
through individual bores and mix in a needle that luer locks to the tip.  The solutions were
combined and extruded through polyethylene tubing (BD, Sparks,  MD) with an inner
diameter of 0.38 mm into a bath of 10 mM HEPES (N-[2-Hydroxyethyl]piperazine-N'-
[2-ethanesulfonic acid]) in a Teflon® coated pan.(Figure 5.1, pg. 80)
5.2.1.2 Coextrusion
The  solutions  were  coextruded  with  variable  parameters  using  an  automated
extrusion device (See appendix B for more detail).  The custom-designed device consists
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of  motorized  2-D  plotter,  controlled  with  Labview  software  (National  Instruments,
Austin, TX) for spatial control of extrusion tubing tip and a stabilized crosshead on a
threaded rod for control of extrusion fluid volume and rates (See Appendix A).  
To  characterize  the  effects  of  varying  the  extrusion  rate  and  crosshead  speed,
microthreads were extruded at a range of syringe pump extrusion rates (0.125, 0.250,
0.500  ml/min)  and  with  varying speed  through the  bath  (550,  1100,  2200 mm/min).
Therefore, with a tubing diameter of 0.38mm, the calculated velocities ranged from 1.84
– 7.35 cm/s for both the plotter and the flow. During data analysis, it became clear that
the speed of the tubing through the bath (plotter velocity) and the speed of the fibrin
solution  out  of  the  tubing  (flow  velocity)  were  directly  and  inversely  correlated.
Therefore,  to  more  accurately  represent  the  results,  these  data  were  compiled  and
described in the results as a rate ratio defined as:
rate ratio= flow velocityplotter velocity
As such, a reported rate ratio of 2 has a mean flow velocity twice as fast as the tubing tip
moves through the bath.  At rate ratios below 1, cohesive threads could not be formed and
were therefore not investigated further.  
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Figure  5.1: Schematic Drawing of Co-extrusion System. Fibrin microthreads were co-extruded at a
crosshead speed of 4.25 mm/min from solutions of fibrinogen and thrombin in 1ml syringes through a
blending connector and into a buffered bath.  The threads were hand drawn through the bath at a rate
approximately matching the flow rate of polymerizing solution from the tubing.
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The pH and temperature of the extrusion solution were also varied and investigated
for their affect on fibrin microthread tensile properties.  The 10 mM HEPES solution was
either heated to body temperature (37oC) or left at room temperature (20oC) and the pH of
the bath was adjusted to either low (6.0), body (7.4), and high (8.0) values.
Finally, threads were removed from the bath, air dried under the tension of their own
weight, and stored at room temperature in a desiccator until use.
5.2.2 Microthread Material Characterization 
5.2.2.1 Scanning Electron Microscopy (SEM)
Fibrin  microthreads  were  imaged  with  a  scanning  electron  microscope  to
characterize thread morphology and surface topography.  Air dried fibrin threads were
mounted on aluminum stubs (Ted Pella, Inc., Redding, CA) coated with double-sided
carbon tape and sputtered coated with a thin layer of gold-palladium for 30 seconds.
Images were acquired at 15kV using a JSM-KLG scanning electron microscope.
5.2.2.2 Thread Swelling
Qualitative volumetric analyses based on the swelling ratio of fibrin threads were
performed using methods described previously.[28]  The cross-sectional  area of  each
thread was calculated from an average of three diameter measurements along its length,
assuming cylindrical thread geometry.  The diameters were measured both dry and after
hydration for at least 30 minutes in phosphate buffered saline (PBS) using a 20x objective
on a Nikon Eclipse E400 microscope fitted with a calibrated reticule.  The swelling ratio
was calculated as the ratio of the wet cross-sectional area to the dry cross-sectional area
for each discrete thread.
5.2.2.3 Mechanical Properties
Microthreads were hydrated and mechanically loaded in uniaxial tension to obtain
stress-strain curves.  Individual threads were mounted vertically with adhesive (Silastic
Silicone Type A, Dow Corning) on vellum frames with precut windows that defined the
region of loading.  For tensile testing, the samples in the vellum frames were clamped
into a custom designed micromechanical testing unit (See Appendix B) consisting of a
horizontal linearly actuated crosshead and a fixed 150g load cell.  Test unit operations
and  data  acquisition  were  controlled  with  LabView  software  (National  Instruments,
Austin, TX).  An initial gauge length of 20 mm was defined as the distance between
adhesive spots across the precut window in the vellum frame.  Threads were hydrated for
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at least 30 minutes prior to testing, but were not tested submerged.  After loading into the
testing apparatus, the edges of each frame were cut leaving the thread intact.  The threads
were then loaded to failure at a 50% strain rate (10 mm/min).  Curves of the 1st Piola
Kirchhoff stress versus Green’s Strain were calculated from the load displacement data
assuming a cylindrical cross-sectional area of each thread and calculating cross-sectional
area based on thread diameter measurements as described above for swelling ratio.  Post-
processing of the mechanical data considered a strain of zero to be when a thread was
minimally loaded to a nominal threshold of 0.01 grams, or less than 1% of the ultimate
load for  the weakest  uncrosslinked thread.   Ultimate  tensile  strength (UTS),  strain at
failure (SAF), and the max tangent modulus or stiffness (E) were calculated from the
stress-strain curves.  The stiffness was defined as the maximum value for a tangent to the
stress-strain curve over an incremental strain of 0.03.
5.2.3 Statistical Analyses
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Figure  5.2:  Characteristic  Stress-Strain  Curves.   Plots  of  stress  (MPa)  versuse  strain
(dimensionless) are reported for hydrated fibrin microthreads (blue points, N=19) under optimized
production conditions.  The red curve represents an average characteristic stress-strain curve with
a toe region exhibiting low stress, followed by a roughly linear higher modulus region until ultimate
failure.
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Statistical  differences  between
means of the data were conducted by
one-way  ANOVA  with  pairwise
multiple  comparisons  (Holm-Sidak
method)  using  SigmaStat  (Systat
Software Inc., Point Richmond, CA).
Values  reported  are  means  and
standard  deviations  unless  otherwise
stated.   A  p  <  0.009  indicated  a
significant  difference  between
experimental groups.
5.3 RESULTS
Fibrin  microthreads  were
coextruded  from  solutions  of
fibrinogen  and  thrombin  into  an
aqueous buffer and formed largely at
the bottom of the bath.  Upon removal
from  the  bath,  the  threads  stretched
and elongated to approximately twice
their  length  while  thinning
considerably  in  cross-sectional
diameter.   All  the  feasible  process
parameters  were  varied  when
possible.   The  fibrinogen
concentration  was  maximized,  by
design, and therefore not varied.  Altering the thrombin concentration led to no cohesive
thread  or  clogging  of  the  tubing  and  was  therefore  excluded  from  later  analyses.
However, the rate ratio, bath temperature and bath pH were scalable vectors and did alter
the overall microthread mechanical properties as described in the appropriate sections
below.  
Hydrated fibrin microthreads were tensile tested until failure and the resulting force-
displacement  data  were  graphed  as  stress  versus  strain.  In  general,  the  tensile  data
collected demonstrated similar characteristic stress-strain plots.  Samples typically began
with toe  region exhibiting low stress,  followed by a  high strain  region of  increasing
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Figure  5.3: Tensile Properties With Varied Rate Ratio.
Fibrin  microthreads  coextruded  at  a  rate  ratio  of  1
demonstrated  low  failure  tensile  strength  and  failure
loads.  The ultimate tensile strength was maximized at a
ratio of 2 to 1, flow velocity to plotter velocity.
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elongation  roughly  correlating  with  the
expulsion of water from the microthread
interior  as  visualized  during
experimentation.  This was followed by a
roughly  linear,  higher  modulus  region
that  continued  until  ultimate  failure.
Stress  strain  curves  for  what  was
eventually  determined  to  be  optimized
production  parameters  are  displayed  in
Figure  5.2,  page  82,  with  an  average
characteristic curve highlighted in red.
5.3.1 Effect of Rate Ratio
Variation
The ratio of the flow velocity to the
plotter  velocity  was  varied  and
investigated for its effects on microthread
diameter  and  tensile  properties.   The
ultimate  tensile  strength  averaged 4.78
MPa  for  a  rate  ratio  of  2  while  ratios
either  above  or  below  2  resulted  in
statistically lower tensile strength (Figure
5.3, pg. 83).  However, the load to failure
for rate ratios 2 and 4 were similar and
both load values were greater than at a rate ratio of 1 (Figure 5.3, pg. 83).  Furthermore,
increasing the rate ratio increased both the wet diameter (Figure 5.4, pg.  84) and the
strain to failure (Figure 5.4, pg. 84) in a roughly linear fashion. 
5.3.2 Effect of Bath pH and Temperature
The temperature and pH of the 10mM HEPES bath solution was varied to determine
the effect on microthread tensile properties.  At a relatively neutral pH (7.4) and at a
higher pH (8.5),  the microthread tensile strength was significantly higher than at lower
pH (6.0) (Figure 5.5, pg. 85).  However the maximum strength was attained at  pH 7.4,
which is roughly the pH of the human body in which fibrin formation typically occurs.
Finally, the tensile strength of microthreads produced at room temperature (25  oC) was
statistically greater than those produced at body temperature of 37 oC (Figure 5.5, pg. 85).
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Figure  5.4:  Diameter  and  Strain  to  Failure  With
Rate Ratio.  The wet diameter and ultimate failure
strain increased linearly with increasing rate ratio
although  linear  regression  correlations  are  not
strong when fitting less than 5  data points.
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5.3.3 Fibrin Microthread Morphology
  The morphology of coextruded fibrin microthreads was evaluated with scanning
electron microscopy.  Fibrin microthreads were consistently and repeatably cylindrical in
shape throughout  the length of the fiber (Figure 5.6,  pg.  87).   The surfaces of fibrin
microthreads were generally  smooth  with limited to  no surface roughness  on a scale
greater than 5 um.  Submicron surface roughness was observed with high magnification
SEM images, but was not quantitatively characterized (Figure 5.6, pg. 87). 
5.4 DISCUSSION
The  goal  of  this  chapter  was  to  develop  fibrin  microthreads  with  a  comparable
morphology  to  collagen  threads.   Achieving  this  goal  would  produce  threads  with
structural and mechanical properties sufficient for the post-manufacture manipulation and
ultimate  fabrication  of  composite  thread  matrices  for  ligament  tissue  regeneration.
Furthermore, we sought to optimize the parameters of fibrin microthread production to
ultimately  achieve  manufacturing  practices  that  could  repeatedly  produce  consistent
microthreads with these optimized morphological characteristics.  
As many process parameters as possible were varied so long as cohesive threads
were ultimately formed.  The first parameters investigated were the velocity of the tubing
through the bath and the velocity of the fibrin solution flowing out of the tubing into the
bath.  These two values were inversely correlated, and were therefore combined into a
rate ratio for improved analysis.  Doubling the rate ratio resulted in close to a three fold
increase  in  the  ultimate  tensile  strength  and  a  10-fold  increase  in  load  to  failure.
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Figure 5.5: Tensile Strength With Varied pH and Temperature.  The ultimate tensile strength of fibrin
microthreads was optimal at a pH close to body pH and at room temperature. *denotes significant
difference from all other conditions, p<0.05
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However,  a  further  increase  in  rate  ratio  resulted  in  similar  loads  at  failure,  but  a
decrease in ultimate tensile strength.   These results  can partially be explained by the
resulting diameters and strains of the microthreads extruded at different rate ratios.  With
increasing rate ratio, the flow out of the tubing was faster than the rate of the tubing
moving  through  the  bath.   This  resulted  in  an  excess  material  deposition  rate  and
therefore  increasing  diameters  and  cross-sectional  areas.   Furthermore,  the  strain
increased linearly as the microthread diameter increased.  This suggests that during the
stretching  of  failure  mode  testing,  the  Poisson's  effect  was  more  apparent  in  large
diameter  threads.   This  is  consistent  with  our  visual  observations  that  during
experimentation, the threads thinned before reaching a critical point of increasing load.
The pH and temperature of the fibrin assembly bath were also modified and tested
for  their  effect  on  the  mechanical  properties  of  the  assembled  microthreads.   These
parameters were chosen under the hypothesis that either pH or temperature may alter the
aggregation of protofibrils during fibrin assembly and ultimately alter the larger scale
mechanical properties.  Previous research demonstrated that the mean sub-micron fiber
diameter  of  the  fibrin architecture varied over  a range of  pH 6.0 to 8.5.[29]  In  our
studies, neither increasing nor decreasing the pH of the fibrin assembly buffer increased
the tensile  strength of the resulting fibrin microthreads.   Furthermore,  optimal  tensile
properties were observed at neutral physiologic pH of 7.4.  Lowering the temperature of
the assembly buffer, from 37 oC to 25 oC, did not have dramatic effects on ultrastructural
properties of fibrin microthreads.  This is consistent with research suggesting that the
sub-micron mean fibril diameter of fibrin did not significantly change between 0, 20, and
37 oC.[29]  In fact, the tensile strength was slightly increased at 25 oC, which ultimately
may simplify the need to maintain temperature during manufacture.
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Table  5.1:  Side-by-side  Comparison  Table  of  Self-Assembled  Collagen  Threads  and  Fibrin
Microthreads
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Fibrin microthreads can be manufactured with morphological properties comparable
to  those  of  self-assembled  collagen  threads  (Summarized  in  Table  5.1,  pg.  86).
Optimized fibrin microthreads attained ultimate tensile strengths of approximately 4.5 +/-
1.8 MPa.  These values are similar to uncrosslinked collagen threads of similar diameter
and are substantially higher than the strength values of 6.0 kPa +/-  2.0 kPa, reported
previously for fibrin gels[30].  These relatively high mechanical properties are not only
advantageous for high load bearing applications including tendons and ligaments,  but
allow for the post-assembly manufacture of braided or woven fibrin scaffolds as well as
composite  scaffolds  of  fibrin  and  other  thread  matrices,  especially  collagen-fibrin
composites.  Although the amount of strain in the low stress regions is greater than that of
uncrosslinked collagen, the strains to failure are not statistically different from collagen
threads  and  the  general  stress  strain  curve  shape  is  similar,  thereby  limiting  stress
shielding effects.   
Morphologically, fibrin and collagen threads share many similar characteristics as
well.  Fibrin microthreads are cylindrical in shape and maintain a consistent cylindrical
shape along the length of the thread.  The diameters are on the same approximate size
scale  as  collagen threads,  typically  ranging from approximately 80 to  100  μm when
hydrated.  Furthermore, the surfaces of fibrin microthreads were quite smooth with a sub-
micron  surface  structure  when  imaged  dehydrated  using  SEM.   Although  collagen
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Figure 5.6: SEM of Collagen and Fibrin Biopolymer Microthreads.  Scanning electron micrographs
demonstrate submicron surface texture on collagen (left) and fibrin (right) microthreads.  Both thread
types have similar cylindrical morphology and consistent diameter.
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microthreads had increased surface roughness, the texture was nominally greater that that
found on fibrin microthreads.
Although  the  development  of  repeatable  and  consistent  fibrin  microthreads  was
successfully demonstrated, the current manufacturing process is not without limitations
or  need  for  further  study.   Current  manufacturing  utilizes  a  syringe  pump extruding
solutions  through  small  diameter  polyethylene  tubing,  approximately  60-80  mm  in
length.   Given  it's  natural  function  as  a  clotting  agent,  fibrin  has  a  propensity  for
polymerizing  within  the  length  of  tubing,  preventing  further  extrusion,  as  well  as
exacerbating  the  already  high  pressure  generated  at  the  junction  between  the  large
diameter syringes and the small diameter tubing.  Therefore, fibrin thread assembly and
polymerization must occur largely outside the confines of the tubing.  This limits the
ability  to  control  certain  biochemical  aspects  of  fibrin  assembly,  such  as  rate  of
polymerization.  The diameter and shape of fibrin microthreads are dictated in part by the
diameter of the tubing, but more significantly by the manual stretching that occurs during
the removal from the formation bath, as well as through gravitational loading from the
threads own mass during drying.
Future studies should investigate natural crosslinking methods, material purity, and
fibrin substructure.   In vivo, fibrin networks are stabilized through crosslinks added by
factor XIIIa,  a transamidase of the tranglutaminase family of enzymes activated from
factor XIII by thrombin and Ca2+.  Therefore the use of transglutaminases during fibrin
polymerization  could  increase  the  strength  and  stiffness  of  fibrin  microthreads.   Our
preliminary data found no increases in tensile strength or stiffness with the addition of
transglutaminase  in  low  doses  (data  not  shown);  however,  these  experiments  were
inconclusive  and  likely  require  further  investigation  of  experimental  techniques  to
acquire more conclusive results.  Furthermore, the ultrastructural properties of the fibrin
fibrillar networks both with and without transglutaminase were not investigated therein
and need further study.  In addition, the starting material used for these studies contains a
significant amount of clottable protein as well as fibrinogen.  Therefore other proteins
may potentially be contained in the mixture including transglutaminase and fibronectin
both of which have been shown to alter fibrin polymerization and cell matrix interactions,
respectively.[18,  31]   Future  studies  should  investigate  the  effects  of  high  purity
fibrinogen preparations on mechanical properties and cellular responses.
In this study, fibrin microthreads were developed with comparable morphological
and  mechanical  properties  to  self-assembled  collagen  threads.   Fibrin  microthreads
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exhibited  consistent  cylindrical  shape  on  a  size-scale  roughly  equivalent  to  collagen
threads  and  with  a  similar  sub-micrometer  surface  roughness.   The  resulting  threads
demonstrated strengths and stiffnesses orders of magnitude greater than fibrin hydrogels
suggesting  that  these  materials  have  significant  utility  for  load  bearing  applications.
Furthermore, these materials can be sterilized, dehydrated, and manipulated by hand or
machine to construct oriented, woven, or composite thread matrices.
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CHAPTER 6: CELLULAR INTERACTIONS ON
FGF-LOADED FIBRIN MICROTHREADS:
EFFECT OF COEXTRUDED FGF-FIBRIN THREADS ON FIBROBLAST
ALIGNMENT, PROLIFERATION, AND MIGRATION
6.1 INTRODUCTION
Fibrin microthreads represent a novel biopolymer material composed of the natural
structural protein of healing tissues but in the conformation of a mechanically robust
thread  matrix  that  can  be  assembled  into  aligned  bundles  for  tissue  regeneration.
Chapter  5  of  this  thesis  demonstrated  the  development  and  characterization of  these
fibrin microthreads with with similar morphology to collagen threads.  However, the
power of fibrin microthreads lies in their potential interactions with cells and growth
factors.  
The fibrin matrix that assembles  in vivo to seal the wound bed acts as a sink for
growth  factors  and  cytokines  while  promoting  the  migration  and  proliferation  of
fibroblasts from the wound margin (See Chapter 2.4).  In particular, fibrin has a high
binding affinity for fibroblast growth factor-2 (FGF-2) which has been implicated as key
example in the matrix bound localization of this signaling protein to promote wound
healing.[1, 2]  FGF-2  specifically  binds and saturates both fibrinogen and polymerized
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fibrin with low Kd values ranging from 1.3 nM for high affinity sites to 260 nM for low
affinity binding sites.[1]  Therefore, in normal plasma concentrations, all FGF-2 should
be bound to fibrinogen[1] and in vivo,  FGF is likely stored in a bound state, becoming
functionally  available  upon  release[3].   FGF-2  binding  to  fibrin  prevents  proteolytic
degradation  [4] and  has the potential to facilitate the aggregation of growth factor and
integrin receptors to promote signal integration.[5]  Integrin αvβ3 and FGFR1 colocalize
when both fibrinogen and FGF-2 are present  [6] within the focal adhesion complex.[7]
Together,  fibrin and FGF-2 potentiate  cell  proliferation[2]  in a manner not seen with
FGF-1,[5] and to do so, requires the integrin  αvβ3.[6, 8]  Additionally, fibrin acts as a
cofactor with FGF-2 in regulating gene expression of proteins involved in pericellular
matrix degradation.[9]  Combined, this data suggests that the matrix aids in the  spatial
regulation of FGF-2, integrins, and signaling to direct wound healing.  
Specifically, the effects of FGF-2 have been investigated on tendon and ligament
during both in vitro and in vivo experiments and most typically demonstrating increased
wound healing characteristics.[10]  In vitro, FGF-2 increases proliferation[11, 12] as well
as migration of tendon fibroblasts in a wound closure model[12] while upregulating the
expression of integrins αvβ3 and α5β1, which are important for angiogenesis and tendon
healing.[8]  In  vivo,  after  injection  into  healing  tendons,  FGF-2  increased  type  III
collagen content as well as tenocyte proliferation.[13]  Using an in vivo canine ligament
model,  addition  of  FGF-2  increased  the  healing  response  marked  by  enhanced
neovascularization.[14]  Similarly, early wound healing was enhanced with the addition
of FGF-2 in a fibrin gel to a defect MCL model.[15]
Additionally, fibrin matrices synthesized with a thread morphology would benefit
from the structural and mechanical advantages of fiber or thread-based structures.  Most
notably, cylindrical substrata with diameters less than 100 μm facilitate contact guidance,
the  natural  alignment  and  orientation  of  cells.[16]   Particularly  in  a  highly  aligned
connective  tissues  such  as  the  ACL (See  Chapter  2.1.1.),  aligned  fibroblasts  lead  to
aligned matrix deposition and ultimately improved strength and regeneration.[17, 18]      
Therefore  the  goal  of  this  chapter  was  to  demonstrate  the  potential  of  fibrin
biopolymer microthreads to regenerate torn ligaments by delivering FGF-2 to promote
migration and proliferation while simultaneously promoting fibroblast  alignment in a
physiologically relevant manner.
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This chapter will investigate the cell response to the optimized fibrin microthreads
developed in Chapter 5 as the control material compared to fibrin threads loaded with
increasing concentrations of FGF-2.  The effect of FGF-2, loaded in the threads during
assembly,  was  determined  on  attachment,  proliferation,  and  migration  as  well  as
fibroblast alignment and cytoskeletal orientation.
6.2 MATERIALS AND METHODS
6.2.1 Fibrin Microthread Manufacture
Fibrin  microthreads  were  co-extruded from solutions  of  fibrinogen and thrombin
using extrusion techniques described in Chapter 5.2.1.  Fibrinogen from bovine plasma
(Sigma, St. Louis, MO F4753) was dissolved in HEPES Buffered Saline (HBS, 20 mM
HEPES, 0.9% NaCl) at 70 mg/mL and stored at -20 oC.  Thrombin from bovine plasma
(Sigma, St. Louis, MO T4648) was stored frozen as a stock solution at a concentration of
40 U/mL in HBS.  A working solution of thrombin was diluted from the stock to a final
concentration  of  6  U/mL  in  40  mM  CaCl2 solution.   Human,  recombinant,  basic
fibroblast growth factor (FGF-2) (Calbiochem, La Jolla, CA) was diluted to 5 μg/mL in
phosphate buffered saline and 0.1% bovine serum albumin, aliquotted, and stored frozen
at -80 oC.
Fibrinogen,  thrombin and FGF solutions were warmed to 37  oC and placed into
separate 1 mL syringes which were inserted into a blending applicator tip (Micromedics,
Inc.,  St.  Paul,  MN).  The  blending  applicator  luer  locks  to  the  two  syringes  through
individual bores and mix in a needle that luer locks to the tip of the applicator.  The
solutions were combined and extruded through polyethylene tubing (BD, Sparks, MD)
with  an  inner  diameter  of  0.38  mm  into  a  bath  of  10  mM  HEPES  (N-[2-
Hydroxyethyl]piperazine-N'-[2-ethanesulfonic  acid])  in  a  Teflon®  coated  pan.   For
threads incorporating growth factor, 40 μl aliquots of FGF-2 stock solution were added to
the fibrinogen solution to reach the desired final concentration and vortexed immediately
prior to extrusion.
Finally, threads were removed from the bath, air dried under the tension of their own
weight, and stored at room temperature in a desiccator until use.
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6.2.2 Cell Culture
Human dermal fibroblasts isolated from neonatal foreskins as previously described
(Chapter 3.2.3) were used for all experiments.  For the cell outgrowth assay, fibroblasts
were  modified  to  overexpress  GFP  as  previously  described  (Chapter  3.2.4).   GFP
modified  and  non-modified  fibroblasts  were  cultured  in  Dulbecco’s  Modified  Eagles
Medium (DMEM; Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine
serum (FBS; Atlanta Biologicals, Lawrenceville, GA) and penicillin/streptomycin (100
U/ 100 μg per mL) (Gibco BRL, Gaithersburg, MD)).  Fibroblasts were incubated at 37
oC in 10% CO2.  GFP fibroblasts (P10-13)  were used for the cell outgrowth bioassay and
non-modified fibroblasts (P7-12) were used for all other assays.
6.2.3 Attachment and Proliferation
6.2.3.1 Thread Bundle Seeding and Culture
To quantify attachment, fibroblasts were seeded onto bundles of normal and FGF-
loaded fibrin microthreads.  To facilitate handling, bundles composed of 10 threads were
adhered to stainless steel rings (ID: 0.750 in, OD: 1.188 in, thickness: 0.005 in, Seastrom,
Twin Falls, ID) with Silastic medical adhesive (Silicone type A, Dow Corning, Midland,
MI).  Bundles were placed individually into wells of a six-well plate containing a 1cm
square of Thermanox® tissue culture plastic (Nalge Nunc, Rochester, NY) adhered to the
center of the well.  Plates were dessicated overnight allowing the silicone to cure.  The
bundles were sterilized in the wells  with 70% isopropyl alcohol,  rinsed 3 times with
sterile  PBS  and  air  dried  overnight.   Fibroblasts  were  seeded  at  a  concentration  of
300,000 cells/mL onto fibrin threads suspended over the Thermonox® square, in a 100 μL
bolus  of  DMEM  containing  10%  FBS  and  incubated  under  normal  cell  culture
conditions.  After 30 minutes, 2 mL of DMEM containing 2% FBS was added to each
well and returned to the incubator.  
After  4  hours  of  attachment,  fibrin  microthread bundles were  transferred to  new
wells  retaining  only  cells  attached  to  the  bundles.   For  determination  of  attachment,
bundles  were  immediately  processed  for  image  acquisition  as  described  below.   For
proliferation, 2 mL of DMEM containing 2% FBS was added to each well and the plate
were returned to normal incubation conditions for a duration of 2, 5, or 7 days. 
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6.2.3.2 Cell Count Quantification
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Figure 6.1: Proliferation Quantification.  Example of 1 of 5 images taken along the length of thread
bundles at  each time point  (left).   Fibroblasts  nuclei  were stained with  Hoechst  nuclear  dye and
images were acquired at 4x magnification (left).  These images were processed with edge detection
software to clarify nuclei (right), then these nuclei were counted with a particle analysis algorithm.
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For quantification, bundles were imaged and cell nuclei counted for determination of
the total number of attached fibroblasts.  Fibrin thread bundles were rinsed once with
sterile  PBS,  and  incubated  with  17mM  Hoechst  nuclear  reagent  in  PBS  (Molecular
Probes, Eugene, OR) for 15 minutes at room temperature.  Bundles were then rinsed in
PBS to clear excess stain, removed from the attachment rings, and placed on slides with
coverslips for viewing and image acquisition.  For each thread bundle, 5 images were
acquired covering the end to end length of the bundle at 4x magnification (Figure 6.1, pg.
95).  The total count for each image was summed for the 5 images of the bundle to
acquire a total cell count.  Images were processed and cell quantity determined using
ImageJ  software  (open  source  software,  NIH).   Images  were  processed  with  edge
detection and converted to binary optimized for cell density (Figure 6.1, pg. 95).  Nuclei
were counted using a particle detection algorithm assuming particles sizes greater than 10
pixels.  This process was repeated on three separate bundles for each condition, giving a
sample size of 3 for each condition.
6.2.4 Cell Outgrowth
Cell outgrowth was determined using the assay developed in Chapter 3.  Briefly,
raised rectangular platforms (0.5 cm X 5 cm) of Thermanox® tissue culture plastic were
elevated  1.5  mm  above  the  surface  of  rectangular  one-well  plates  (Nalge  Nunc
International, Rochester, NY).  Microthreads were suspended across the raised platforms
spaced 1 cm apart, and the thread ends attached to the tissue culture plates with Silastic®
medical adhesive (Dow Corning, Midland, MI).  The systems were sterilized with 70%
isopropanol overnight and rinsed 3 times in sterile PBS.  The systems were air dried in a
laminar flow hood prior to seeding.
To  seed  cell  migration  assays,  0.5-mL  aliquots  of  fibroblast-populated  collagen
lattice were placed onto each platform. These lattices were produced by mixing 3.0 mL of
5 × 105 cells/mL subconfluent GFP transduced fibroblasts with 2.4 mL of type I collagen
(2.5  mg/mL)  and 0.6 mL 5 × DMEM.  After  the  gels  were  allowed to  set  at  room
temperature for 1 hr, the one-well plates were filled with 20 mL of DMEM supplemented
with 2% FBS to a height just  above the platforms and threads.   Every 24 hours, the
threads were visualized with a Nikon Eclipse TS100 inverted epifluorescent microscope
coupled with a SpotRT CCD Camera (Diagnostic Instruments,  Sterling Heights,  MI).
Measurements of the distance to the furthest  cell  on the thread from the edge of the
platform as the cells migrated out of the gel onto the threads were taken using a calibrated
reticule in the eyepiece of the microscope.  The average migration rates reported are
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averages of values measured daily between days 3-6.  The sample size was determined
from the number of viable microthread-platform intersection sites.  Individual threads
were randomly placed in the system, and the experimenter was blinded to the identities
until measurements were complete.  
6.2.5 Fixing and Staining
For  determination  of  fibroblast  alignment  and  orientation,  bundles  of  fibrin
microthreads were seeded with cells, fixed, and stained.  Bundles of 10 microthreads of
each type were assembled and seeded as described (Section 6.2.3.1, pg 94).  After 4 hours
of attachment, bundles were rinsed twice in PBS and fixed in 4% formaldehyde (Ted
Pella, Redding, CA) and 0.2% Triton (Sigma, St. Louis, MO).  Samples were rinsed 2
times in a PBS and incubated for 15 minutes in PBS and 1%BSA. Samples were then
stained with 165 nM Alexaflour  488 phalloidin (Molecular  Probes,  Eugene,  OR) and
17mM Hoechst nuclear reagent (Molecular Probes, Eugene, OR) for 45 minutes.
For  imaging  of  attachment  and  proliferation,  as  well  as  determining  viability,
bundles  of  fibrin  microthreads  stained  with  a  live/dead  stain.    Bundles  of  10
microthreads were assembled and seeded as described (Section 6.2.3.1, pg 94).  After 4
hours of attachment, bundles were removed from the seeding wells and transferred to a
new  well  for  staining.   Half  of  these  samples  were  immediately  stained,  while  the
remaining  were  cultured  for  7  days  under  normal  culture  as  indicated  previously.
Bundles  were  incubated  after  removal  of  media,  in  1.5  mL  of  a  4  μM  ethidium
homodimer-1 and 2 μM calcein AM solution (Molecular Probes, Eugene, OR).  Bundles
were incubated at room temperature for 30 minutes.  Calcein (green, Ex/em 495nm/515
nm) is retained in living cells while ethidium (red, Ex/em 495nm/635 nm) is excluded by
intact plasma membrane, but enters damaged membranes where it  can fluoresce upon
binding to nucleic acid.  Thread bundles were then cut from attachment rings and placed
on slides for fluorescent imaging.  Images were then acquired on a Nikon Eclipse E400
microscope.
6.2.6 Scanning Electron Microscopy (SEM)
For SEM, samples were fixed either after seeding as previously described (Section
6.2.3.1,  pg  94)  or  after  cell  outgrowth  during  5  days  in  the  bioassay,  cultured  as
previously described (Section 6.2.4, pg 96).  Reagents for SEM were purchased from Ted
Pella, Redding, CA unless otherwise stated.  The media was removed and samples were
fixed in a modified Karnovsky fixative of 2% gluteraldehyde, 4% formaldehyde, 0.1M
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cacodylate  and 4mM CaCl2
(Sigma,  St.  Louis,  MO) for
90 minutes.   Samples  were
then washed twice in  0.1M
cacodylate  and  1.5mM
CaCl2 before  a  secondary
fixative  of  1%   osmium
tetraoxide  in  0.1M
cacodylate and 1.5mMCaCl2
for  1  hour.   Next,  samples
were washed twice in 0.1M
cacodylate,  then  replaced
with 50% ethanol,  followed
by  a  block  stain  in  2%
uranyl  acetate  in  50%
ethanol for 1 hour.  Finally
samples were dehydrated in
increasing concentrations of
ethanol  up  to  100%  and
dried in a critical point drier.  
Cell-seeded  fibrin  microthreads  were  then  imaged  with  a  scanning  electron
microscope.  Thread were mounted on aluminum stubs (Ted Pella, Inc., Redding, CA)
coated with double-sided carbon tape and sputtered coated with a thin layer of gold-
palladium for 30 seconds.  Images were acquired at 15kV using a JSM-KLG scanning
electron microscope.
6.2.7 Statistical Analyses
Statistical analyses were performed using SigmaStat 3.1 software (Systat Software,
Inc., San Jose, CA).  All experiments results were statistically evaluated using one-way
analysis of variance (ANOVA) with an overall significance of P < 0.05.  In most cases, a
Holm-Sidak  pairwise  multiple  comparison  tests  were  performed  on  the  results  to
determine  significant  difference between groups.   In  certain  cases  where indicated,  a
Holm-Sidak multiple comparison versus the control group was performed to determine
significant difference between samples and the control.
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Figure  6.2:  FGF-2  Incorporation  Did  Not  Alter  Fibroblast
Attachment.   The  total  number  of  fibroblasts  attached  to  fibrin
bundles  with  varying  concentrations  of  FGF-2  were  not
significantly different from each other or control (0 ng/mL) after 4
hours  of  fibroblast  attachment.  (reference  lines  are  the  mean  ±
standard deviation of all data points)
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6.3 RESULTS
6.3.1 Attachment
Fibroblast attachment to bundles of fibrin microthreads containing various quantities
of FGF-2 was measured by quantifying the total number of adhered cells after 4 hours.
The number of fibroblasts attaching to control threads averaged 1200 cells.  The mean
attachment  value for  FGF-2 loaded microthreads was not  significantly  different  from
controls and did not change with increasing concentrations of FGF-2 (Figure 6.2, pg. 98).
6.3.2 Proliferation
Cell proliferation was quantified on days 2, 5, and 7 for control fibrin microthreads
and threads loading with varying amounts of FGF-2.  Fibroblasts proliferated readily on
both FGF-2 loaded and control fibrin microthreads.  Total cell numbers were 3-4 times
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Figure  6.3: Cell Proliferation with Time and Concentration of FGF-2.  Fibroblasts proliferated on
threads with or without FGF-2 loaded.  FGF-2 increased proliferation over unloaded controls, and
the effect of this increase is more dramatic as time in culture increased.
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greater  by  day  2  than  after  initial  attachment  and  increased  over  the  length  of  the
experiment for all conditions.  Total cell numbers increased with the addition of FGF-2
loaded in the fibrin microthreads; however this phenomenon was most pronounced at
later  time points  (Figure 6.3 and  Figure 6.4,  pg.  99,  100).   Regardless of time point
analyzed,  the  proliferation  versus  FGF-2  concentration  dose-response  curves
demonstrated  a  general  arching  trend;  increasing  FGF-2  concentrations  increased
proliferation with lower levels of FGF-2, but typically plateaued and decreased by the
highest levels of FGF-2 (Figure 6.3, pg.  99).  By day 7, despite low sample sizes, all
FGF-2 loaded threads had statistically greater total cell numbers than unloaded controls
(Figure 6.4, pg. 100).  When normalized to the average number of cells attached for each
experimental condition, the fold increase on FGF-2 loaded threads by day 7 was almost
twice that of unloaded controls (Figure 6.5, pg. 101).
6.3.3 Cell Outgrowth
The  cell  outgrowth  on  the  surface  of  fibrin  microthreads  either  loaded  with
increasing concentrations of FGF-2 or unloaded were measured using the discrete thread
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Figure  6.4: Cell Proliferation Increased with FGF-2 Incorporation.  At day 5,
total cell numbers on FGF-2 were higher than controls, and by day 7, total cell
numbers were significantly greater than controls. (*denotes significant difference
by one-way ANOVA, p > 0.05)
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method  of  characterization
developed  in  Chapter  3  of
this  thesis.   The  cell
outgrowth  rate  for  control
fibrin  microthreads  was
0.34  ± 0.11  mm/day.
However,  the  addition  of
FGF-2  into  fibrin
microthreads  significantly
increased the cell outgrowth
rate  to  nearly  double  the
rate  of  control  threads
(Figure 6.6, pg.  101).  The
concentration  of  FGF-2
loaded  into  the  fibrin
threads did not significantly
change  the  cell  outgrowth
velocity.
6.3.4 Cell and Cytoskeletal
Alignment
Fibroblast alignment on fibrin
microthreads was investigated both
on  discrete  threads  after  culture
during studies of cell outgrowth as
well  as  when  combined  into
aligned  bundles  of  microthreads.
Fibroblasts readily align along the
long  axis  of  fibrin  microthreads
both  on  aligned  bundles  (Figure
6.7B,  pg.  102)  as  well  as  on
individual  fibers  (Figure  6.8,  pg.
103)  and  maintained  their
alignment  during  culture.
Fibroblasts  on  individual
microthreads  fixed  and  imaged
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Figure 6.5: FGF-2 Incorporation Increases Proliferation On Fibrin
Microthreads.   The  fold  increase  in  cell  number  on  fibrin
microthreads was determined by measure the total cell number and
normalizing to value to the average cell number attached for each
FGF-2 concentration.  Proliferation was greater on FGF-2 loaded
threads  by  day  2  of  culture  and  by  day  7  were  all  significantly
greater  than  unloaded  controls.   (*denotes  significant  difference
from control by one-way ANOVA, p > 0.05)
Figure  6.6: Effect of FGF-2 on Cell Outgrowth.  The cell
outgrowth rate on the surface of fibrin microthreads was
measured on threads with increasing quantities of FGF-2
loaded  into  the  thread  substructure.   The  cell  outgrowth
rate was significantly higher upon inclusion of FGF-2, but
was not effected by FGF-2 quantity. (* denotes siginficant
difference from all other conditions by one-way ANOVA, p>
0.05)
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with SEM demonstrated elongation parallel  to  the long axis  of threads in both areas
containing many cells  as  well  as in areas containing few cells  (Figure 6.8,  pg.  103).
When seeded onto bundles of aligned fibrin microthreads, the fibroblasts initially tended
to align and aggregate in the grooves between adjacent threads, forming an extremely
thin and elongated morphology (Figure 6.7, pg. 102).
The  cytoskeletal  organization  of  fibroblasts  on  fibrin  microthreads  was  clearly
distinguishable  from that  under  standard  2-D tissue  culture  conditions.   On standard
tissue culture  treated plastic,  the  visualized cytoskeletal  components  demonstrated no
preferential  direction (Figure  6.7A,  pg.  102),  while  filamentous actin  bundles  stained
with phalloidin were noticeably oriented in parallel aligned bundles down the length the
fibrin threads when cultured on microthreads (Figure 6.7C, pg. 102).  
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Figure 6.7: Cell and Cytoskeletal Alignment on Fibrin Microthreads.  Fibroblasts seeded on bundles
of  fibrin  microthreads  were  stained  for  filamentous  actin  (Phalloidin,  green)  and  nucleic  acid
(Hoechst, blue) after 4 hours of attachment.  (A) Control fibroblasts on tissue culture plastic showed
now preferential alignment or orientation. (B) Fibroblasts on fibrin threads aligned along the long
axis of the fibers (highlighted white dashed line) particularly in the grooves between fibers (inset
shown without drawn thread boundary line).   (C) Fibroblast actin is  oriented in parallel  arrays
along the long axis of fibrin microthread. [scale bars = 5 μm]
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6.4 DISCUSSION
Overall,  fibroblasts  readily  attach,
proliferate,  and  migrate  on  fibrin
microthreads,  therefore  representing
viable scaffolds for ACL regeneration.
Fibroblasts  attached  to  the  surface  of
fibrin  microthreads  after  seeding,
remaining greater than 99% viable for
the duration of culture as indicated by
viability  staining  and  imaging  (Figure
6.9, pg.  104).  Furthermore, fibroblasts
exhibited  substantial  proliferation
during seven days of culture leading to
complete  encapsulation  of  threads
within  a  layer  of  aligned  fibroblasts
(Figure 6.10, pg. 105).  
FGF-2  was  added  to  the
substructure  fibrin  matrix  during
fabrication  signaling  an  increased
cellular response in fibroblasts.  FGF-2
is  not  only  considered  a  potent
mitogenic  and  chemotactic  growth
factor, but has also been implicated as a
matrix  bound  co-factor  in  regulating
wound  healing  gene  expression.
Although  no  effect  was  seen  on
fibroblast  attachment  (Figure  6.2,  pg.  98),  incorporation  of  FGF-2  into  the  fibrin
microthread matrix resulted in significant increases in migration (Figure 6.6, pg. 101) and
proliferation (Figure 6.5, pg. 101).    Particularly by day 7 of culture, addition of FGF-2
into  the  matrix  significantly  increased  proliferation  over  control  threads,  in  a  varied
manner dependent on FGF-2 quantity (Figure 6.4, pg.  100).  While increasing FGF-2
concentration  at  low  levels  increased  proliferation,  total  cell  numbers  eventually
plateaued (Figure 6.3, pg. 99).  At high concentrations of FGF-2, the total cell numbers
were typically lower than at low concentration (Figure 6.3, pg.  99).  Dose dependent
effects are not uncommon with growth factors including FGF-2, although these findings
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Figure  6.8:  Cell  Alignment  on  Individual  Fibrin
Microthreads.   Samples  were  taken  during  the  late
stages of the cell outgrowth assay (Day 7), fixed, and
dehydrated  for  imaging  with  SEM.   Individual  cells
can  be  seen  aligned  along  the  long  axis  of  the
microthread  (blue  highlighting  added  for  emphasis
during analysis, post-acquisition ).
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are typically cell dependent as well.  In tenocytes, FGF-2 stimulated type I and type III
collagen production at low levels, but suppressed it at high values.[11]  In periodontal
ligament cells, FGF-2 downregulated the gene expression of col I and upregulated the
gene expression of  MMP-1.[19]   The results  of our study demonstrate  similar  trends
suggesting that  sub-maximal  concentrations  of  FGF-2 may be  optimal  to  direct  cell-
mediated matrix synthesis.
The cell outgrowth was increased on all thread types loaded with FGF-2; however,
little  variation  was  seen  with  increasing  concentrations  of  FGF-2  within  the  matrix
(Figure 6.6, pg.  101).  This may in effect be a result of the quantity of growth factor
present on the surface of the fibrin microthreads and control of growth factor exposure by
degradation.   As  fibroblasts  reach  a  profibrotic  phenotype  in  the  later  stages  of  the
proliferation assay and as fibrin/FGF-2 stimulates MMP production, more fibrin matrix is
broken down, exposing more FGF-2.  This could account for the increasing response to
FGF-2 apparent during later time points in the proliferation experiment and the relative
non-stimulatory  effect  above  baseline  with  increasing  FGF-2  during  cell  outgrowth
studies.
104
Figure  6.9: Attachment Imaging.  After seeding bundles of fibrin microthreads with
fibroblasts,  the bundles  were imaged with   calcein,  a  stain of  viable  cells  (green).
[Error bars 50 μm]  
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Fibroblasts  align along the long axis of  fibrin microthreads regardless  of  growth
factor presence.  In particular, the fibroblasts preferentially aggregated and attached in the
grooves between adjacent microthreads and subsequently aligning the actin cytoskeletal
components (Figure 6.7 and  Figure 6.8, pg.  102 and  103).  The cytoskeleton has been
shown to play a role in the coordination of ECM deposition in tendon fibroblasts.[20]
This occurs through a mechanism where aligned actin filaments orient collagen fibrils
within the finger-like projects of the cell membrane that eventually deposit the fibril in
the ECM.[20]  Therefore, fibroblast alignment ultimate leads to aligned matrix depostion.
We  hypothesize  that  using  fibrin  microthreads  could  lead  to  decreasing  the
disorganization of normal wound healing matrix by producing more aligned and ordered
wound ECM.    A more aligned collagen matrix would also likely have increased tensile
properties due to the improved biomechanical protein interactions.  Furthermore, aligned
fibroblasts  more  closely  mimic  the  spindle-like  cell  morphology  of  native  ligament
fibroblasts lending a more biomimetic cell shape and therefore cell function.
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Figure  6.10:  Proliferation  Imaging.   By  day  7,  fibroblasts
completely encapsulated fibrin microthreads as visualized, where
viable  cells  stained  green  (arrow  heads)  and  dead  cell  nuclei
stained red (arrows)
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CHAPTER 7: DISCUSSION AND FUTURE WORK:
BIOPOLYMER MICROTHREADS
7.1 OVERVIEW
This thesis describes the development of a cell outgrowth metric, the use of that
metric to analyze cellular responses to material properties, and the creation of a novel
biomaterial designed to improve on the current material limitations elucidated during our
initial  studies.   I  developed a novel  in vitro method of  characterizing fibrous thread
matrices by probing their ability to promote tissue ingrowth from a wound margin as a
measure of their ability to promote repopulate and regeneration.  This method is useful in
the  optimization  of  thread  scaffolds,  and  is  sensitive  enough to  distinguish  between
subtle variations in biopolymer chemistry and organization.  Furthermore, I used this
method to characterize the effects of crosslinking on the cell outgrowth and correlated
the findings with the mechanical properties of collagen threads.  The results suggest that
crosslinking  is  required  to  achieve  sufficient  mechanical  properties  for  high  stress
applications such as ACL replacement,  but  regardless of technique, crosslinking will
attenuate the tissue ingrowth properties of the threads.   To improve the regenerative
capacity of these scaffolds, I developed novel fibrin microthread matrices with a similar
morphology to collagen threads and sufficient mechanical strength to be incorporated in
composite thread scaffold systems.  These fibrin microthreads can be loaded with FGF-
2,  a  potent  mitogen  and  chemotactic  agent  that  works  synergistically  with  fibrin  in
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regulating cell signaling and gene expression.  I successfully demonstrated increases in
fibroblast  migration  and  proliferation  in  FGF-2-loaded  fibrin  threads  with  the
concomitant promotion of oriented, aligned, spindle-like fibroblast morphology.  These
results suggest that fibrin-FGF-2 microthreads have distinct advantages as a biomaterial
for the rapid regeneration of injured tissues with an increased wound healing response.
7.2 BIOPOLYMER THREADS FOR ACL REGENERATION
Overall, collagen and fibrin biopolymer microthreads are promising materials for the
regeneration of torn anterior cruciate ligaments (ACL).  Being assembled from the native
structural  proteins  of  ligaments  and  provision  matrix  respectively,  both  materials  are
biomimetic on multiple levels.  Each retain a biochemistry that mimics the extracellular
matrix, while being assembled into microthreads and bundles that structurally replicate
aligned soft connective tissue such as tendons and ligaments.  These ECM cues are what
distinguish biopolymer threads from synthetic polymers and what make them attractive
for applications in tissue regeneration. 
Thread-based  matrices  are  not  new  to  bioengineered  ACL  research.   Synthetic
polymer thread matrices were manufactured extensively for ACL replacements, but were
limited by extremely high failure rates caused by poor integration, stress shielding, and
fatigue  failure[1].   Researchers  are  investigating  more  traditional  braided  or  woven
degradable materials such as poly L-lactic acid (PLLA)[2, 3]; however, it is unclear how
these  polymers  will  support  tissue  ingrowth  or  regeneration,  particularly  given  the
increase  in  concentration of  acidic  byproducts  at  the  wound site  during  degradation.
Biologically  inspired  fibers  of  silk[4,  5] from  spider  cocoons  or  chitosan/alginate
fibers[6,  7] made  from sea  shells  and  seaweed  both  offer  degradable  alternatives  to
synthetic  polymers.   However,  these  materials  are  still  foreign bodies  and ultimately
cannot  be  expected  to  elicit  matrix  signaling  or  cellular  responses  that  direct  tissue
regeneration.  
Both  collagen  and  fibrin  biopolymer  microthreads  are  composed  of  the  natural
structural proteins of healthy and healing ligament tissue.  These materials remodel and
degrade under normal wound healing pathways, maintain robust mechanical properties,
and can regulate gene expression through integrin signaling in a biologically predictable
manner.   Specifically,  collagen  thread  matrices  have  been  widely  investigated  as  a
degradable scaffold for many years and demonstrated moderate success in vivo (Chapter
2.2.2.1).   Yet  to  attain  strength  and  degradation  rates  required  for  load  bearing
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applications  such  as  ligament  regeneration,  these  threads  must  be  physically  or
chemically crosslinked.  Numerous methods have been investigated (Chapter 2.2.2.1 -
Collagen Crosslinking)  and the results  of  this  thesis  quantitatively confirm that  most
commonly  employed  crosslinking  techniques  reduce  cell  outgrowth  on  the  threads.
While collagen is an advantageous biomaterial for many of the previously stated reasons,
overcoming this limitation will require a novel strategy for promoting tissue ingrowth.  
Incorporating fibrin biopolymer microthreads into a composite matrix with collagen
threads would be a simple,  yet elegant solution to improving the tissue ingrowth and
remodeling characteristics of these acellular ligament scaffolds.  Fibrin has been shown
to  differentially  alter  cell  function  through  integrin  mediated  interactions  [8-11].   In
contrast, collagen attenuates collagen production as part of the dynamic reciprocity of
matrix signaling, a mechanism not seen on fibrin, which promotes migration as well as
matrix synthesis [8].  By combining collagen and fibrin thread matrices, an acellular graft
can be assembled that uses fibrin to promote migration and matrix synthesis during early
regeneration and crosslinked self-assembled collagen for strength and long term stability.
7.3 METHOD OF CHARACTERIZATION
This  thesis  describes  a  novel  in  vitro model  system for  quantitatively measuring
tissue ingrowth onto discrete biopolymer thread matrices that closely mimics ACL tissue
regeneration. In this system, we maintain a structurally and biochemically relevant 3-D
contextual environment, but in a system that closely mimics the mechanisms of cellular
repopulation  that  occurs  during  ACL  replacement  surgery  with  acellular  matrices.
Results  of  studies  using  this  bioassay  determined  that threads  composed  of  collagen
showed  a  significantly  greater  outgrowth  velocity  than  synthetic  threads.   Although
crosslinking decreased this velocity, these lowest values were still almost twice that of
synthetic threads.  
While  designed  originally  for  the  investigation  of  collagen  threads,  this  model
system has wide ranging applications for the in vitro investigation of tendon and ligament
regeneration  as  well  as  in  the  development  of  engineered  fiber-based  biomaterials.
Simple  modifications  to  the  methods  described  would  allow  for  the  quantitative
evaluation of tissue regeneration capacity for any particular cell lineage.  For example,
researchers have suggested that fibroblasts isolated from the MCL and ACL of the knee
have  slightly  different  phenotypes.[12-16]  Their  inherent  capacity  for  for  tissue
regeneration  can  be  measured  in  the  selection  of  an  appropriate  cell  line  for  tissue
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engineering of ACL.  Furthermore, the bioassay can systematically probe modifications
to surface biochemistry or topography.  Specifically in this thesis, the bioassay was used
to evaluate the  addition of FGF-2 to fibrin microthreads and confirmed not  only the
presence  of  FGF-2  in  the  matrices  but  the  maintenance  of  biological  activity.   This
concept could be extended to investigate the effects of other signaling cues that regulate
migration and proliferation, such as IGF-1,[17] on cell outgrowth.
Although current testing included only measurement of the cell outgrowth metric,
numerous other measurements could be generated from this system.  The total number of
cells on threads could be quantified to improve the validity of the cell outgrowth metric.
Once the cells have reached confluence on the threads and begin the remodeling phase,
these  cell-seeded  threads  could  be  excised  and  assayed  for  synthesis  of  collagens,
tenascins, MMPs, or other important matrix molecules.  Furthermore, at a range of time
points during both the ingrowth and the remodeling phases, the mRNA could be extracted
and quantified with reverse transcriptase polymerase chain reaction (rtPCR) to investigate
any number of regenerative markers or signals.  Utilizing these additional measurements
would  further  improve  understanding  of  the  model  system  while  opening  future
possibilities  for  asking  different  questions  about  cell  matrix  interactions  in  a  3-D
biologically relevant context.
While generally successful, the method for quantifying tissue ingrowth is not without
limitation.  Current methods for quantifying population density were suboptimal due to
poor  image  contrast,  cell  delineation  detail,  and  limited  imaging  field  of  view.
Improvements were clearly seen when daily Fura-2 staining protocols were replaced by
the use of a GFP-expressing fibroblast cell line; however, using fibroblasts modified to
express GFP sequestered to the nucleus only, rather than the cytoplasm, could allow for
simple quantification of cell number using image analysis software.  Measuring percent
confluence or population density would aid in modeling the cell outgrowth on threads
and allow for a more accurate representation of collected data.  Furthermore, the entire
system  could  be  improved  by  tracking  cells  in  real  time  to  reduce  the  day  to  day
variations and experimental error.  Additionally, the current system works well as metric
for determining differences in vitro, but the direct correlation between in vitro results and
in vivo response has yet to be systematically investigated.
Overall, the in vitro bioassay of tissue ingrowth is a useful tool for the investigation
fiber biomaterials and the regeneration of soft connective tissues including tendon and
ligament.  In the future, this  in vitro bioassay will enable us to identify parameters to
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optimize  the  rate  of  cell  outgrowth for  the  development  of  constructs  for  soft  tissue
regeneration, as well as to determine fine variations in the cell-matrix interactions as a
function of matrix materials and surface biochemistries.
7.4 FIBRIN BIOPOLYMER MICROTHREADS
Fibrin microthreads represent a novel biopolymer material composed of the natural
structural  protein of healing tissues but in the conformation of a mechanically robust
thread matrix that can be assembled into aligned bundles for tissue regeneration.  Under
normal culture conditions, fibroblasts attached, remained viable, and exhibited substantial
proliferation during seven days of culture leading to complete encapsulation of fibrin
threads within a layer of aligned fibroblasts.  Fibroblasts align along the long axis of
fibrin microthreads individually and in bundles, preferentially aggregating in the grooves
between adjacent microthreads.  This alignment mimics the cell morphology of ligament
fibroblasts  and  has  implications  for  the  control  of  cell  function.   Cell  alignment
subsequently orients actin cytoskeletal components that have been shown to play a role in
the coordination of ECM deposition in tendon fibroblasts.[18]  We hypothesize that using
fibrin microthreads could lead to increasing the organization of normal wound healing
matrix by producing more aligned and ordered wound ECM.    
FGF-2 was added in the substructure of fibrin thread matrix during manufacture to
signal an increased wound healing response in fibroblasts.  FGF-2 is not only considered
a potent mitogenic and chemotactic growth factor, but has also been implicated as a fibrin
matrix bound co-factor in regulating wound healing gene expression.  While FGF-2 did
not  increase  attachment,  FGF-2  loaded  fibrin  microthreads  promoted  increased  cell
outgrowth and proliferation.  While clearly responding to the addition of FGF-2, it is
equivocal  whether  this  response  is  the  simple  result  of  FGF-2  signaling  or  a  more
complex co-regulatory response to fibrin and FGF-2.  Regardless, fibrin microthreads are
a  promising biomaterial  for  tissue regeneration particularly  for  their  matrix  signaling
capabilities particularly when combined with matrix bound growth factors such as FGF-
2.
Fibrin microthreads are mechanically robust thread material, but alone do not attain
sufficient  tensile  properties  for  high  load  bearing  situations  such  as  ligament  tissue
regeneration.  In vivo, fibrin networks are naturally crosslinked by factor XIIIa, a member
of  the transgultaminase family  of  enzymes.   Transgultaminases  have been previously
been isolated and investigated in fibrin and collagen materials, demonstrating increased
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strength  and  stiffness  in  both[19-23].   My  initial  investigations  demonstrated  no
differences in strength with the addition of transglutaminase (data not shown), but these
findings were incomplete and require a more thorough investigation of techniques and
methods to be conclusive.  Other crosslinking methods such as exposure to ultraviolet
light and EDC crosslinking chemistry that were investigated for collagen threads may be
equally successful in altering the magnitude of fibrin strength and stiffness, but these
techniques would likely result in similar impedance of cell matrix interactions[24].
Other benefits of these novel fibrin microthread scaffolds is that they can be made
from autologous materials  and ultimately  be  designed to  reverse-engineer  the  wound
healing milieu.  Fibrinogen can be readily isolated from a patient's own blood for the
development  of  autologous  graft  materials,  thereby  making  immunological  rejection
negligible.   Fibrinogen  can  be  further  purified  during  isolation,  but  this  may  not  be
necessary.   Using  starting  materials  containing  fibrinogen  as  well  as  plasma-derived
cytokines and growth factors could lead to a autologous fibrin microthread that maintains
both fibrin and growth factor signaling capabilities in a mechanically strong morphology.
Regardless,  fibrin  microthreads  can  be  readily  assembled  with  growth  factors  and
cytokines in a controlled manner that will ultimately allow for the reverse-engineering of
granulation tissue matrix in aligned and oriented mechanically stable grafts.
7.5 FUTURE WORK
Future research involving collagen and fibrin microthreads should focus on three
vital areas including biomaterial development, cell-matrix interactions, and application
diversification.   Biomaterial  investigations  should  include  further  characterization  of
degradation,  development  of  composite  fibrin/collagen  thread  scaffolds,  and  in  vivo
implantation studies.  Studies of cell-matrix interactions could delve into the comparative
integrin signaling mechanisms between collagen and fibrin microthreads.  The final area
of future study would include investigation of microthread matrices, particularly fibrin,
for applications in the regeneration of tissues other than ligament.
7.5.1 Biomaterial Development
Results of this thesis suggest that collagen and fibrin microthreads are promising
materials  for  the  regeneration  of  torn  ACL tissue,  meriting  future  consideration  and
investigation.   As  previously  discussed,  some  combination  of  crosslinked  collagen
threads  and  growth  factor  loaded  fibrin  threads  may  make  for  the  ideal  composite
scaffold for ACL regeneration.  Future investigations should focus on combinatoric ratios
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of collagen and fibrin threads to optimize both strength and cell outgrowth.  Furthermore,
biomaterial composite modeling techniques may be useful in the prediction of functional
outcomes such as tensile strength of composite collagen/fibrin microthread matrices.  A
significantly useful next step would include implantation studies designed to investigate
the short and medium term outcomes of fibrin, fibrin/FGF, and composite fibrin/collagen
microthreads for scaffold remodeling and new tissue synthesis.
While collagen thread matrices have been widely investigated (Chapter 2..2.2.1), the
novel fibrin microthread matrices developed in this thesis require further characterization.
Fibrin  thread  matrices  remain  largely  intact  during  seven  days  of  standard  culture
conditions during testing, but their in vitro and in vivo degradation characteristics remain
largely undetermined.  To be a truly viable candidate for tissue regeneration applications,
fibrin microthreads must maintain structural stability and degrade at a rate matching new
tissue  synthesis.   Studies  investigating  the  degradation  characteristics  should  look  to
determine these rates as well as controlling them through crosslinking with factor XIIIa
[22, 23], transglutaminases [22], or carbodiimides.
Further fibrin microthread material modifications could include alterations to thread
size or incorporation of additional growth factors and function peptides.  The diameter of
fibrin threads investigated herein is dependent on both the diameter of the extrusion head
as well as the magnitude of pre-stretching that occurs during removal from the aqueous
buffer and subsequent drying under the weight of gravity.   The microthread diameter
could  theoretically  be  reduced  by  mechanical  stretching  while  hydrated.   While  the
current radius of curvature supports fibroblast alignment and orientation, fibrin threads
with smaller diameters may allow for more spatial regulation of cytoskeletal components,
focal  adhesions,  and ultimately cell  function.   Beyond simple  mechanical  alterations,
fibrin had been molecularly modified to incorporate bifunctional bioactive peptides, such
as  RDG  sequences.[25]  Furthermore,  fibrin  materials  have  been  modified  for  the
controlled release of growth factors including BMP-2 [26, 27], β−NGF [28], VEGF [29],
and other heparin binding growth factors[30, 31].  In brief, a host of fibrin modifications
are  available  for  future  investigations  to  further  control  cell  function  for  tissue
regeneration applications.
7.5.2 Cell-Matrix Interactions
Future  work  is  necessary  to  acquire  a  more  thorough  understanding  of  the
mechanisms involved in regulating cell-matrix interactions on collagen and fibrin thread
matrices.  The ECM is more than a simple structural material.  It acts as a regulator of
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cell function through integrin-meditated mechanisms and the localization of cytokines
and growth factors.[32]   On collagen and fibrin,  cells  demonstrate  matrix  dependent
expression of integrins  [9,  11] and  response to growth factors[8,  11].   A more direct
comparison between collagen and fibrin threads could elucidate the existence of a similar
response, confirming previous findings and translating them to more mechanically stable
regeneration  template.   Furthermore,  these  results  may  assist  in  explaining  the
insufficient tissue ingrowth and regeneration experienced with collagen thread matrices
during  in vivo implantation studies[33].  Investigating signaling pathways on collagen
and fibrin threads, when compared with collagen and fibrin hydrogels, could improve the
understanding  of  how cell  morphology  and  alignment  alter  signaling  in  biologically
relevant 3-D matrices.    Tests directly comparing collagen and fibrin signaling could lay
the groundwork for the control of wound regeneration through the temporal direction of
cell  function  by  the  collagen  and  fibrin  ECM  and  spatial  direction  of  regeneration
dictated by the alignment and orientation of thread matrices.  
7.5.3 Alternative Applications
Although initially developed to manufacture robust composite thread matrices with
collagen for ligament  regeneration, fibrin microthreads have applications well  beyond
that singular tissue.  In cross-hatch or weave patterns, fibrin thread fabrics could be used
as patches for dermal regeneration or plastic surgery.  The morphology of scar tissue is
different from normal  skin due to more parallel  oriented collagen fiber bundles  [34].
Using a cross-hatch pattern could ideally prevent the uni-axial fibroblast alignment that
leads to parallel oriented collagen bundle formation prevalent during dermal scar tissue
formation.
Fibrin  biomaterials  have  also  shown  promise  as  supporting  scaffolds  for  nerve
regeneration.[35]  Autologous fibrin glue has been shown to increase axonal regeneration
in a rabbit  peroneal  nerve defect.[36]   The authors  of  this  research suggest  that  this
response may be the combined result of the fibrinogen network as well as growth factors
present in or trapped by the glue.[36]  Heparin binding peptides have been incorporated
into fibrin gels  to enhance neurite extension for nerve tissue engineering.[30]  These
designer  matrices can be used to control  the release of  growth factors  such as  nerve
growth  factor[28],  neurotrophin-3[37], and  other  heparin  binding  growth  factors[31].
Furthermore,  neurite  alignment  can  be  controlled  with  oriented  fibrin  fibril
alignment[38].   These  results suggest  that  fibrin  biopolymer  threads  could  similarly
control  neurite extension, especially given the morphological homology to bundles of
nerve ganglia.  Future fibrin microthreads research could investigate incorporating neural
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growth factors and controlling neurite extension for the repair of peripheral and spinal
nerve injuries.  
While  fibrin  hydrogel  matrices  have  been  suggested  for  cardiovascular  tissue
engineering applications[39,  40],  the  authors  themselves  have  suggested that  the  low
stiffness and stability of fibrin hyrdogels are a significant limitation of their use.  Fibrin
microthreads alone or in combination with additional cell seeded fibrin hydrogels could
alleviate  the  initial  stability  issues,  while  simultaneously  promoting  aligned  collagen
deposition  and  matrix  regeneration.   Furthermore,  Jockenhoevel  et  al.  suggest  that
scaffold contraction in fibrin hydrogel matrices makes the formation of tissue engineered
hydrogel  constructs  difficult,  while  preventing  this  contraction  by  border  fixation
promotes collagen production  [39].  This phenomenon is similar to the effects seen in
fixed and floating collagen gels,  where fibroblasts  in unconstrained collagen gels  are
quiescent and apoptotic, while fibroblasts in constrained gels are activated, proliferative,
and collagen producing.[41]  Fibroblasts did not significantly contract fibrin microthread
matrices during initial one weeks seeding experiments and could therefore reduce gel
contraction issues by allowing a semi-rigid structure for attachment and proliferation of
myofibroblasts  for  cardiac  applications.   In  an  interesting  twist  on  cardiovascular
applications,  fibrin  microthreads  wrapped  sequentially  around  a   mandrel  could  be
cultured  in  layers  with  cells  in  the  development  of  bioengineered  blood  vessels,
expanding on the use of fibrin gels for tissue engineered small diameter blood vessels[42,
43].   Due to their  robust  mechanical  properties,  fibrin threads can be manipulated to
develop structurally stable 3-D environments for the control of oriented aligned tissue
engineering  scaffolds  in  a  natural  biochemical  environment  that  simulates  the  native
wound provisional matrix.  
7.6 CONCLUSIONS
The  primary  goal  of  this  thesis  was  to  develop  and  investigate  biopolymer
microthread technologies for repair of injured anterior cruciate ligaments.  An  in vitro
method of characterizing tissue ingrowth on collagen thread scaffolds was designed and
successfully used to probe cell function on polymer and biopolymer thread matrices.  The
results of these studies demonstrated an increased ingrowth on biopolymer threads over
synthetic polymers, but an attenuation in fibroblast ingrowth when collagen biopolymer
threads  were  crosslinked.   Since  crosslinking  of  self-assembled  collagen  threads  is
necessary in vivo to increase strength and decrease the otherwise rapid degradation rate,
an alternative biopolymer thread technology based on fibrin was developed.  These fibrin
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biopolymer microthreads have drastically increased mechanical strength properties over
fibrin hydrogels, possess the ability of fiber matrices to organize and align cells, and can
readily  incorporate  matrix  bound  growth  factors  for  increased  migration  and
proliferation.   The  ultimate  goal  of  these  novel  fibrin  biopolymer  microthreads  is  to
improve  the  wound  healing  cell-signaling  capability  of  acellular  thread  matrices  to
increase tissue ingrowth, scaffold remodeling, and tissue synthesis.  
A  secondary,  but  equally  important,  conclusion  of  this  thesis  is  the  underlying
importance that surface-protein interactions play in dictating outcome of cell-fate process
and  cell  function  on  thread  matrices.   This  reoccurring  theme  was  part  of  both  the
rationale  and  outcomes  of  this  biomaterials  research,  from  justifying  the  use  of
biopolymer  matrices  to  helping  explain  the  variations  in  cell  outgrowth  seen  with
crosslinking.   Collagen was initially chosen for  threads because of  the structural  and
biochemical  homology  of  the  protein  to  native  tissues.   Cells  adhere  and  respond
differently to the naturally derived protein than to foreign materials like plastics.  We
hypothesize that crosslinking alters the ability of serum proteins to adsorb to the surface
of collagen threads, and subsequently reduces the ability of cells to attach and migrate on
the surface.  Fibrin was selected as a protein for thread assembly because of its favorable
protein  interactions,  including  its  ability  to  act  as  a  sponge  for  growth  factors  and
cytokines as well as it's differential, integrin-mediated signaling capabilities.  The high
binding affinity and the possible role in matrix co-localization made FGF-2 and fibrin a
prosperous combination. The results of the studies in this thesis strongly suggest that cell-
protein-biomaterial  interactions  play  a  crucial  part  in  the  future  of  bioengineered
materials for ligament regeneration and should not be overlooked.
In conclusion, collagen and fibrin biopolymer microthreads are promising acellular
materials for the regeneration of torn anterior cruciate ligaments.  Future in vitro and in
vivo studies should continue to investigate the material properties of composite fibrin and
crosslinked  collagen  scaffolds,  while  further  characterizing  the  degradation  of  fibrin
thread  scaffolds  as  well  as  the  differential  integrin-mediated  signaling capabilities  of
collagen and fibrin microthreads that direct cell-based ligament regeneration.
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Introduction
To improve the consistency and repeatability, an automated 2-axis thread extrusion
device was constructed for the assembly of biopolymer thread matrices.  Design of this
device was undertaken and advised in conjunction with the 4 undergraduate students as
part of the fulfillment of their Major Qualify Project, entitled “Designing an Extrusion
System  to  Optimize  the  Production  of  Self-Assembled  Collagen  Microthreads”,  by
William Bishop, Diana Camire,  Ngoc Chau Duong, Jason Robinson.[1]  This  project
received  the  2005  Provost's  MQP  Award  in  the  WPI  Department  of  Biomedical
Engineering.
Threads extruded from solutions of type I collagen have been widely investigated as
biomaterials  for  the  regeneration  of  soft  connective  tissue,  particularly  tendons  and
ligaments (Chapter 2.1.1.1).  The extrusion process as described requires the pumping of
collagen solutions through small diameter tubing and into a fiber formation buffer, using
methods modified largely from Pins et al.[2][3][4]  As the pumped solution flows out of
the tubing, the tubing end is carefully manually drawn slowly through the bath at a rate
approximately matching the flow rate of solution exiting the tubing.  This hand-drawn
procedure  was  not  only  laborious,  but  generally  inconsistent  with  poor  repeatability.
Hence, the goal of the project was to develop an thread extrusion device with automated
features to more accurately control the positional coordination of the tubing exit orifice,
thereby increasing thread consistency while reducing batch-to-batch variation.
Device
The final device design consisted of two motor/controller integrated stepper motors,
each controlling 1-axis of motion.  The stepper motors (LIN Engineering, Santa Clara,
CA) had integrated motor controller and driver allowing for full programming through
serial port attachments to a computer with the addition of RS485-R232 converters.  These
motors turn pulley/belts systems that translocate suspended carriages in a vehicle system
(Figure A1).  The suspended carriage contains a tubing attachment rod for local guidance
of the tubing at the extrusion tip and off-axis tilt of the carriage is limited by the use of
two stabilizing stainless steel track-rods in each axis. The vehicle system is inverted and
placed on stainless steel legs, elevated above the temperature controlled extrusion bath.
Tubing, extending from the end of a syringe in a syringe pump is threaded through the
top of the vehicle system, attached to the tubing attachment rod, and guided through the
bath  solution.   Motion  of  the  motors  was  controlled  using  a  Labview  (National
Instruments, Austin, TX) program described below.
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Testing and Results
Diameter  and  tensile  tests  were  performed  to  analyze  and  compare  the  fibers
produced automatically with the manually extruded fibers.  The results showed that the
fibers produce with the automated extrusion device exhibit more uniform structural and
mechanical  properties  than  those  produced  manually.   The  average  value  for  the
unhydrated fiber diameter was 70 µm with a standard deviation of only 0.5 µm.  Fibers
produced using the manual extrusion method were 53 ± 7.6 um.  Fibers extruded using
the  automated  device  clearly  demonstrate  smaller  variation  compared  to  those  fibers
extruded via the currently system (Figure A2).  The tensile strength for the automated and
a2
Figure A1:  Image of inverted carriage vehicle system (A) and CAD drawing of the
same in operational orientation (B).  Image of full setup automated extrusion device
including carriage vehicle system elevated on stainless steel supports and a
temperature controlled water bath (C).  (Device has a 3' by 2' footprint)
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manually extruded fibers were 0.7 ± 0.05 and 1.5 ±0.2 MPa respectively.  Hydrated fiber
diameters were 350 ± 6.8 and 140 ±19 microns, and strain at failure were 0.80 ± 8 and
0.42 ± .12 for automated extrusion and manually extruded threads respectively.  Further
results can be seen in table A1 below.
a3
Figure A2:  Increased consistency with automated extrusion.  Diameter measurements in microns along
the length of threads either manually drawn (left) or autoextruded (right).  Variation both along the length
of threads as well as between threads is minimal with autoextrusion.
Table A1.  Side-by-side comparison of automated and manual
extrusion
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Figure A3.  Graphical user interface of the 2-axis automated thread
extrusion device displayed rotated  90 degrees.
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Labview Interface
Labview was  used  control  the  motors  for  the  2-axis  automated  thread  extrusion
device (Figure A4, A5).  The program was designed in two parts.  The first allows the
user to manually manipulate the extrusion tip through the bath in the x-direction and y-
direction using the large buttons on the raised upper left panel (Figure A3).  The portions
not  on the raised panel  let  the  user  set  the specification for  the  automated  extrusion
process (Figure A3).  These settings include bath parameters, that dictate the size of the
extrusion path and distance between threads, as well as the syringe pump parameters.
The syringe pump parameters should ideally match those input on the syringe pump, and
are used in the calculation of volumetric flow rates to extrude at a rate twice the speed of
the extrusion head through the bath.  These settings are preset based on optimized results
of fibrin thread extrusion discussed in Chapter 5.  Once the user clicks the large green,
'Run' icon, the program will actuate the motors to translocate the extrusion tip in straight
line patterns, the full length of the bath input parameters, with line spacing as specified in
the input parameters.  As the program runs, the current flow rate at the tip is displayed
while the number of threads produced is sequentially incremented and displayed.
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Figure A4.  Block diagram of the Labview code for the automated
extrusion device (sequential 0) displayed rotated 90 degrees.
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Figure A5.  Block diagram of the Labview code for the automated extrusion device (sequential 1)
displayed rotated 90 degrees (hidden from view behind sequential 1 in figure A4)
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Ultimately,  the  automated 2-axis  thread extrusion device developed increases the
consistency and drastically reduces the batch-to-batch variation in production of collagen
threads.   Furthermore,  this  device  was  successfully  adapted  to  control  the  extrusion
process of fibrin biopolymer microthreads discussed in Chapters 5 and 6.  
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Introduction
In  order  to  analyze  the  mechanical  properties  of  collagen  and fibrin  biopolymer
microthreads, a micromechanical testing device was manufactured in house for a small
fraction of the estimated $75,000 cost of a professional mechanical  testing apparatus.
The device is designed for controlled uni-axial tensile testing of small diameter, limited
strength polymers.  
Device 
The micromechanical tester consists of a loading frame, force transducer, and linear
actuator (Figure B1).  The linear actuator is a syringe pump (KDScientific, Holliston,
MA), which acts as simple bar on a threaded rod to pull the sample at a controlled speed.
The loading frame includes two, custom-machined, stainless-steel platforms which are
secured  separately  to  the  crosshead  and  the  force  transducer.   The  force  transducer
(kindly lent by Peter Grigg, Ph.D. at the University of Massachusetts Medical School)
b1
Figure B1.  Schematic of the micromechanical tester.  Samples are adhered to vellum frames which
define the initial gauge length (upper left inset).  Samples are then clamped in place, the edges of the
frame cut leaving only the thread, and pulled to failure at a constant strain rate.  A Labview program
on a computer controls the linear actuation and the resulting voltages from the load cell are transmitted
to the computer. Although images are schematic and  not to scale, the gauge length is 2cm.
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reports a voltage linearly with force in the 0-150 gram loading range and is securely
attached to a fixed portion of the syringe pump.  Both the linear actuator (syringe pump)
and the force transducer (via an oscilloscope, Tektronix, Model TDS2000, Beaverton,
OR) are controlled with Labview software (NI, Austin, TX).   
Testing Procedure
Individual thread samples are adhered to vellum frames, precut with windows to the
defined gauge length (Figure B1 inset).  Samples are then hydrated for 30 minutes in
phosphate buffered saline.  After reaching swelling equilibrium, the diameters of each
thread are measured in three locations along the length of the thread using a calibrated
reticle in the eyepiece of a microscope.  These diameters are later used for the calculation
of initial cross-sectional area, need for the determination of tensile strength.  Once the
diameter measurements are complete, vellum test frames are then clamped into the tester
on horizontal platforms, and the edges of the test frame are cut to leaving only the thread
remaining between the actuator and the load cell (Figure B1 inset).  Finally, using the
associated Labview program, the sample is pulled to failure at a constant (50%) strain
rate.
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Labview Interface
The graphical user interface (GUI) for this program is shown below (Figure B2).
The program is started and stopped with the ON/OFF button in the upper left corner (lit
green when running).  There is only one main input for the program allowing the user to
set the strain rate in mm/min.  Other settings including channel and port selection are
available to match hardware settings on the oscilloscope and computer.  The test/reset
toggle switch changes between testing mode and return to origin mode.  In test mode,
pressing the green go button runs a test at the desired strain rate until the sample breaks.
Clicking stop then brings up a prompt to save the data to the computer hard drive.  In
reset mode, pressing go will return the actuator to its original position to begin an new
test.  During test mode, the interface displays the current load in grams.
b3
Figure B2. Labview graphical user interface of the micromechanical testing apparatus.
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Figure B3.  Block diagram of the Labview code for the
micromechanical tester displayed rotated 90 degrees.
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Figure B4.  List of labview sub VIs called in the micromechanical testing software including custom
VIs, Labview VIs, and device manufacturers VIs (top).  Heirarchy of the sub VIs necessary for
program function including custom (blue) and manufacturers (red) Vis (bottom).
